Been Looking For Alternatives


The world of medicine has evolved with the changing needs and demands of the patient, the third-party payer, and a growing appreciation of the intimate relationship shared between the healthcare provider and patient. The evolution of medicine is not limited to these facets alone. An active reflection of the origins and heritage of medicine leads to a redefinition of medical care. Whether all forms of medicine must be compared to “Western-allopathic” medicine is now being overtly challenged by many patients and some conventional healthcare providers.
Many forms of medicine claim the Hippocratic model as their founding paradigm. However, the question could be raised as to whether Hippocrates would be accepted in the second millennium A.D. by his modern peers. Indeed, would his empirical approach to medicine stand up fully to the current medical model of scientific burden of proof?
Statistics show us that over 70 percent of the world’s population uses something other than the Western-allopathic form of medicine as a primary source of medical care. This is not to dismiss the need for modern medicine, but rather to serve as a pivot for reflection of other forms of medicine that have sustained generations prior to our current era. In fact, some 25–33 percent of frequently used conventional prescription medicines originate from natural substances.
It is this new appreciation and objective perspective that has fostered the popularity of what is commonly called Complementary and Alternative Medicine or CAM. It is worthwhile to note that in order to have a complementary and alternative form of care, a single model must proclaim itself the primary form of care.
The goal of this series is to offer valuable insights into medical therapies currently categorized in the realm of CAM by Western-allopathic medicine. As more and more clinical trials are performed leading to scientific validation, current CAM therapies become embraced as mainstream treatment options. The intent of this series is to review healthcare therapies. The criteria for review are that the particular therapy has a foundation of clinical success, partial or full research validation, and/or rich historical use. The reviews of different therapies will provide critical insight into additional adjunctive therapies that might be incorporated in patient care. They will also provide a heighten appreciation of CAM as well as enhance the ability to converse about CAM therapies in an ever-evolving medical model.
Reflection on the present humbles all disciplines; for as we judge our predecessors, so shall we be judged by future generations for both current brilliance and shortcomings. Medicine is a part of an evolving reality. It is up to each provider to enrich history in the making.

Introduction

The adage “The mind is a terrible thing to waste” truly lacks a depth of understanding and critical perspective essential to support foundational healing. When addressing brain-centered health promotion, patient and clinician alike must astutely appreciate that the “mind” is inseparable from the “body”; the brain, without question, is a physical structure that in its absence would eliminate any discussion of the concept of mind, psyche, or mental function. As an organ that influences the function of the entire being, the brain is central to both mental and physical health.
A simplistic illustration that compares the heart’s function to that of the brain can be made to exemplify an appreciation of the brain and its function relative to mental and physical well-being. The heart beats over 100,000 times a day; it does so prior to our birth to the moment we die without exception, so we hope. This constant and reliable performance, giving blood throughout the body, serves as the cornerstone of the circulatory system and the flow of life. If the heart, which requires a constant source of energy, were to become inadequately fueled without the proper nourishment, it would begin to fail to maintain the very circulatory system that sustains our existence. Classically described conditions such as vitamin B-1 deficiency (known as wet beriberi) as well as recently discovered nutrient (Coenzyme Q10 and carnitine) deficiencies all contribute to the health of the cardiovascular system.
Such is the dilemma faced by the brain. Regardless of the brain’s resilience, there is a time and a place in which inadequate intake can begin to yield the signs and symptoms of psychological or organic brain-altered function. Notable is that proper brain functioning is largely individual and can be affected by internal and external variables that may alter the needs of a given person’s brain to function within normal expectations. Numerous nutrients must be present in
sufficient levels, including B-1 as with the heart, to maintain brain function, yet variables and individual genetic signatures can change the required needs.
Whether it is heart or brain function as the center of discussion, both function as a result of a complex series of biochemical reactions, yielding nerve impulses and chemical reactions that maintain function. Notable in both circumstances is that the difference between the adequate and optimal functions of each can make the difference between surviving and thriving. The presentation of the clinical and germane medical research relative to supporting brain function targets the augmentation of function, with the goal of shifting away from surviving and becoming closer to thriving within the confines of human understanding of the miraculous creation of the central processor, the brain, which governs the human body’s entire operating system.
Indeed the concepts of mind, mental and psychological attributes are all dependent upon a very real and physical component of the body, that being the human brain. Often, the terms “mental” or “psychological” are attributed to the mind portion of the mind-body connection.
Throughout this work, it is our hope that the reader does not look at the mind as separate from the body. Realize that the physical presence of a properly functioning brain is the requisite for mental health, accepted psychological presentation, and healthy functioning of the central nervous system. We have thus intentionally included such conditions as Parkinson’s and multiple sclerosis in the list of health conditions addressed. Though Parkinson’s and multiple sclerosis reflect a well-delineated spectrum of organic brain-altered function, they are in many ways no more organic than the patient with depression.
This book offers a select view of natural medicine interventions, focusing on nutritional and botanical treatments, referred to within the confines of these covers as “Nutra-botanical” therapies, evidenced by clinical practice and research findings. The individual sections of this work are intended as springboards for further investigation by the reader. Often, the human dilemma arises from accepting limits when perceptions of confining factors seem to have been reached even though a new perspective may be just a glimpse away over the walls of our personal reality’s boundaries.
It is not the intent of this book to advocate for the replacement of standard drug therapy.
However, individuals suffering from a health condition affecting brain performance should not limit their options to drug therapy when other biochemical interventions could perpetuate heightened function and the ever-important quality-of-life issue. A concerted effort for the integration of natural medicine approaches alongside standard drug therapy should be pursued in every patient-doctor relationship. The sharing of all therapeutic interventions being pursued with all clinical providers is of paramount importance in order to avoid unnecessary potential drug–natural medicine interactions. Tell your medical doctor if you are on any medication and use—or plan to use—natural treatments.
By supporting health through the use of optimal nutrition, people are placed in a decision-making role regarding their health. Previously, health was attrib-
uted to nothing more than luck and the use of medicines designed to treat the symptoms of the disease itself. With today’s new focus on prevention of disease by fueling the body and its systems correctly, people can now make a decision to pursue health rather than simply react once a disease manifests.
May all that read the following pages do so with an open mind and—equally important—a healthy brain.

Brain Ailments and Nutra-Botanical Interventions
ADD/ADHD
Attention deficit disorder (ADD), formerly known as attention deficit/hyper-activity disorder (ADHD), is one of the most common mental disorders among children today. It is estimated that approximately 3 percent to 5 percent of all children (two to three times as many boys are affected than girls) or nearly 2 million American children (which correlates to one child in each classroom in the United States) have ADHD according to the National Institute of Mental Health.1 ADHD does not only affect children, as symptoms can progress into adulthood as well.
The specific causes of ADHD are currently unknown, with several factors being responsible in different people. No solitary causative factor has been identified as being responsible for the different behavior patterns observed in ADHD. ADHD is only diagnosed by certain characteristic behavior patterns that are observed over time; no other clear physical signs can be seen. Common behavioral pattern categories in ADHD include inattention, impulsivity, and hyper-activity.
• Inattention: This is marked by difficulty in keeping the mind focused on any one subject and a short attention span. People with ADHD often become bored after only a few minutes at work on a subject, and placing focused attention on new or unfamiliar topics can be challenging.
• Impulsivity: This is marked by an inability to refrain from immediate reactions, making it difficult to wait and first think before speaking or acting.
• Hyperactivity: This is marked by constant perpetual motion; staying in one place and sitting still can be difficult. Adults may feel quite restless and may start several projects and have a difficult time finishing them.
Diagnosis of ADHD is based upon an analysis of the person’s behavioral patterns, which are compared to established criteria. These criteria are defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). The manual outlines the three previously mentioned behavior patterns, and people may display varying amounts of each pattern or only one. Because nearly everyone displays some of these symptoms at some time in their life, certain criteria, including age of onset (early in life, before age seven), duration of symptoms (continuous for at least six months), frequency (occurring more often in themselves than others of similar age), and most importantly, behavior(s), must occur in at least two different areas of the person’s life, namely, school, home, work, or social settings.
A recent report issued by the Centers for Disease Control and Prevention claimed that nearly 1.6 million elementary school–aged children have a diagnosis of ADHD, and a national survey revealed that the parents of 7 percent of children ages 6–11 years old were told by a healthcare professional that their child had ADHD.2 The report also included the following demographic information: boys are nearly three times as likely to have ADHD than girls; white children are twice as likely than Hispanic and black children to have a diagnosis of ADHD; children with health insurance are diagnosed with ADHD more often than children without health insurance; and children with ADHD use more healthcare services, including mental health services, than those without ADHD. This report went on to propose that ADHD is probably overdiagnosed in those with regular access and may be underdiagnosed in those with limited healthcare access.
A common neurodevelopmental disorder, ADHD results in impaired educational processes, social growth, and adaptation that lead to increasing rates of behavioral difficulty, depression, school dropouts, and substance abuse,3 which have lead to the mass prescription of stimulant psychotropic medications in children affected with this disorder. With no fully established biological causes recognized, ADHD does display prominent heritability. Mainstream treatment focuses on the use of mainly stimulant drugs, and because of the perceived relative success of these drugs in alleviating ADHD symptoms, many studies have focused mainly on genes that are responsible for the development and regulation of brain neurotransmitter systems, specifically that of dopamine, wherein the physiologic basis for the action of these drugs exists.
Genetic factors do play a role in the genesis of ADHD; estimates of herita-bility are greater than those of nearly every other child and adolescent psychiatric disorder and first-degree relatives have increased rates of ADHD, including conduct and affective disorders as well as substance abuse and dependency. Additionally, the subtypes of ADHD (impulsivity, hyperactivity, inattention) do not correlate with that of additional family members, leading researchers to conclude that nongenetic factors are responsible for intrafamialial variability.4 Factors other than genetics have been implicated in the development of ADHD prior to birth. Prenatal exposure to nicotine and psychosocial adversity have been
identified as risk factors for ADHD; a review of the studies in ADHD literature exploring the relationship between prenatal exposure to these factors and the risk of developing ADHD revealed that smoking (specifically nicotine exposure) and exposure to psychosocial stress during pregnancy indicated greater and modest risk, respectively, in contributing to the development of ADHD.5 Other causes/contributors of ADHD that have been implicated in the literature include food sensitivities and allergies, food additive intolerance, imbalance and deficiency of nutrients, environmental toxicity (including heavy metal poisoning, thyroid irregularities, and other toxic pollutants).6

NUTRITIONAL FACTORS

The role of vitamins and minerals in brain function is equally important to their contribution to other organ systems. Just as organs and tissue systems may be compromised by inadequate or imbalanced nutrients, the functioning of the brain is easily affected by these imbalances or lack thereof; research points to the benefits of supplementation for nutrient deficiencies that resulted in improved academic and behavioral performance in ADHD children.7 One hallmark study followed the effects of vitamin and mineral supplementation in healthy schoolchildren over 18 years old. Researchers found that supplementation with vitamins and minerals resulted in significantly less antisocial behavior and improved cognitive performance in children taking the supplements when compared to those taking a placebo.8 However, improvement was not noted unless a frank nutrient deficiency of at least one nutrient (most often folic acid, thiamine, pyridoxine, vitamin C, or niacin) was found in blood testing. Because of findings such as these, the importance of multivitamin and mineral supplementation comes into play. It is interesting to note that these children had actual blood-level deficiencies; this comes at quite a nutritional cost with the wide food availability seen in modern times in the United States. Multinutrient dosing provides a backup strategy in the event of inadequate intake, or more commonly, inefficient absorption and utilization of these nutrients. A body that does not receive or is unable to fully utilize the nutrients necessary for optimal functioning will exhibit symptoms of dysfunction at its weakest areas. Studies investigating the use of B vitamins have yielded interesting results as well. One investigator employed varying combinations of B vitamins to successfully treat hyperactive children (more properly known as hyperkinesis) who did not respond to treatment with Feingold’s diet (a diet espousing the removal of food additives and salicylate-containing foods).9
One B vitamin in particular, vitamin B-6 (pyridoxine) has been shown to be an effective treatment for hyperactive children; a double-blind study comparing the use of vitamin B-6 to methylphenidate (also known as Ritalin—the most commonly prescribed drug for ADHD) revealed a slightly greater effectiveness of B-6.10 What is even more interesting in this study is that the researchers based their idea for the study on the observation noted by other doctors that hyperactive


children tended to have lower blood levels of a specific neurotransmitter (serotonin) and that supplementing with large amounts of B-6 normalized the levels of serotonin and subsequently improved the children’s behavior. B-6 serves as an enzymatic cofactor in the metabolism of several neurotransmitters, including serotonin, dopamine, and histidine.11 The use of B-6 among physicians for the treatment of ADHD symptoms is widespread; it enjoys a positive reputation among clinicians treating these patients.
Phosphatidylserine is a biological molecule known as a “phospholipid.” Phospholipids are one of the main components of cellular membranes in the human body and serve to stabilize the other constituents of which the cellular membranes are composed. Phosphatidylserine is the main phospholipid of human brain cells, and it serves to regulate cellular functions such as controlling the internal environment of the cell, communication between cells, signal transduction (communication from outside the cell to within), release of secretory vesicles (another mode of cellular communication), and regulation of cell growth and division.12 Phosphatidylserine is beneficial to several different brain functions and also contributes to nerve cell synaptic membranes, a key anatomical aspect of nerve signal production and transmission. As a supplement, its benefits include increased neurologic energy via facilitated synaptic communication and increased production, release, and effectiveness of the neurotransmitter dopamine.13 One study investigating the use of phosphatidylserine supplementation in ADHD patients resulted in a slightly greater than 90 percent improvement in these cases, with doses of 200 to 300 milligrams per day for up to four months providing the greatest absolution of symptoms.14 Supplemental administration of phosphatidylserine is thought to normalize brain lipid content, thereby assisting the return of normalized function of neuronal cells.15

OTHER NUTRIENTS

Iron: Insufficient iron is one of the most common nutrient deficiencies among children in the United States,16 and it is known to contribute to decreased attention span, activity, and persistence. Supplementation of nonanemic children with ADHD resulted in fewer symptoms of ADHD (marked by a 30 percent improvement).17 Interestingly, iron serves as an essential cofactor in the synthesis of the brain neurotransmitters dopamine, norepinephrine, and serotonin, and deficiency in the early years of life can negatively affect neural and behavioral development.18 It is essential to note that iron poisoning is the leading cause of accidental poisoning, thus guidance by a skilled healthcare provider is essential and close monitoring is a must.
Magnesium: Magnesium is another commonly deficient nutritional mineral. Magnesium supplementation can be helpful in alleviating some symptoms of ADHD. In one study, one group of children with ADHD was treated for six months with supplemental magnesium and changes
in ADHD symptoms were compared to another group of ADHD children who did not take the supplement. Investigators noted a “significant” decrease in hyperactivity symptoms in the treatment group.19 Another study demonstrated actual deficiencies of magnesium in 95 percent of ADHD children studied, leading the researchers to conclude that magnesium deficiency in children with ADHD occurs more often than in healthy children without ADHD.20
Zinc: A collection of studies reveal that the level of this mineral is low in people with ADHD,21 and lower serum zinc levels are found in children with ADHD in comparison to children without.22 A relationship exists between levels of free fatty acids in the blood and zinc in children with ADHD; these children, when compared to controls without ADHD, were found to have low blood levels of zinc and free fatty acids.23 This indicates that a deficiency of zinc may contribute to the development of ADHD; the study hypothesized that the low levels of free fatty acids may be a result of the decreased zinc levels. Another interesting study revealed a relationship between the responsiveness to standard stimulant pharmacotherapy and zinc levels in the body: low zinc levels equated to poor treatment response from the medication.24 Zinc serves as a cofactor in the synthesis of neurotransmitters and indirectly affects dopamine metabolism, a neurotransmitter that is believed to be involved in ADHD (low levels of dopamine are associated with ADHD, and supplementation of dopamine has alleviated some ADHD symptoms).25 As the principal investigator of the ZAD (zinc–attention deficit) study, one of the authors of this book, Chris D. Meletis, has noted, through the course of reviewing the scientific literature and clinical findings over the last decade, a clear relationship between low levels of zinc in relation to copper stores and notable signs and symptoms of attention dysfunctions and cognitive deficits.
Because solitary nutrient deficiencies have been implicated in ADHD, it stands to reason that inadequate doses of the earlier mentioned nutrients in combination may act synergistically to cause ADHD. A group of researchers determined that the most common nutrient deficiencies among children with ADHD were magnesium, copper, zinc, calcium, and iron, and these deficiencies occur more often among hyperactive children than healthy children; these deficiencies were determined by measuring their levels in blood serum, red blood cells, and in the hair.26 Of the implicated nutrients, magnesium was the most frequently deficient. Additionally, when the researchers supplemented the ADHD children with magnesium, zinc, and calcium, hyperactivity was decreased; and when a group of these children was treated with standard therapy minus magnesium, symptoms of hyperactivity actually increased.
These studies underscore an important revelation in ADHD in that the cause of these symptoms seems to be related to one or more types of suboptimal nutrient
levels. A common theme carried throughout this book and noted in medicinal literature is that each individual has a unique weakness that becomes more manifest when certain environmental influences are exerted (in this case inadequate levels of micronutrients). When adequately supplied with correct nutrition, symptoms are often diminished and can be attenuated with time. In the treatment of the person with ADHD, it may not be as important to discover the exact nutrient or nutrients that are lacking in order to alleviate symptoms. By prescribing a full-spectrum nutritional plan (that may or may not include dietary alterations and supplements), people with ADHD receive the nutritional factors that are needed to avert the manifestation of their symptoms. Patients’ individual nutritional needs should be taken into account prior to prescribing a nutritional treatment plan. An individualized approach is important; each person with ADHD may react differently to various nutritional factors. Both current and past dietary practices and habits are important to consider; the development of physio-logic systems depend on varying levels and types of nutrients at different periods during the course of development.
Nutritional factors other than deficiency play a large role in the symptomology of ADHD. Food additives, refined sugars, food sensitivities, and food allergies have been linked to ADHD; mounting evidence has shown that children with ADHD will react to more than one food and or its components, leading to negative behaviors.27 Dietary modification plays an equally important role to ensuring adequate nutritional supplementation; both treatments should be part of the ADHD treatment regimen. One of the most influential dietary approaches in the treatment of ADHD is the Feingold diet. Starting in the1970s, Feingold claimed that the cause of up to 50 percent of hyperactivity in children was attributable to food additives, including artificial colorings, flavors, and preservatives as well as naturally occurring salicylates.28 Feingold arrived at this conclusion by investigating 1,200 cases of food additive–linked behavioral and learning disorders in patients; he implicated more than 3,000 different food additives in these cases. A large body of research is dedicated to negating this relationship, however Murray and Pizzorno, in reviewing the outcome data from theses studies, report that 50 percent of the children in these studies actually improved (experienced less hyperactivity) when on the Feingold diet.17
There are approximately 5,000 food additives in use today, most of which are used to preserve and enhance the appearance of food; Americans consume nearly 15 grams per day on a per capita basis (nearly 100 million pounds of food coloring alone is ingested on a yearly basis in the United States).14 A study of 78 children with hyperactivity were placed on an elimination diet designed to remove offending foods that may cause hyperactive symptoms and 59 of these children experienced less hyperactivity while on the diet.29 In a crossover portion of the study, the researchers were able to disguise previously established offending foods by mixing them in foods that were tolerated. This resulted in worsened behavior and impaired psychological test performance, demonstrating that observable changes in behavior associated with diet are reproducible using
double-blind methods. The investigators used this point to emphasize the ability of the parent/teacher/caretaker’s ability to note the relationship between food ingestion and behavior outcomes and to consider these observations as valid when they present this association to the family physician.
A review of 23 double-blind studies investigating the roles of food dyes versus ordinary foods as the cause of worsened ADHD behavior revealed a worsening of symptoms following dye consumption in eight of nine studies using ADHD children. There was improvement when a food additive–free diet was consumed. In 10 of the other 14 studies, children with ADHD and asthma, food allergies, and/or eczema saw their symptoms improve when additive-free foods were con-sumed.30 Other subjects in these studies experienced a worsening of symptoms when they consumed food dyes, corn, wheat, dairy products, soy, oranges, and chocolate. Another study demonstrated that 73 percent of ADHD children responded favorably to a food additive elimination diet and also worsened when certain foods, dyes, and additives were reintroduced into their diet.31 Another study employed the use of a diet consisting of rice, turkey, pear, and lettuce in the treatment of ADHD symptoms. Of the children studied, 62 percent demonstrated an improvement of symptoms of 50 percent or greater on the Connors list and the ADHD Rating Scale at the end of the study period, leading the researchers to conclude that ADHD children can experience statistically significant symptom improvement when placed on an elimination diet.32 These studies demonstrate the benefits of removing certain foods that may be suspect in causing ADHD symptoms; foods containing additives and those that may be allergenic should be among the first to eliminate from the diets of patients with ADHD—they more than likely play a significant role in the etiology of ADHD. Dietary modification should be attempted prior to treating symptoms with pharmaceuticals.


CONCLUSION

With no specific etiology, ADHD is a perplexing condition that continues to increase in incidence. This chapter includes only a sampling of the studies demonstrating various links between ADHD and nutritional factors. In addition to micronutrient deficiencies, food additives and allergenic foods play a large role in the treatment of ADHD. Although it is difficult to imply that these are the causes of ADHD, research does show a causal relationship: when such foods are removed, patients have fewer symptoms, and when patients are supplemented with the correct amount of nutrients, negative symptoms decrease. Readers of this chapter are strongly encouraged to investigate the pharmaceuticals that are prescribed for ADHD; a large amount of data regarding their toxicity and effects on the developing nervous system are a must-know.
The question that must be posed is whether all the millions of children diagnosed with ADD/ADHD were born drug deficient or whether a deeper fundamental cause needs to be addressed. An analogy may be drawn between the
performance and potential of a large eight-cylinder Corvette sports car and the health of a newborn: regardless of the inherent potential of such a high-performance vehicle, if it is operated with suboptimal fuel, then the full horsepower and drivability of such an amazing creation will not be realized, just as the human body’s complex fuel needs are essential for peak performance.

NUTRIENTS

• Diet A diet that includes carbohydrates, proteins, and fats in a ratio of 40:30:30 percent three times per day

• Multivitamin/mineral A suitable age-specific supplement should be taken twice per day with meals

• B vitamin complex One capsule of B complex twice per day with meals.

• Phosphatidylserine 200–300 milligrams per day

• Iron Must establish the presence of a deficiency prior to supplementing this nutrient*

• Magnesium 5 milligrams per kilogram body weight per day

• Zinc 25 milligrams per day *Testing for food allergies and food sensitivities is imperative.


Alcoholism (Alcohol Abuse/ Dependence)

DEFINITION

Although alcoholism, or alcohol abuse or dependence, is not necessarily caused by deficiencies of nutritional factors, it may be propagated by and definitively leads to frank nutrient deficiencies with startling health effects. Alcoholism, or alcohol dependence, is by definition a disease. Alcohol dependence has a chronic, progressive course, follows a predictable course, and has symptoms; and the risk of developing alcohol dependence is influenced by a person’s genes and lifestyle. Cravings can be a strong as the need for food or water, and a person who is alcohol dependent will continue to drink despite its negative effect on family, career, and health. The four most common symptoms of alcohol dependence are:
• Cravings
• Loss of control (unable to stop drinking once drinking has begun)
• Physical dependence manifested by nausea, sweating, tremors, and anxiety when alcohol is withdrawn
• Tolerance, manifested by the need for increasing amounts of alcohol in order to feel the effects of alcohol
More expansive definitions of alcohol dependence and abuse have been developed for clinical and research purposes; this criteria is included in volumes such as Diagnostic and Statistical Manual of Mental Disorders, fourth edition, published by the American Psychiatric Association, as well as in the International Classification Diseases, published by the World Health Organization.

STATISTICS (PREVALENCE AND ETIOLOGY)

The most recent statistics surrounding alcoholism places the lifetime prevalence of the disease in the United States at 20 percent (9.8 million) in men and 8 percent (3.9 million) in women, with a heritability (attribute to both genetic and lifestyle influences) for both sexes at 50–60 percent.1 Afflicting more than 14 million Americans (1 out of every 13), alcoholism is often associated with several other predisposing disorders such as antisocial personality, depression, anxiety, and tobacco addiction (nearly 80 percent of alcoholics are cigarette smokers). Recent evidence classifies alcoholics into two broad categories: Type 1 alcoholics begin drinking later in life in response to feelings of anxiety, guilt, and avoidance of harm. Type 2 alcoholics are more often men with decreased levels of the neurotransmitter serotonin in their brain and who act impulsively and antisocially.
Recent statistics reveal nearly 20,000 people died from alcohol-induced deaths, excluding motor vehicle fatalities in one year in the United States, 62 percent of 18-year-old and older Americans drank alcohol in the past year, 32 percent of drinkers had five or more drinks on one occasion at least once in the past year, and 61 percent of men 18–24 years and 42 percent of women had five or more drinks on the same occasion.2 The toll of alcoholism and drunk driving has been well publicized in the last two decades, with social and judicial tolerance decreasing substantially. The disease of alcoholism itself is lesser appreciated; as like many people with varying types of chronic disease, alcoholics are at some point along their disease continuum able to maintain outward appearances of normalcy.
Causes of alcoholism vary between genetic and lifestyle influences. As stated earlier, a large percentage (50–60 percent) of children of alcoholics will be alcohol dependent themselves. Additionally, researchers have been searching for a definitive genetic link that explains the origins of alcoholic behavior. A recent ongoing study, “The Collaborative Study on the Genetics of Alcoholism (COGA),” is searching for the genes that may contribute to alcoholism and some of its related traits (phenotypes) that include depression. The study so far has revealed a positive link between depressive syndrome (depression that may or may not occur in concert with increased alcohol intake) and alcoholic subjects. Further, this study has linked alcohol dependency and depression to specific chromosomal regions, namely on chromosome #1, suggesting that a solitary gene or genes on chromosome #1 may predispose people to depression and/or alcoholism, which may be induced by depression.3
Specific nutritional deficiencies have not yet been elucidated in the cause of alcoholism itself. However, the progression of the disease is definitively marked by specific conditions resulting from specific nutrient deficiencies and their effects on the human body. As alcoholism progresses, the brain, liver, gastrointestinal tract, and pancreas are severely affected. Nutrient deficiency in alcoholism is attributed by decreased intake (chronic progressive alcohol
ics derive more and more calories from alcohol rather than food), reduced storage as a result of decreased food intake and nutrient replacement, and impaired utilization due to the effects of alcohol on the gastrointestinal tract.

BOTANICAL MEDICINES IN THE TREATMENT OF ALCOHOLISM

The effects of botanical medicines on alcoholism are providing interesting results. Several herbs demonstrate a reducing effect on voluntary alcohol intake in animal models of alcoholism, suggesting interesting new forms of therapy for alcoholism, and therefore may also demonstrate a preventative effect in individuals prone to this disease. Among the herbs with these effects are Hypericum perforatum (St. John’s Wort), Peuraria lobata (kudzu), Salvia miltiorrhiza (Dan Shen), and Tabernanthe iboga (Iboga). Additionally, these plants demonstrate an ability to reduce alcohol absorption from the gastrointestinal tract.4
Salvia miltiorrhiza
The use of this herb in reducing alcohol intake in laboratory animals has been demonstrated in several recent studies. Salvia is a botanical medicine with a long history of use in China. Administration of a standardized extract of Salvia dose dependently delayed alcohol drinking in ethanol-preferring animals and was compensated by increased water intake.5 Another study demonstrated the ability of the standardized extract of the herb to reduce alcohol intake by 40 percent in animals that were conditioned to prefer alcohol; this effect is attributed to the ability of the extract to alter ethanol absorption from the gastrointestinal tract: 200 milligrams per kilogram of Salvia miltiorrhiza decreased blood alcohol levels by up to 60 percent compared to control animals. Furthermore, alcohol-dependent animals dosed with Salvia extract were less able to discern the effects of alcohol-laden water from plain water than other animals trained to do so; the authors of the study conclude that the reducing effect of Salvia miltiorrhiza extract on ethanol absorption in animals may have caused a decreased perception of the psychoactive effects of ethanol.6
Additionally, Salvia also demonstrates antirelapse effects.7 Alcohol-dependent animals demonstrate a transient increased rate of alcohol consumption in comparison to previous levels after a period of deprivation. Considered to model alcohol relapse in human alcoholics, alcohol-dependent animals treated with Salvia extract exhibited a complete suppression of extra alcohol consumed following deprivation. Because of these findings, Salvia may possess antirelapse properties in addition to its alcohol-curbing properties and may constitute a novel strategy for reducing and controlling alcohol consumption in human alcoholics. Hypericum Perforatum
Hypericum, also known as St. John’s Wort, has been established as an effective treatment for mild to moderate depression. Both depression and alcoholism share similar nuerochemical weaknesses, such as decreased brain serotonin levels. In one study, a standardized extract of St. John’s Wort was shown to be significantly effective in decreasing alcohol intake, and these effects did not decrease due to tolerance after consecutive doses.8 In another experiment, alcohol-preferring animals were given a dry extract of Hypericum and a 30–40 percent reduction in alcohol intake was noted.9 It was noted in this study that the effects of Hypericum were selective in that food or water intake was unmodified, and further examination revealed that the decreased alcohol-ingesting effects were not attributable to the antidepressant effects of the herb (decreased alcohol consumption was noted after a single administration of the medicine, whereas antidepressant effects were only noted after repeated doses), and the effects were not related to altered pharmacokinetics of alcohol either. Hypericum has been demonstrated repeatedly to inhibit alcohol intake in alcohol-dependent animals, yet a clear mechanism has not been established. Further studies are needed to identify the exact mechanism for St. John’s Wort on alcohol intake; however, the existing findings demonstrate St. John’s Wort as a potential therapuetic agent in the treatment of alcoholism.
Pueraria Lobata Kudzu (Pueraria lobata) exerts several profound pharmacological actions including antidipsotropic (antialcohol abuse) activity. Pueraria has a history of use in treating the symptoms of alcohol overdose (hangover), including stomach upset, headache, nausea, vomiting, and dizziness. In traditional Chinese medicine, kudzu was used for managing alcoholism and drunkenness and other disease conditions. An extract of kudzu, known as daidzein, can decrease alcohol consumption and blood-alcohol levels, as well as decrease the duration of alcohol-induced sleep in animal models; and the ability of kudzu to lower blood-alcohol levels is attributed to its ability to delay gastric emptying, slowing the entrance of alcohol into the bloodstream.10 Other affects of kudzu on the body, which may contribute to its use in treating excessive alcohol intake, include its ability to decrease platelt aggregation; its antioxidant ability; the ability to dilate heart and brain blood vessels, increasing flow to these areas; and increased blood oxygen levels.11
An extract of the plant was shown to suppress the alcohol intake of alcohol-dependent animals when given a choice between water and alcohol.12 Researchers attribute two isoflavone constituents of the plant, daidzin and daidzein, for this action. Additionally, other studies have repeated and confirmed the suppres-sant effect of this plant on both genetically alcohol-dependent animals and on animals that were trained to crave large amounts of alcohol. Earlier research
suspected that daidzin was capable of inhibiting an enzyme known to detoxify alcohol known as aldehyde dehydrogenase. Disulfiram, otherwise known as antabuse, is a pharmaceutical medication used by some patients incapable of stopping alcohol intake that operates on this mechanism. When a person consumes alcohol while taking this medication, only small amounts of alcohol will cause tremendous nausea and physical suffering, acting as a deterrent to continued alcohol intake. However, newer research reveals that inhibition of aldehyde dehydrogenase is not the mechanism that inhibits drinking behavior, and it is suspected that daidzin operates in a different biochemical pathway. Newer research has revealed that daidzin inhibits a second step of a pathway known as MAO/ALDH-2 (monoamine oxidase/aldehyde dehyrdogenase-2), a pathway of alcohol detoxification in the body, leading to its suppressive effect on alcohol-craving animals.13
Tabernanthe Iboga (Iboga) Native to Africa, Iboga has been used ceremonially as a hallucinogen. A powerful medicinal plant, Iboga has several pharmacological effects that have led it to be employed in the use of breaking addictive cycles, including tobacco and alcohol addiction. An extract of this plant (Ibogaine) can cause stimulation of the brain (central nervous system) ranging from mild excitation to euphoria and hallucinations.14 Additionally, iboaine exerts serotonergic effects, meaning that it can mimic the effects of this neurotransmitter, which is often found in low amounts in alcoholics. Animal studies have shown that these effects may exert some value in the treatment of human addiction, including alcoholism.15 Ibogaine administered to animals exerts short-lived decreases in alcohol intake, and it is suspected that longer term effects may be mediated over long-term treatment periods with this plant extract as the extract is stored in fatty tissues, allowing for a sort of time release effect.16 Iboga and its constituent iboaine have been used successfully in breaking cycles of addiction; further studies of the plant medicine may reveal greater understanding of its use in breaking alcohol dependency.

NUTRIENTS AND ALCOHOLISM

Thaimine The most well-known vitamin deficiency associated with alcoholism is that of thiamine (B-1) deficiency. Classically, long-term deprivation of this vitamin leads to Wernicke-Korsakoff syndrome and features neurologic symptoms such as confusion, memory loss, impaired movements, and peripheral neuropathy. Wernicke-Korsakoff syndrome is actually two disorders that can occur independently or together. Wernicke’s disease involves damage to the central and peripheral nervous systems, and can include alcohol withdrawal symptoms.
Korsakoff syndrome involves impairment of memory and intellectual skills. The most distinctive symptom is confabulation, or fabrication of facts as the person tries to fill in gaps in memory when recounting experiences. Depending on time of treatment and how long the patient has been deprived of thiamine, this condition may or may not be reversible. Treatment of this condition involves the administration of thiamine intravenously and in repeated doses over a period of days to weeks.
Zinc Zinc is required for several biological functions including DNA synthesis, cell division, and expression of genes. Additionally, zinc is required for the functioning of numerous enzymes in biologic systems and immune system function. Alcoholism is a predisposing factor for zinc deficiency due to the effects of alcohol on nutrient absorption. Zinc can positively affect the metabolism of alcohol in the body and can reinforce the functioning of both stomach and liver alcohol dehydrogenase enzymes.17 These effects can lead to increased metabolism of alcohol in the body, thereby negating some of its negative side effects, especially in the liver and brain.
The development of alcohol dependence is accompanied by a decrease in zinc content in an area of the brain known as the hippocampus, and supplementation of zinc may prevent this deficiency.18 In another interesting study demonstrating the importance of zinc and alcoholism, alcohol-dependent animals were shown to have deficient zinc brain levels, and when supplemented with zinc, alcohol consumption was reduced.19 These studies demonstrate a link between zinc and healthy brain functioning; supplementation of zinc in chronic alcoholics may serve to improve treatment and prevent some negative long-term effects of deficiency.
Niacin Deficiency of niacin (vitamin B-3) is known to occur in alcoholics as well. Frank deficiency of niacin leads to a disease known as pellagra. Pellagra leads to the triad: dermatitis, diarrhea, and dementia, eventually followed by death; skin changes are characteristic and define the condition by themselves. Often masked by other alcohol-related nutritional deficiencies, pellagra can coexist with other vitamin deficiency diseases in chronic alcoholics. Because of this, supplementation with a multivitamin and mineral is imperative in the treatment of chronic alcoholic disease, although pellagra by itself is responsive to niacin therapy.
Considered a mainly psychiatric disease, the known familial and genetic influences on this disease have become increasingly well defined. Indeed, the ad-age that genetics may load the gun, but diet and lifestyle pull the trigger rings true when it comes to alcoholism. Not everyone with a family history of alcoholism becomes an alcoholic. Nutritional, botanical, and lifestyle can all help
ward off the consequences of alcoholism. A preemptive strategy for individuals with family histories of alcohol abuse should at a very young age (at least age 12) take a multivitamin that has abundant sources of chromium and zinc in balance with other nutrients. Taking these nutrients in the form of a high-quality multivitamin is better than individual dosing, since these and most nutrients are dependent on the synergy of other vitamins and minerals. Another important consideration is to look for early signs of hypoglycemia that clinically appear to present in some, but not all, alcoholics. Thus the presentation of fluctuations of blood sugar after eating or if a meal is missed may be a warning sign indicating that working with a nutritionally oriented physician could be helpful.

BOTANICALS*

• Hypericum perforatum (St. John’s Wort)
300 milligrams (standardized to 0.3 percent hypericin or 4 percent hyperforin content), three times daily
• Pueraria lobata (Kudzu)
1,500 milligrams root extract, twice daily
Salvia miltiorrhiza (Dan Shen)
2,000–3,000 milligrams, twice daily
• Tabernanthe iboga (Iboga)
The standardized extract Ibogaine is efficacious at 200–300 milligrams twice daily. However, this herb is hallucinogenic and should only be used under close medical supervision.

NUTRIENTS**

• B-1 (Thiamine) Doses of 5 to 300 milligrams have been used depending on state of deficiency. A good starting dose is 10 milligrams twice per day.

• B-3 (Niacin) 100 milligrams three times per day

• Chromium 200 micrograms twice per day

• Zinc 40 milligrams per day, divided doses with food
*It is important to consume these doses with a multivitamin/mineral supplement, as many nutrients are dependent on each other for proper assimilation and physiologic synergy.
**All herbs should be taken in capsule or tablet form or as a tea; liquid extracts should be avoided due to potential alcohol content that can be as high as 50 percent (100 proof).



Alzheimer’s Disease

Alzheimer’s disease (AD) is a progressive degenerative disease of the brain and is the most common form of dementia among older people. Typically, it affects the part of the brain that controls thoughts, memory, and language skills. Alzheimer’s disease is physically manifested inside the brain by amyloid plaques and tangled neuronal fibers that replace normal brain cell organization. Additionally, nerve cells die in vital areas of the brain responsible for memory and other cognitive abilities, and some brain chemicals responsible for cell-to-cell communication are found in lower levels, disrupting the thinking process. At this point in time, no definitive cause or cure is known for Alzheimer’s disease; rather there are probably numerous causes that affect each person differently. The diagnosis of AD is made on a presumptive basis; after interviewing and testing a patient, and speaking with the people with whom the patient is closest, a probable diagnosis can be made. However, a definitive diagnosis cannot be positively established until an autopsy is performed, when a pathologist can confirm the existence of the previously mentioned anatomical changes (neurofibrillary tangles and plaques). The clinical course of AD is fairly well established at this point in time; mortality rates increase with greater levels of cognitive disabilities.
It is estimated that approximately 4.5 million Americans have Alzheimer’s disease. Symptoms typically begin after the age of 60, although rarely younger people can also develop Alzheimer’s disease. Close to 5 percent of men and women ages 65 to 74 have Alzheimer’s disease, and the numbers increase to nearly 50 percent in those age 85 and older; the number of people in this age group will grow to 8.5 million by 2030. Despite these numbers, it is important to note that Alzheimer’s disease is not a normal part of aging; rather it is a disease process related to the continuous effects of external and internal events in
the environment and body. At the current rate of disease incidence, 14 million Americans will have AD in the next 50 years. From the time of initial symptom presentation, a person with AD will live an average of eight years; however, some will live up to 20 years with AD. In the United States, $100 billion is spent on AD; the majority of health insurance plans, including Medicare, do not cover the long-term care that many AD patients require. Perhaps related to this, 70 percent of people with AD live at home, and immediate family and friends provide nearly 75 percent of their care. The rest of the care provided for AD patients costs an average of $12,500 per year per family, which is paid almost entirely out of pocket. For families who have the means to provide nursing home care, the average cost for this is $42,000 per year and can cost up to $70,000 in some parts of the country. Average lifetime cost per AD patient is $174,000; AD is ranked as the third most costly disease to have, after heart disease and cancer. Finding a cure for AD is costly as well; the U.S. government spent close to $349.2 million for Alzheimer’s disease research in 1998 alone.1
In addition to these costs, it is widely stated that there are always two patients in AD, the person with AD and his or her caregiver, often a spouse. Caregivers bear a huge burden in caring for the person with AD; large amounts of physical, emotional, and financial stress are often the result. Support is crucial for the caregiver in these situations; caring for a patient with AD has been compared to caring for an infant, a task that is not commonly endured by most seniors. Depression is quite common in caregivers of AD patients, as well in the patients themselves.2

ETIOLOGY

Although a complete understanding of the origins of AD are not firmly established at this time, conclusions can be drawn from epidemiologic studies (studies of specific populations of people) hinting at possible disease initiators. Presently, four specific risk factors for AD have been identified: increasing age, familial clustering of the disease, the presence of the apolipoprotein E variation, (epsilon 4 allele), and Down’s syndrome (a type of mental retardation). The following are associations that have been fairly well established, although not all of them hold true in every population study. For instance, more women suffer from AD than men; people with lower levels of education have more AD; history of depression and past head injury are risk factors; and aluminum exposure (occupational and food/waterborne sources) add excess risk, as do high blood pressure and other vascular diseases. Aluminum exposure is a particularly troubling association, especially because, as Americans consume more and more soda out of aluminum cans (despite their being “sealed” on the inside), our exposure to aluminum continues to increase. Also, the popular fad of using aluminum foil on the barbecue grill and in the oven add extra risk as well. Population studies have also revealed protective factors for AD as well, including: estrogen use by postmenopausal women; use of nonsteroidal antiinflammatory drugs in arthritis;
exercise and active lifestyles; moderate amounts of red wine; and a diet high in vitamins B-6, B-12, and folate.3 The use of lifestyle and nutritional therapies as preventative medicines will be covered in greater detail later in this chapter.

GENES

Family history is an important factor in the development of Alzheimer’s disease. Familial Alzheimer’s occurs in much younger people (age 30 to 60) and is inherited through genetic transmission. The more common form of Alzheimer’s disease is known as late-onset and displays no obvious inheritable pattern; not everyone with a family history of AD will end up getting the disease. So far, the only identifiable genetic risk factor in the development of AD is a gene that produces a variation in a common protein that all people manufacture. This protein, known as apolipoprotein E (apoE), is produced under normal circumstances and serves the function of transporting cholesterol in the blood stream. The variant version of this gene has been found in people with AD. Much needs to be learned about Alzheimer’s disease in addition to genetic causes. Increasing evidence is mounting in discovering the factors that precipitate the disease and factors that may provide some type of relief for disease symptoms.

DIET

Recent research findings suggest a probable role of the diet in age-related cognitive decline and dementia, including Alzheimer’s disease. Senior populations consuming a diet high in monounsaturated fatty acids (Mediterranean diet) display protection against age-related cognitive decline, whereas fish consumption and fortified cereals seem to reduce the prevalence of AD in Europe and North America. In addition, aluminum consumption, whether in foods or water, may increase the risk of developing AD, and deficiencies of the vitamins B-6, B-12, E, C, and folate can negatively affect memory capability and cognitive decline. These findings demonstrate that the use of antioxidants and dietary macronutrients in the form of beneficial fatty acids and grains may act as preventative factors in the development of dementia and other conditions of cognitive decline.4
AD is becoming more common in Western societies due to both longer life and most probably increasing incidence. There are numerous hints that AD may be linked to the typical Western diet (characterized by excessive intakes of sugar, refined carbohydrates with a high glycemic index, high saturated fats, and decreased consumption of unrefined seeds, nuts, and vegetables, with high amounts of fiber, vitamins, and antioxidants) as well as seafood (containing omega-3 fatty acids).5 Because it is has been hypothesized that AD may be promoted by the side effects of the aforementioned dietary trends, it stands to reason that this disease may be prevented or attenuated by adhering to simple dietary measures with effects that include increasing insulin sensitivity (by decreasing refined
sugars and saturated fats), improving the intake ratio of omega-3 to omega-6 fatty acids (by increasing fish and seed oil consumption), and by increasing intake of antioxidants such as folic acid, vitamins B-6 and B-12, and flavonoid food compounds. Currently, studies are underway to determine the effects of such preventive measures.

HOMOCYSTEINE

Homocysteine is an amino acid metabolite of another vital amino acid in the body, methionine. Homocysteine is produced through a process in which methionine donates a part of its chemical structure to other metabolic reactions in the body; the end result produces homocysteine. Homocysteine does have uses in the body; however, large amounts of research now implicate this amino acid as a critical risk factor in the pathogenesis of both heart disease and AD. Additionally, it is also well known that the vitamins B-12 and folate directly reduce levels of homocysteine in the blood, and lower levels of homocysteine are related to decreased amounts of cardiovascular disease. New research now implicates homocysteine in the development of cognitive function decline, including age-related memory loss and AD. When present in large amounts, homocysteine is known to inflict vascular damage throughout the body, including the blood vessels in the brain. This amino acid causes vascular damage that compromises brain functioning, leading to areas of damaged brain (infarcts) and resultant dementia. Elevated levels of homocysteine (hyperhomocysteinemia) have been shown to be an independent risk factor for cognitive decline, and a correlation exists between hyperhomocysteinemia and AD, including low levels of folate and the vitamins B-6 and B-12.6 More recently, Seshadri and colleagues have shown hyperhomocysteinemia to be a significant, independent risk factor for dementia and AD; they found a graduated increase in risk of both dementia and AD that directly correlated with homocysteine concentration after controlling for established AD risk factors.7
Additionally, these researchers noted that homocysteine levels decreased in conjunction with increased B vitamin levels, leading to the hypothesis that dementia and AD may possibly be circumvented by an alteration in dietary habits that include fortification and or consumption of B vitamins in greater amounts.

ANTIOXIDANTS

The oxidative process, evidenced by protein, lipid, and DNA oxidation, plays a major role in the initiation and propagation of several human disease conditions, including AD.8 Reactive oxygen species (ROS; otherwise known as free radicals) extol neurologic damage via direct oxidative destruction or through secondary events that initiate programmed cell death (apoptosis). Excessive production of ROS is known to contribute to degenerative brain conditions, propa-
gating several detrimental effects on the brain tissue. Experimental evidence demonstrates a neuroprotective role of direct application of antioxidants, and studies are underway to establish antioxidant compounds as clinically protective agents.9
Measurements of lipid and protein oxidative processes along with total antioxidative capacity have been taken from patients with both the familial and late-onset forms of AD, as well as from similarly aged healthy control subjects. Samples from the AD patients exhibited a profound increase in biologic products of pro-oxidative processes, whereas the antioxidant potential of these same samples were lower than those of the control subjects. Additionally, when intentionally exposed to oxidative agents, the cellular samples of the familial AD patients exhibited greater oxidative damage than those from controls. These results demonstrate the role of oxidation as a significant early event in the development of AD.10
New evidence continues to mount in the role of oxidation and the development of AD; some of this evidence points to oxidative damage prior to the formation of both beta-amyloid-containing plaques and neurofibrillary tangles (disease-defining physical signs in the brain tissue). In a review of studies that explored the use of antioxidants as a preventative medicine in AD, a positive relationship has been identified between dietary intake of antioxidants and a decreased association with AD.11 Such evidence is highly suggestive of the possibility of using antioxidants as an early preventative and treatment strategy in AD. At this time, studies have not established a directly measurable answer that antioxidants can completely protect against AD. Because of the multifactorial contributions to the development of this disease, and the evidence provided so far detailing the link between oxidative damage and AD, it is highly suggested that antioxidant therapy be considered among the key treatment and prevention strategies for AD.

STANDARD MEDICATIONS AND AD

At this time, AD is considered largely a disease caused by numerous insults. Current drug therapy has not proven to be successful in the treatment of AD; it aims to control symptoms of the disease, rather than prevent it. However, newer therapies are being directed at manipulation of the development of aberrant proteins that appear in people with AD. Standard therapy primarily involves the use of drugs known as acetycholinesterase inhibitors that allow the neurotransmitter acetylcholine to stay present in the brain for longer periods of time, producing a stronger effect. Only used in mild to moderate AD, patients with advanced disease are not as readily helped. Treatment for dementia is mainly focused on attempts at preserving and or improving the patients and their family’s quality of life; this includes treatment of the concomitant medical and emotional issues facing these patients and their family.

BOTANICAL MEDICINES AND ALZHEIMER’S DISEASE

The use of botanical medicines in AD is providing new therapies that are comparable to some standard pharmaceutical medications, but without the side effects. Botanical medicines including Ginkgo biloba, Rosmarinus officinalis, Salvia officinalis (sage), and Melissa officinalis (balm) have positive effects on the clinical course of AD and have been scrutinized in modern efficacy studies.
Ginkgo biloba
Ginkgo is perhaps best known for its memory-enhancing qualities in healthy people. These effects carry over into AD, a disease with obvious severe memory impairment. The active constituents of ginkgo, known as ginkgolides, have antioxidant, neuroprotective, and cholinergic activities that are relevant to the disease mechanisms in AD. The therapuetic efficacy of standardized ginkgo extracts in comparison to placebo is similar to the most currently prescribed cholinesterase inhibitors pharmaceuticals including tacrine, donepezil, rivastigmine, and metrifonate and has few if any side effects.12 Because of ginkgo’s effectiveness at treating dementia, it is registered as a drug of choice for treating AD in Europe.13 Ginkgo has been shown to have similar pharmacologic effect and clinical efficacy to prescription medications used to treat reduced cerebral performance. The principal actions of ginkgo include improved blood flow properties; protective effects against ischemia and hypoxia in the brain; improvements in nerve cell energy metabolism, antiswelling and myelin (the insulating layer surrounding nerve cells that allows for nerve transmission) protecting effects; and antioxidant and free radical scavenging activity, as well as nonspecific effects on neurotransmitters and their receptors.14 Furthermore, clinical trails have demonstrated the beneficial effects of ginkgo on cognitive performance, global functioning, and activities of daily living.
The most recent evidence for the effectiveness of ginkgo extract indicates a protective effect against neuronal damage from several sources; however, the exact cellular and molecular mechanisms of action are unknown at this time. In experimental cell lines that produce AD-causing amyloid-beta neuro-fibrillary tangles (a key diagnostic finding in AD), formation of the tangles was inhibited along with cell-specific self-destruction (apoptosis), prompting investigators to conclude that prevention of apoptosis and inhibition of amyloid-beta accumulation underscore the neuroprotective effects of Ginkgo biloba.15
When combined with the phospholipid molecule phosphatidylcholine, ginkgo is better absorbed by the tissues in which it has an affect. Phosphati-dylcholine acts as a “waterproof” carrier of the herb, assisting its delivery to the brain tissues and resulting in greater efficacy of the herb.
Rosmarinus officinalis
This herb is often listed among herbal treatment recommendations for AD and dementia. Similar to ginkgo, rosemary purportedly improves blood flow to certain areas of the body and has been used historically as an aid for improving cerebral function, specifically with memory loss and dementia. Rosemary posses fairly strong antioxidant capacity,16 and therefore may be useful in the treatment and prevention of AD. More research is needed exploring the use of this herb and its applications in AD. The German Commission E monograph suggests a dose of 4–6 grams (3/4 to 1 1/4 teaspoons) of rosemary leaf per day.17 This amount can be incorporated into a tea taken several times a day. No known drug-rosemary interactions are recognized, and no negative side effects are associated with moderate use of the above dose. Large amounts should be avoided in pregnant women, as the oil contained in the leaf may act to disrupt preganancy.18
Salvia officinalis (Sage) and Melissa officinalis (Balm)
Historic medical reference books from Europe document the effects and use of the herbs sage and balm as having memory-enhancing properties and were used for this purpose among others. Interestingly, modern discoveries of clinically relevant pharmacologic actions in plant medicines with historic applications have revealed strong links tying historic use with modern scientific explanations. It has been revealed that sage and balm both exhibit cholinergic activities, meaning they have similar effects to the neurotransmitter acetyl-choline (specific neurons that utilize this neurotransmitter degenerate in AD—thus the use of cholinergic pharmaceuticals).
The use of Melissa officinalis in treating the symptoms of mild to moderate AD was recently shown to produce a “significantly better” outcome in alleviating AD symptoms when compared to a placebo medication.19 Additionally, the AD patients treated with Melissa exhibited less agitation, a common occurrence in people with AD. The treatment dose in this study was only 60 drops a day of extract. Both behavior and psychological symptoms can be extremely problematic in this population of patients, and management is difficult for both the patient and caregiver. Another study using an essential oil derived from Melissa was tested to determine its use in alleviating symptoms of agitation in patients with advanced cognitive impairment and AD. In this study, the oil of balm was incorporated into lotions that were applied to the patient’s face and arms twice a day for four weeks, and its effects were compared to a placebo oil-lotion base. Sixty percent of the treatment group experienced a reduction of roughly 30 percent in agitation symptoms as determined by the Cohen-Mansfield Agitation Inventory (CMAI) and quality of life indices (percentage of time spent socially withdrawn and percentage of time engaged in constructive activities, measured with Dementia Care Mapping).20

Salvia officinalis, more popularly known as sage, has been tested in studies to determine its effectiveness in treating AD symptoms. These studies were based on the knowledge of the cholinergic binding properties of sage as well as its betterment of mood and cognitive performance in humans. One study used a dose of 60 drops sage extract in patients with mild to moderate AD over four months. According the researchers, the herb created a “significant better out-come” on cognitive function when compared to placebo, and patients taking the active medicine exhibited less agitation than those taking placebo.21 The use of sage as a medication in AD is supported by further research; extracts of sage have been shown to possess cholinergic (via anticholinesterase), antioxidant, anti-inflammatory, and sedative effects, all of which are clinically relevant in the treatment of AD.22 Salvia can reduce the neuropsychiatric symptoms experienced by people suffering from AD, making the use of this herb a suitable choice in the treatment of AD.
Acetyl-L-carnitine This nutrient has been shown to be helpful in some aspects of AD as well. Acetyl-L-carnitine (Alc) occurs naturally in the body and is somewhat structurally related to acetylcholine, the neurotransmitter and may contribute toward its formation.23 Taken as a supplement, Alc is useful in AD, age-related memory deficits, and senile depression. On the cellular level, Alc assists in transporting acetyl groups (portions of fatty acid molecules) into the power generator (mitochondria) of the cell and promotes the manufacture and release of acetyl-choline.24 This is important in AD because part of the disease process involves loss of the neurons that respond to the acetylcholine neurotransmitter, and ace-tylcholine in the brain is easily depleted.25 Used therapeutically, Alc has demonstrated neuroprotective actions, improves neurotransmitter pathways, enhances synthesis of acetylcholine, enhances synaptic transmission, and increases blood flow to the brain in people with cerebrovascular disease.26

OTHER INFORMATION FOR PREDICTION

Prediction of disease is becoming more and more of a focus in medicine today using the best of technology. However, one interesting aspect of AD is that one’s fingerprints may yield relatively significant information about their risk of developing AD. There are several types of fingerprint patterns that all humans share; this does not mean that they are all alike, but rather that we all share certain fingerprint features (so much so that each pattern has a name) much like we all have two eyes, yet none are alike. The frequency of the major fingerprint patterns (ulnar loops, radial loops, arches, and whorls) was studied in a group of men with early and late-onset degenerative dementia in comparison to healthy control subjects.27 The people with early onset disease had a significantly larger amount of ulnar loops than the late-onset and control groups. Similar findings
have been discovered in similar studies,28 indicating that there is a deeper bio-logic basis for the occurrence of early onset dementia. In this type of disease occurrence, it is noted that these people are “prone” to getting the disease. Predicting the possibility of disease occurrence may be possible utilizing fingerprint analysis. More studies are needed to absolutely correlate these finding with early onset disease, however.

CONCLUSION

Treatment of AD and its symptoms is a challenge. Standard medications offer some relief of symptoms; however, these medications are not free from side effects, and almost more importantly, few if any medical treatments are geared toward preventing AD prior to the appearance of symptoms. New research is exploring gene alteration and reversal of the pathologic disease changes in the brain; however, a greater emphasis must be placed on preventing this disease through the use of nutritional and herbal medications, the most promising of which have been reviewed in this chapter. As medical science continues to learn more about the disease process involved, greater emphasis will be placed on preventing the organ damage that serves as a precursor to Alzheimer’s disease.
Alzheimer’s by some patients is feared even more than heart disease or cancer, for the concept of being trapped within one’s body without the according mental connectivity with the outside world is terrifying. There are now medications that can assist many patients in their battle with this dreaded condition. Likewise aggressive and consistent use of select natural medicines can augment brain function by supporting normal biochemical pathways.

NUTRIENTS

• Dietary
The anti-AD diet should include healthy portions of complex carbohydrates in the form of fruits and vegetables, grains, nuts, and seeds, as well as essential fatty acid-rich sources such as cold-water fish and seed oils (flax, borage)
• Multivitamin/mineral
Two tablets, twice per day with food or as directed
• Antioxidants
A rich antioxidant supplement should be taken twice per day

BOTANICALS

• Ginkgo 60 milligrams twice per day (24% standardized)

• Rosemary Crude herb (leaf): 1–2 grams in a tea twice per day  Liquid extract (1:1 in 45 percent alcohol) 2–4 milliliters three times per day

Salvia officinalis (sage) 1–2 grams twice per day

Melissa officinalis (balm) Liquid extract (1:1 in 45 percent alcohol) twice per day


Anorexia

Anorexia nervosa (AN) is a severe psychiatric disorder characterized by a combination of abnormal eating behavior and weight regulation with disturbances of attitudes toward body weight and shape. It is a condition worthy of great respect and, if not treated properly by skilled specialized healthcare providers, can lead to death or serious lifelong consequences. Anorexia nervosa has been defined as the relentless pursuit of a thin physique, in which a person does not maintain normal body weight that is appropriate for his or her age and weight. Often, people with anorexia weigh 85 percent or less of the norm for their height and age group. These people are terrified of becoming fat, continuously deny the dangers of their own low weight, and will feel as if they are overweight despite their thinness. Additional symptoms include depression, social withdrawal, irritability, and sometimes compulsive food habits and rituals. Some people may experience problems such as assumption of adolescent roles or fears of adult responsibilities and have ineffective coping skills with life problems.
Estimates of the prevalence of these disease range from 0.5 percent to 2 percent of the female adolescent population with an average age of onset between 14 and 18 years. Another way of looking at these numbers reveals that approximately 1 percent of all female adolescents have anorexia nervosa. However, it must be recognized that accurate data is difficult to obtain due to the secretive nature of the disorder and the fact that a large majority of those affected do not seek treatment. The large majority of the populations suffering from anorexia nervosa are adolescents, although this disease can affect young adults and other age groups. Anorexia nervosa is uncommon among males; however, it is estimated that 5–10 percent of diagnosed cases are males younger than 14 years of age. In older adolescents, however, 10–30 percent of those with anorexia are males.

Among the diagnostic criteria are a refusal to maintain body weight at or above a minimally normal weight for age and height (less than 85 percent of expected weight); an intense fear of gaining weight; a disturbed view of one’s physical status; denial of the danger associated with low weight; and, in menstruating females, the absence of at least three consecutive menstrual cycles (amenorrhea). In addition, a full physical exam is required to rule out other physical disorders manifested by mental states, and a full diagnostic interview performed by a licensed mental health professional must be made before an official diagnosis can be made.
There is no solitary cause of eating disorders such as anorexia. Causes are multifactorial and may vary from person to person. Despite the difficulty in isolating the exact causes of anorexia, research is discovering pertinent information relating to biologic, societal-cultural, and psychological factors. Biologically related issues include genetic influences that predispose certain people to different types of behaviors that may lead to the development of eating disorders. There is a large body of research pointing to this possibility. Twin studies (studies of twins and their health) and family studies indicated that sisters of anorexics have a higher incidence of anorexia than those in the general population, and twin studies demonstrate a similar pattern, with even higher concordant rates.
In fact, one study estimated the influence of heritability, or the influence that genes have on physical manifestations of a particular disease or condition, of anorexia nervosa as 50–80 percent.1 A search for a definitive gene or gene mutation as the cause of anorexia has been unrewarding, despite the strong familial link that exists. Researchers are in agreement that further large-scale prospective (will an anorexic woman more often have anorexic children than a nonanorexic woman?) and adoption (is anorexia related to family dynamics?) studies are needed. A better understanding of the heritability of anorexia will, of course, allow for greater understanding of its causes and therefore better treatment and preventions.
Similar to other psychiatric conditions, hormones play an important role. Some older research defined a link between anorexia and hormonal dys-regulation, specifically in the hypothalamus and pituitary gland. Not definitely linked as causes of anorexia, perturbations in hormone levels are the result of chronic and recurrent starvation. Loss of adipose (fat) tissue and starvation has an effect on mental states, producing anxiety, depression, and personality changes.2 Another aspect of anorexia nervosa may be anorexia athletica, or compulsive exercise. Intense and excessive exercise will produce endorphins, the opioid-like brain chemical that allows us to feel good and masks pain. Coupled with muscle breakdown (starvation causes the muscles to be broken down for fuel) from starvation and intense exercise, this phenomenon may produce a high feeling, creating another addictive component in the already addictive pattern.
Another component of anorexia nervosa includes sociocultural effects. A commonly discussed problem is the image of women that is projected in popular media, which portray a body image that is difficult for the large majority of
women to obtain. Anorexia and eating disorders are more common in the industrialized countries, although as other countries in the world become more modernized, their rates of anorexia also increase. It is thought that anorexics are sensitive to disapproval and approval, and the media is often blamed for projecting that self-worth is to be equated with a lean physique. Indeed a powerful effector, media and its many outlets may very well play a role in the development of eating disorders in all age groups, particularly adolescents, the most impressionable of all age groups. Anorexia nervosa is supported by an interesting paradox in that incredible amounts of food are widely available and much of modern life is centered on obtaining and consuming “fun” and “extreme” foods, yet a slender physique is highly praised throughout the popular media. As for male anorexics, an emphasis on a muscular build leads to fanatical attempts to build a similar physique that leads young men to exercise to the point of physical exhaustion.
Psychological states play a large role in the etiology of anorexia, and the development of psychological factors are often linked to familial status, wherein both influence each other. The interaction of anorexic behavior and family environment are intertwined, and factors such as family dysfunction, sexual abuse, excessively strict parenting, and self-esteem issues are often linked to anorexic behaviors. People with anorexia exhibit low self-esteem, inadequacy, fear of growing up, poor conflict resolution, and separation issues from parents. Families with anorexics have been described as too closely intertwined, and overprotective; often there are issues between the two parents and triangulation is a common occurrence. This is not to say that the problem is the fault of the parents, yet the proverbial straw that breaks the camel’s back may be, in part, due to family dynamics.
The consideration of all factors in the development of anorexia nervosa must be considered when attempts at prevention and treatment are being made. Sociocultural and psychological origins may at first look to be more difficult to treat than biological factors; however, by acknowledging the role of biology and the effects that a well-nurtured organism has on psychologic outcomes and responses to sociocultural influences, one may be better equipped to deal with and respond to these external influences. Because all factors are interrelated, considering individual biology is the first place to begin treating and preventing anorexia nervosa.

NUTRITIONAL FACTORS

A large area of research into nutritional causes of anorexia has been dedicated to the effects of the mineral zinc and its role in the development of anorexia and other eating disorders. Although many anorexics exhibit the signs and symptoms of zinc deficiency (loss of appetite, dermatitis, depression, diarrhea, and weight loss), it is difficult to postulate whether a deficiency in zinc leads to more intense manifestations of the disease or whether progression of the disease and
resultant malnutrition causes zinc deficiency, manifesting these symptoms. However, as it is true for many diseases, causes and symptoms are often difficult to separate into definitive categories of cause and effect. The premise of this book is to provide the facts and research demonstrating that proper health factors (nutrition) allow the body and brain to function correctly, negating the development of diseases. Therefore, it is logical to reason that a person with suboptimal levels of nutritional factors may be biologically prone, or more susceptible, to a condition when deprived of adequate resources. The role of zinc and its effects on proper biologic functioning has been revealed in a number of areas pertaining to the development and treatment of anorexia.
Clinical effects of suboptimal zinc levels include emotional disorders, weight loss, and biochemical and hormonal endocrine organ function (production of estrogen, thymopoietin, and prolactin), all of which are observed in anorexics and those with other eating disorders.3 Several studies involving zinc supplementation and weight gain have provided interesting results in this area. These studies were designed to explore the relationship between zinc supplementation and weight gain in anorexic females, as measured by rate of increase of the body mass index (BMI), which is a measurement derived by calculating a person’s height and weight to determine appropriate weight. When anorexics were supplemented with 100 milligrams of zinc until they acquired a 10 percent increase in BMI, the rate of weight gain was twice that of anorexics who were not treated in this particular study.4 In another study utilizing 50 milligrams of zinc one time per day, 17 of the 20 women participants were able to increase their weight by 15 percent, one patient increased her weight by 57 percent in two years, and another had an increase of 24 percent in only three months.5 Additionally, after starting on the zinc therapy, no weight loss was recorded in any of the patients.
In addition to assisting with weight gain and preventing weight loss, zinc plays an important role in treating some of the psychological aspects of anorexia nervosa. After comparing mean urinary zinc excretion in a group of female adolescents with anorexia compared to a group of nonanorexics, it was concluded in one study that the zinc status of these patients was compromised due to inadequate intake of zinc.6 The patients were treated with 50 milligrams of zinc for six months; after which they exhibited decreased levels of depression and anxiety (assessed by the Zung Depression Scale and the State-Trait Anxiety Inventory), leading researchers to suggest that anorexics with low levels of zinc may benefit from zinc supplementation. In addition, these women also experienced gains in height and weight, clearing of skin abnormalities, improved taste, and acceleration of sexual maturation in comparison to controls not treated with zinc. The outcomes from this study underlie the premise that fueling the body correctly with the appropriate nutrients assists the mind in functioning at optimal levels. Many other examples of mood and nutritional supplementation exist in the literature that will be highlighted in subsequent chapters.
In addition to zinc deficiency and its benefits on weight and mood, other vitamins play an important role as well. Calcium, magnesium, vitamin D, vitamin B-1 (thiamine), vitamin B-12, folate, and copper, as well as essential fatty acid deficiencies have been reported in women with anorexia symptoms.7 A stark example of the effects of generalized vitamin supplementation was recently outlined in a study in which women with mild to moderate symptoms of depression who were not taking any other medications were instructed to take a multivitamin and mineral and to walk outdoors at a level of 60 percent of maximum heart rate. In comparison to the control/placebo group, the women on the multivitamin regimen experienced improvement in their overall mood, self-esteem, and general sense of well-being, and they experienced decreased depressive symptoms.8
Essential fatty acid status is, of course, greatly altered in anorexics, following a period of food restriction. A study that examined the levels of essential fatty acids in anorexics revealed fatty acid deficiencies that were different from those seen in simple fatty acid deficiencies as well as that of chronic malnutrition. Researchers noted significant changes in the structure of the fatty acids present in anorexics, implying that this was the effect of the body synthesizing its own type of replacement fatty acid, which did not appear to be a suitable alternative to the typical fatty acid found in cellular membranes, allowing for their normally optimal fluidlike function.9 The significance of these altered fatty acids is a decrease in membrane fluidity (a physiologic state that allows for greater communication between cells throughout the body). Decreased levels of essential fatty acids have numerous health implications and have been associated with conditions such as coronary artery disease, depression, cancer, arthritis, Crohn’s disease, ulcerative colitis, and lupus.10 Another group of researchers has advanced the theory that inappropriate utilization and deficiency of essential fatty acids may precipitate anorexia nervosa.11 Combined with metabolic abnormalities of hormone systems, a cascade of irregularities (which are far beyond the scope of this chapter) of fatty acid metabolism culminates in an impairment of the endocrine system causing sensations of fullness (satiety) and alterations in body image perception by the individual affected. New theories that provide a role for nutritional factors in the development of diseases such as anorexia provide greater insight into the treatment and prevention of these diseases with proper use of nutritional cofactors.

CONCLUSION

Nutrition can play an important role in the prevention of symptoms of depression, especially in those prone to these feelings. By supplementing the brain with adequate levels of nutritional cofactors, one may prevent metabolic dysregulation that so often accompanies anorexia nervosa and other eating disorders. Nutritional deficiencies may contribute to the cycle of decreased nutritional status followed by less-than-optimal neurologic and physiologic functions,

driving the symptoms of this disease. Anorexia nervosa is a complex disease with many contributing factors that all may have beginnings in less-than-adequate nutrition. One of the chief initial occurrences in this disease is a decrease in food intake. Diets in the United States, and for that matter the rest of the modernized world, do not provide optimal amounts of the vitamins, minerals, and trace mineral cofactors that play vital roles in hormonal regulation and carbohydrate and protein metabolism. When a person with anorexia begins to decrease their food intake, they may be propagating the symptoms of this disease by further tipping the scales in favor of nutrient deficiency.
We live in a society that sends so many cues to our children via advertising, with print and nonprint marketing both reflecting overly thin models, that for those who biochemically predisposed to undereating, the maladies of anorexia are all too often triggered to manifest. Indeed, if as a society we are to curb such unnecessary health trials, we must be more careful in our selection of our models who end up being role models for mind, body, and spirit.

NUTRIENTS

• Zinc 50 milligrams per day

• Calcium 500 milligrams per day

• Magnesium 300–400 milligrams per day

• Vitamin D 400 International Units per day

• B-1 20–30 milligrams per day

• B-12 1,000 micrograms per day

• Folate 1–2 milligrams per day

• Copper 1–2 milligrams per day

• Essential Fatty Acids 2–3 grams per day


Anxiety

Anxiety seems to becoming more and more prevalent today. Anxiety has become a permanent fixture in many people’s lives, affecting not only the mind, but also the body and day-to-day living as well. This chapter will address anxiety not only in the sense of an officially diagnosed psychological disorder, but also as a generalized state that so many people find themselves in from a variety of causes. Anxiety can be defined in two different ways: the first defines anxiety as an apprehensive, uneasy state of mind, typically due to an anticipated event (i.e., life stressors), and the second, more clinical definition defines anxiety as an abnormal, overwhelming feeling of apprehension or fear that is punctuated by physiologic reactions such as tension, sweating, and rapid pulse. This picture of anxiety more often involves extreme self-doubt over one’s ability to cope with the stres-sor. Regardless of definition, anxiety affects both the mind and the body to varying degrees, and more people find their lives full of these feelings.
The prevalence of anxiety in the population today is undoubtedly on the rise. Americans in particular continue to work longer hours, all the while balancing relationships, family, and home responsibilities. Because of this, it is no wonder that more people experience stress and anxiety today than ever before. However, it is an arguable point whether more people are experiencing pathologic anxiety, or what would be considered a true anxiety disorder as diagnosed by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). (This publication describes the diagnostic criteria for the most common mental disorders including diagnois, treatment, and research findings. It is published by the American Psychiatric Association and is the main diagnostic reference for Mental Health professionals in the United States.) Regardless, anxiety is an ever-increasing problem among people today, with more and more of them seeking treatment options to relieve their suffering.
DSM-IV diagnosed anxiety disorders are the most common psychiatric illnesses affecting both adults and children today. Anxiety disorders may spring from a set of complex risk factors including genetic predisposition, alterations in neurochemicals, personality traits, and life events. Anxiety disorders can be grouped into the following general categories.
• Generalized Anxiety Disorder: This is characterized by excessive, unrealistic worries that last beyond six months. This form of anxiety can be accompanied by physical symptoms associated with stress such as insomnia, gastrointestinal upset, and headaches.
• Obsessive-Compulsive Disorder: People suffering form this form of anxiety often experience persistent, recurring thoughts that are caused by exaggerated fears or anxiety. These obsessive thoughts may cause the person to perform ritualized routines in an attempt to absolve their anxieties.
• Panic Disorder: People with panic disorder suffer from debilitating attacks of panic that are often accompanied by symptoms such as heart palpitations, chest tightness, difficulty breathing, and overwhelming fear.
• Post-Traumatic Stress Disorder (PTSD): This type of stress becomes manifested following an extremely traumatic event. People with PTSD generally experience flashbacks, avoidance behaviors, emotional numbing, and physiologic symptoms such as insomnia and poor concentration.
• Social Anxiety Disorder: Characterized by an extreme fear of being judged by others or becoming embarrassed typically leads people with this type of anxiety to avoid situations involving other people.
• Specific Phobias: People with phobias will react with an intense level of fear to a specific situation or object that can lead to avoidance of the most common everyday situations.
It is estimated that 19 million adults in the United States suffer from anxiety disorders. The cost of anxiety disorders is estimated to be nearly $42 billion a year; nearly $23 billion is associated with the cost of repeated medical visits for the relief of symptoms caused by anxiety that appear to be physical illnesses, and people with anxiety are three to five times more likely to see a doctor and are six times more likely to be hospitalized for these disorders than those without.1 The economic and individual burdens of anxiety disorders are high as these conditions can be chronic and quite disabling. People with anxiety disorders utilize primary healthcare providers more often than psychiatric medical personnel, exerting a large cost on the healthcare system itself. Costs are incurred in the psychiatric, emergency care, hospital, medication, and primary-care sectors of the healthcare system; costs also include decreased productivity and work absenteeism. Only 30 percent of individuals afflicted with anxiety disorders seek
treatment for their condition, and 30 million people will experience some type of anxiety disorder at apoint in their lives.2 Affixing a specific number to the prevalence of anxiety is difficult because small changes in diagnostic criteria, interviewing, and study methods can greatly affect the results.
As mentioned previously, the etiology of anxiety disorders is multifactorial. The likelihood of developing anxiety involves a combination of life experiences, genes, and personality/psychological traits. The individual effects of these influences differ from person to person and between types of anxiety. The roles of some influences weigh differently in each type of anxiety as well, such as the familial pattern in panic disorder, despite the fact that no genes have been found that directly link the two. It is, however, generally accepted that the large majority of anxiety is rooted in stressful lifestyles and events; most anxiety disorders share a state of increased arousal and fear.3 It is important to note, however, that in many classic anxiety states there is no immediate external stressful event occurring. Science continues to attempt to uncover a complete understanding of the neurobiology of anxiety.

DIETARY FACTORS

Diet in itself is a major contributor to anxiety states and may also serve to inhibit the onset of anxiety. Perhaps one of the most important contributors to the perpetuation of anxiety is hypoglycemia, or lowered blood sugar levels due to infrequent eating or inadequate dietary choices. Symptoms of hypoglycemia have been traced to the deprivation of glucose in neurons themselves, and symptoms of low blood sugar include effects that are the result of the autonomic nervous system’s perception of the physiologic changes caused by hypoglycemia, which can include anxiety, sweating, hunger, tremors, and palpitations.4 People who do not consume the proper nutritional fuels to sustain blood sugar are at risk from this physiological phenomenon. Nearly everyone can associate with the aforementioned symptoms occurring in the late afternoon following no lunch or very little lunch with inadequate caloric value. Infrequent and/or poor food choices with a high glycemic index (foods that greatly raise one’s blood sugar leading to a drastic, reflexive lowering of blood glucose levels) are the most frequent causes of this syndrome. Other symptoms might include irritability, poor concentration, and fatigue. In one study, patients demonstrating anxiety in the form of obsessive behavior secondary to hypoglycemia (confirmed by glucose tolerance test) were treated with dietary therapy intended to avert hypoglycemic states.5 One of the subjects demonstrated a complete recovery following the dietary therapy and the other subject has made improvements comparable to his level of compliance to the therapy. Although small in nature, this study provides insight into origins and treatments for anxiety syndromes; maintaining adequate blood sugar levels (90–110 milligrams per deciliter) may serve as a key factor in preventing episodes of anxiety. One of the most interesting studies investigating the link between diet and anxiety looked at the relationship between type
of diet (vegetarian versus omnivorous) and levels of anxiety and depression. In a group of 80 subjects, significant differences in anxiety and depression levels existed between the two groups, with increased anxiety and depression in the omnivore group.6 The reasons for this are at this time undetermined; however, increased regulation of blood sugar levels may be one of the reasons for the outcome of this study.
Other precipitating causes of anxiety include dietary influences such as alcohol and caffeine. Although alcohol does exert a calming effect on the brain via its depressant effects (alcohol targets gamma-aminobutyric acid receptor [GABA(A)]–neurons; potentiation of the response of these inhibitory neurotransmitter receptors results in anxiolytic, sedative, and anesthetic activities in the human brain), it also may be responsible for increased feelings of anxiety. Subjects in one study given ethanol or a placebo were evaluated for anxiety using the Spielberger State Anxiety Inventory, a measuring device for anxiety. Subjects who received the ethanol experienced significant increases in anxiety compared to the placebo group, which actually reported decreased feelings of tension following administration of the placebo.7 As a drug that primarily exerts negative effects on brain function, alcohol should be avoided in people with increased feelings of anxiety. This is not to say, however, that alcohol should be entirely avoided by all people who at times feel anxious, but people who choose to drink and have elevated levels of anxiety should use extreme caution. Moderation, of course, is always recommended, especially in the case of anxiety.
Caffeine, on the other hand is a well-known stimulant drug, causing excitatory neurotransmission. The effects of caffeine were studied in a group of patients with agoraphobia and panic disorder; caffeine consumption produced significant increases in anxiety, nervousness, fear, nauseas, heart palpitations, restlessness, and tremors compared to the group of patients taking a placebo.8 Additionally, 71 percent of the patients taking caffeine in this study reported that the effects of caffeine were very much like the symptoms experienced during a panic attack. Another study demonstrated that patients with anxiety had anxiety levels that directly correlated with their level of caffeine consumption.9 The results of this study also suggested that people with anxiety had an increased sensitivity to the effects of only one cup of coffee; this sensitivity was reinforced by the observation that more patients with panic disorder were more likely to discontinue coffee because of its negative side effects compared to controls. Caffeine overdose may also mimic anxiety disorders, and increased sensitivity to caffeine may contribute to these patients’ symptoms; some cases of anxiety were improved for the duration of a six-month follow-up period after the discontinuation of caffeine.10 Because of these findings, it is important that patients with anxiety disorders avoid caffeine-containing foods and beverages as this may prove to be beneficial for them.

INTERVENTIONS IN ANXIETY

Treatments for anxiety disorders themselves include psychological therapies (psychotherapy and others), medication, and a combination of both. Typical medications employed in the treatment of anxiety include selective serotonin reuptake inhibitors (SSRIs), tricyclic antidepressants, benzodiazepines, beta-blockers, and monoamine oxidase inhibitors (MAOIs). These medications can be helpful to some patients; however, a large majority of people on these medications report negative side effects and discomfort with these therapies.
Several nonpharmacologic treatments for anxiety exist and have been backed by appropriate research trials. Attempts at treating anxiety without the use of pharmaceutical drugs can exist on two levels. The first is to medicate (palliate) the patient with a treatment that acts similarly to accepted pharmaceuticals or one that elicits a calming/sedative effect on the patient. The second therapeutic approach involves the use of medicines that serve to prevent the initiation of anxiety in the first place; this involves various nutritional and/or botanical therapies that work to alter a patient’s susceptibility to anxiety (prevention). The use of counseling and other forms of psychotherapy should always be considered in the treatment of a person with anxiety; a review of these therapies are not included in the scope of this book. Instead, the authors are attempting to highlight biochemical interventions (not that psychotherapy does not alter brain biochemistry itself). The complexity of anxiety warrants that several therapies be used; however, a change in treatments, whether pharmaceutical or naturally derived, demands strict attention to side effects and interactions that may occur as a side effect of using these treatments.

VITAMIN AND MINERAL DEFICIENCIES

Niacin The basis for health functioning of any organism is complete nutrition. Yes, it is often argued that an organism, or a person for that matter, can get by on less-than-optimal amounts of the basic nutritional necessities. Getting by is, however, a less-than-optimal state of being. Several vitamin and mineral nutrients and their lack in certain people may contribute to the occurrence of anxiety. Nicotinamide, a form of the B vitamin niacin, is known to have similar effects to benzodiazepines on the brain.11 Nicotinamide acts to stimulate the GABA-benzodiazepine receptor complex, an inhibitory neuron grouping, thereby exerting a calming effect through modulation of these specific neurons.12 Other experiments designed to test the efficacy of nicotinamide and brain function revealed that GABA nerve receptors were under less control (meaning that because they are inhibitory in nature, when they are not engaged the brain is more excitable—which in theory may lead to more anxiety) when nicotinamide was lacking in the test subject, and reintroduction of nicotinamide lead to a
 calming effect on the GABA receptors.13 Supplementation with adequate amounts of niacin may contribute to fewer anxiety symptoms.
Pyridoxine Pyridoxine, otherwise known as vitamin B-6, is an important coenzyme in the biosynthesis of the neurotransmitters GABA, dopamine, and serotonin, all of which are affected in anxiety, as well as depression and perception of pain. Additionally, deficiency of pyridoxine causes an increased sympathetic discharge (increased excitatory nerve impulses) and hypertension in animals that has been hypothesized to reflect a decrease in production of the previously mentioned neurotransmitters. Further, adding pyridoxine to the diets of these animals will lower their blood pressure.14 In a separate study investigating the use of magnesium and pyridoxine on anxiety-related premenstrual symptoms, investigators found that women who were supplemented with 200 milligrams of magnesium and 50 milligrams of pyridoxine each day experienced a significant reduction in anxiety-related PMS symptoms such as nervous tension, irritability, and generalized anxiety.15 Although magnesium could be considered a confounding variable in relation to the complete anxiolytic effects of pyridoxine, the information contained in this study is relevant in reference to the effects of vitamin B-6 on resolving anxiety and related symptoms.
Magnesium Magnesium supplementation enjoys a broad reputation as having a calmative effect on anxiety symptoms and stress levels. Only a few indirect studies of magnesium’s effect on anxiety exist; however, these studies demonstrate interesting results. Daro observed decreased levels of nervousness as well as insom-nia in patients supplemented with 200 milligrams of magnesium in combination with 400 milligrams calcium,16 and Seelig noted an association between magnesium deficiency and anxiety symptoms.17 A separate study investigated the use of magnesium in postsurgical patients and its effectiveness in alleviating pain. Patients were infused with magnesium both during and following surgery and were evaluated for anxiety levels. Patients receiving the magnesium infusion required significantly less pain medication (morphine and fentanyl) in comparison to the control group that received no magnesium, and the magnesium group reported less anxiety as well.18 Magnesium deficiency is common in the typical American diet, with one major survey determining that adequate magnesium is lacking in nearly 72 percent of people’s diets. It also found that 50 percent of people consume less than three-quarters of the Recommended Daily Allowance (RDA) of magnesium and 30 percent of these people ate less than half of the RDA for magnesium.19 People taking oral contraceptives–diuretic medicines (medicine that is designed to increase water loss from the body through urination) or large amounts of laxatives may be at risk of magnesium deficiency. In
addition, deficiency of magnesium has been linked to conditions such as cardiovascular diseases, alcoholism, kidney diseases, premenstrual syndrome, and cramping.20

CONCLUSION

These studies endorse the idea that adequate levels of nutrition are essential in both the prevention and treatment of anxiety symptoms. With multiple causes, anxiety is a condition that more than likely has multiple treatments in different individuals. Treating the person who has anxiety with adequate nutritional sources may possibly alter anxiety levels and offer the patient a greater quality of life.
To be human is to be anxious at some point in one’s existence. Yet, when anxiety becomes a fixture in one’s life, it is time to preemptively seek a way to intervene in order to redirect one’s life back onto a more calm, relaxed, and enjoyable road. It is not surprising to many to see more and more advertisements for anxiety medications and national talk shows discussing how to cope with the trials and tribulations of life that seem to more often than ever throw us into tailspins. By far, the best defense is a good offense, and nourishing one’s body is a great way to start. Also, the proper use of relaxing and stress-reducing exercise, mental exercises, and even prayer can all play a very important role in maintaining that inner peace that we all desire to not only achieve but to maintain at least most of the time.

NUTRIENTS

• Dietary Maintaining recommended blood sugar levels (90–110) throughout the day

• Niacin 25 milligrams per day

• Pyridoxine 25 milligrams per day

• Magnesium 300–400 milligrams per day

Autism

Autism is a highly complex developmental disability that can become manifest within the first three years of life. A neurological disorder that adversely affects brain function, autism affects mainly communication and social interaction areas, leaving the child with difficulties in both verbal and nonverbal communications. One of five related disorders among the Pervasive Developmental Disorders grouping, autism has a specific set of diagnostic criteria that is defined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). Autism affects each individual differently and with varying severity. Overall, autism incidence is fairly consistent around the globe and displays no racial or ethnic trends. The following statistical information reveals the most current statistics surrounding autism1:
• 1 to 1.5 million Americans have autism, affecting 2–6 per 1,000 individuals.
• It is the fastest growing developmental disability, affecting 1 out of every 250 children born.
• It is four times more common in boys than girls.
• Incidence is currently growing at 10–17 percent annually.
• Ninety percent of care costs are directed at autistic adults, costing $90 billion per year.
Autism affects each individual differently; those afflicted with autism process the world differently, leading to abnormal behaviors in comparison to other people in their age grouping. A person with autism may perceive certain normal sounds or sensations differently, and communication can be limited to repeated phrases or words or the use of gestures and pointing. Autistic people may

laugh, cry, or be upset for reasons that others are unaware of; they may appear aloof and prefer solitude, refusing to be touched. They may appear to have a hearing problem, not responding to any sounds or words despite normal audio-logic testing. Some of these behaviors are thought to be the result of an inability of the autistic person to integrate sensory information.
No specific cause of autism is known at this time; however, it is widely thought that an alteration in brain structure and function cause the symptoms of autism (autistic brains are of different size and shape than a person without autism). Currently, researchers are investigating the link between genes and autism, as many families display patterns among their members with autism or other related disorders. An autism gene or grouping of genes has not yet been isolated, nor has a single weak link or trigger that results in the development of autism. Other research is investigating events during pregnancy and delivery, environmental factors, metabolic diseases, and toxic exposures as other possible causes of autism.
Other considerations of causative factors in autism include the occurrence of the disorder in greater frequency with other medical conditions such as Fragile X syndrome, tuberous sclerosis, untreated phenylketonuria (PKU), and congenital rubella. One of the most debated causative factors for autism is that of mercury-containing vaccines, a theory with much plausible weight despite widespread refutation of this theory by the medical establishment. Because of the absence of one specific causative factor, autism is considered a condition that people are born with or have the potential to develop if exposed to a certain factor. Autism is not due to bad parenting or poorly disciplined children, and it is not caused by any known psychological factors that may affect the child.
Not diagnosable using standard medical testing, autism is diagnosed wholly on observing the patient’s behavior, especially the communicative and developmental aspects. Autism does share some of the same characteristics as the other previously mentioned Pervasive Developmental Disorders, and other tests may be necessary to differentiate autism from one of these other conditions, including metabolic testing. Early diagnosis is considered essential, because the sooner treatment and education is initiated, the better the outcomes that are achieved.2 Autism is detectable at the very earliest by 18 to 24 months and can become fully obvious by 24 months to 6 years of age. Some of the earliest signs a physician will screen for include: absence of babbling or cooing and gestures by 12 months, absence of speech by 16 months, absence of two-word phrases by 24 months, and a reversion or loss of language or social skills at any age thereon. Any one of these symptoms does not confirm a diagnosis; however, further testing by a physician is warranted. Several screening behavioral and communications tests are used to diagnose autism, including the Childhood Autism Rating Scale, Checklist for Autism in Toddlers (CHAT), Autism Screening Questionnaire, and the Screening Test for Autism in Two-Year Olds, all of which feature objective observational approaches to evaluating a child suspected of having autism.
In perhaps one of the most comprehensive pieces written on the various causes of autism, Kidd explores the link between numerous causative factors and their roles in the development of autism.3 Among the causes investigated in that text are congenital factors such as inborn errors of metabolism, prenatal susceptibilities and the genetic interplay between the two; biochemical imperfections such as impaired hepatic detoxification abilities and nutritional deficits; central nervous system factors such as imbalances and abnormalities of neurotransmitters; gastrointestinal tract dysfunction including impaired digestion and food intolerances; and immune system dysregulation including hypersensitivity and abnormalities in antibody- and cell-mediated functions.

NUTRITIONAL FACTORS

The vitamin and mineral status of children with autism is a subject that requires much attention. Although not implicated in the causation of autism, vitamin and mineral therapy may be beneficial for these people, due to their often less-than-optimal eating and resultant nutritional status. Feeding dysfunction, wherein the autistic child will only consume certain foods for lengthy durations, can set the autistic person up for stark nutritional deficiencies.4 An evaluation of autistic children’s nutrient status in one study revealed that greater than 50 percent of the subjects had insufficient levels of vitamins A, thiamine (B-1), niacin (B-3), pantothenic acid (B-5), and biotin as well as the minerals magnesium, selenium, and zinc.5 In addition to these nutrient deficiencies, the subjects had less-than-optimal levels of essential fatty acids (omega-3 eicosapentaenoic acid [EPA] and the omega-6 dihomogammalinolenic acid [DGLA] fatty acids) and essential amino acids. A study that investigated the supplementation of autistic children with a multivitamin and mineral over a three-month period resulted in improvements in bowel pattern symptoms and sleep quality, in addition to elevations in blood levels of vitamins C and B-6, revealing some of the benefits of nutritional supplementation for these childen.6
Other research on nutrient-focused deficiencies and treatment of autistic symptoms has provided interesting results in this area. The use of folic acid as a treatment for people with autism was begun with the use of this vitamin in large doses (250 mcg of folic acid per pound of body weight per day) in the treatment of Fragile X syndrome (a common familial form of mental retardation with behaviors similar to autism) as well as children with autsim.7 In addition, the Autism Research Institute (ARI) proclaims a strongly positive effect from folic acid supplementation according to their “better:worse” scale, a collection and average of comments from thousands of parents who treat their children with various therapies.8
Vitamin C (ascorbic acid) use in autism was tested in a 30-week trial in which the vitamin was supplemented at a dose of 8 grams per 70-kilogram body weight per day; a reduction in symptom severity was noted among the group supplemented with vitamin C.9 The Autism Research Institute scores vitamin C as
highly favorable, with a better:worse ratio of 16:1.8 An essential nutrient not manufactured by the human body, ascorbic acid plays an integral role in the functioning of several metabolic pathways, namely that of neurotransmitter production. More studies are needed in order to determine the full efficacy of vitamin C in autism therapy.
Zinc is also given a very favorable better:worse ratio from the Autism Research Institute, with a ratio of 17:1.8 One study of zinc in autism revealed that nearly 90 percent of autistic cases in the study were deficient in zinc, while at the same time 90 percent of the subjects had excessive copper levels.10 A normal biologic occurrence, zinc and copper levels are intimately linked wherein levels of one nutrient will rise resulting in corresponding decrease in the other nutrient, and vise versa. However, low levels of zinc are not favorable in any condition, especially those affecting the brain, because of zinc’s importance in neurologic tissue function and synthesis of the brain neurotransmitter serotonin, which is dependent on zinc-driven enzyme systems. Another study again found elevated copper:zinc levels in 85 percent of the autistic children enrolled.11 It is difficult to analyze the role of zinc in particular in autism from these studies; however, the importance of zinc in proper biologic function cannot be understated. The second most abundant trace element in the human body, zinc totals nearly 2 grams.12 Several of the proteins involved in gene regulation (and therefore biologic function) contain varying amounts of zinc, and it is found in approximately 300 enzymes, 100 of which depend on zinc as a catalyst.13 Additionally, zinc plays a large role in growth, development, behavior, and learning.14 Zinc is highly important in the normal and healthy function of the individual, and plays an important role in the autistic patient.
The role of essential fatty acids (EFAs) (omega-3 and omega-6 fatty acids) is integral to proper health and proper metabolic functioning. The clinical effects associated with disproportionate intake and metabolism of the two main EFAs, linoleic and alpha-linolenic acids, are most readily apparent in their metabolic byproduct concentrations in the membrane phospholipid layer, the fat-and-pro-tein-composed cellular coat that is directly responsible for correct cellular function. Cellular fatty acid content can be manipulated by dietary intake and disease processes, thereby altering the severity, character, and intensity of pathologies.15
EFAs allow for both inter- and intracellular communication, providing the substrate for signal messengers between cells. The longest of the biologically active fatty acids plays a highly important role in the neurological development of both fetal and postnatal stages.16 Additionally, infants have a limited ability to synthesize the longer chain fatty acids (that can serve as building blocks for EFAs) from shorter chain fatty acids typically found in the Western diet. Perhaps because of this, nature has done its part in assuring that infants receive these essential fats in breast milk, which contains the longer chain omega-3 and omega-6 fatty acids docosahexaenoic acid (DHA) and arachidonic acid (AA).17
Richardson and Ross have proposed that abnormalities in fatty acid distribution in membrane phospholipid metabolism may play a significant role in the
development of several neurodevelopmental and psychiatric disorders including ADHD, dyslexia, coordination disorders (dyspraxia), and autism.18 These researchers explain that the aforementioned disorders may have causation in disorders of phospholipid dysfunction, explaining the high amount of similar symptomology between those conditions and their familial grouping. Omega-3 fatty acids were found to be nearly 100 percent deficient in a population of autistic cases studied,10 whereas another study determined that blood plasma levels of omega-3 fatty acids were decreased by 20 percent in comparison to control subjects in another study.19 As reported by the Autism Research Index, essential fatty acid supplementation retains a better:worse ratio of 12:1 among people that care for autistic persons.8 Theory dictates that humans probably evolved on a diet containing a 1:1 ratio of omega-6 to omega-3 fatty acids, yet modern times have produced typical Western diets that consist of a ratio between 10:1 and 25:1, and in some cases it may be as high as 40:1. Undoubtedly, this imbalance has definitely contributed to several chronic health conditions, and newer research is elucidating the role of proper fatty acid balance and intake in autism.
A large amount of research focused on vitamin B-6 (pyridoxine) and the mineral magnesium provide very interesting results in the treatment of autism. Pyridoxine is required for the metabolism of amino acids (the building blocks of protein), carbohydrates, and lipids (fats). Pyridoxine is converted to two different coenzymes, pyridoxal phosphate and pyridoxamine phosphate, both of which play a major role in numerous metabolic reactions in the body, such as synthesis of the neurotransmitters gamma-aminobutyric acid (GABA) and the metabolism of serotonin, norepinephrine, epinephrine, and dopamine, as well as the metabolism of polyunsaturated fatty acids and phospholipids.20 As one of the most abundant minerals in the body, magnesium plays an integral role in upwards of 300 different cellular reactions and is required for the formation of cyclic AMP, an internal cellular signaling molecule.21 Additionally, magnesium shepards ion movements across the cellular membranes and is critical to proper muscular and nervous electrical impulses.22
A series of trials using both combination therapy (pyridoxine and magnesium) and solitary administration of pyridoxine and magnesium produced positive results in autistic children only when the combination therapy was administered.23 Improvements in behavior were noted along with measurements of improved biochemical markers in relation to autistic biology (Urinary homovanillic acid excretion decreased—a measurement of improved dopamine utilization in the body) as well as improved electrophysiological measurements (improved neuro-logic nerve transmission). The results from another study utilizing large doses of pyridoxine in autistic children yielded significant benefits from the treatment including increased eye contact, greater interest in the surrounding environment, decreased tantrums and self-stimulatory behaviors, and improved speech.24 In a review of 18 different studies utilizing magnesium and pyridoxine to treat autism, Rimland summarized that each study led to some type of positive results among the autistic subjects, and no significantly untoward side effects were noted
in each study.25 Galand writes in a review of magnesium and its use in stress and neuropsychiatric disorders that neuronal hyperexcitability is one manifestation of low magnesium stores, and supplementation with magnesium in conjunction with pyridoxine benefits approximately 40 percent of autistic patients, perhaps due to magnesium’s effect on dopamine metabolism.26
Dimethylglycine A form of the amino acid glycine, dimethylglycine (DMG) exists in foods as well as transiently in the body for small amounts of time in small quantities as a result of rapid metabolism.27 It has been used recently to improve neurological function, prevent epileptic seizures (one-third of people with autism will have seizures,28 although they do not have epilepsy), reduce the effects of stress (internally and externally), and as an anti-inflammatory agent. Having received a mildly favorable rating by the Autism Research Index,8 DMG is used in the treatment of autism symptoms despite relatively little research into this molecule. However, the studies that exist present favorable results. In a double-blind study comparing DMG to a placebo, 37 autistic children were treated with DMG for four weeks.29 Improvement in behavior was noted among both the placebo and DMG group; however, the difference was not statistically significant. Some of the children responded favorably to the DMG supplementation, and a smaller percentage of negative changes were noted in the DMG group. In his report on autism and its treatment using magnesium, B-6, and DMG, Rimland cites a trial of DMG use in Korea by a Lee Dae Kun, director of the Pusan Research Center on Child Problems, in which DMG was shown to provide beneficial effects on 80 percent of the supplemented autistic children.25 Rimland recommends that the initial starting dose of DMG be approximately 60 milligrams per day with a morning meal, and then slowly increased to 500 milligrams per day; effects may become noticeable within one to four weeks, although sometimes they are evident sooner.25

CONCLUSION

A highly challenging condition to treat, autism is becoming more common in our society. The causes of autism remain highly elusive today; and yet similar to several other “disorder-type” conditions affecting the brain, autism more than likely has multiple contributing factors. Supplying the autistic person with early and continuous nutritional treatment provides an effective, safe way to augment standard treatment and supplies a much-needed boost to current pharmaceutical therapeutics. Because autism is a highly individualized condition and improvements are gained after large amounts of effort, caregivers and physicians are encouraged to explore the most effective nutritional therapies that the individual autistic derives the most benefit from, even if only minimal improvements are noted.

Clinically, there is no greater single privilege than helping unlock the world of an individual suffering from autism. Indeed the untapped potential of all of us is amazing, and to work with the wonderfully dynamic individuals with autism provides the opportunity to help solve each unique biochemical, environmental, and genetic riddle relative to the proper and most effective intervention. The previously approaches shed light on a select few therapies, and one should allow adequate time with any given series of treatments so that the support of the body’s biochemical and psychological pathways have time to respond. Yet, the key, as with most health conditions, is to never stop knocking on the door of invention. After all, necessity is the mother of invention and many talented clinicians and researchers are seeking the answers to this and other puzzling health concerns.

NUTRIENTS

• Folic acid 1–2 grams per day, divided doses

• Vitamin C 3–4 grams per 70 kilograms body weight

• Zinc 40 milligrams per day

• Essential Fatty Acids (EPA/DHA) 2–3 grams per day

• Pyridoxine 50–100 milligrams per day

• Magnesium 5 milligrams per kilogram body weight per day in divided doses

• Dimethylglycine 60–500 milligrams per day; this dose should be worked up to slowly


Bipolar Disorder

Bipolar disorder, also known as manic depression, is a condition that is punctuated by wide changes in mood, thought, energy levels, and behavior. A person with bipolar disorder may witness his or her moods alternating between excessive highs (mania) and excessive lows (depression). Changes can be apparent for as little as a couple of hours to days, weeks, and even months. The cyclical or episodic occurrences of depression and mania can be solitary in nature, and episodes of mixed mania and depression can appear as well, becoming increasingly frequent leading to disruptions in all aspects of the person’s life.
Affecting approximately 2.3 million adults in the United States,1 or nearly 1.2 percent of the population age 18 years and older in any given year,2 bipolar disorder typically begins in late adolescence. Bipolar disorder can occur in younger people and may be masked as depression during teenage years; however, it can begin in young children and in older adults as well. The average age at onset of the first episode of mania is in the early 20s.3 Bipolar disorder is not a personality flaw or character weakness, and it affects men and women equally and shows no preferential distribution among age groups, race, ethnicity, and social class.
Although different from clinical depression, the depressive episodes in bipolar disorder are similar. The following are standard attributes of a depressive episode (not all people with bipolar disorder will experience the range of symptoms listed):
• Loss of energy, persistent lethargy
• Prolonged sadness or unexplained crying spells
• Irritability, anger, worry, agitation, anxiety
• Inability to take pleasure in former interests, social withdrawal
• Pessimism, indifference
• Feelings of guilt, worthlessness
• Inability to concentrate, indecisiveness
• Significant changes in appetite and sleep patterns
• Unexplained aches and pains
• Recurring thoughts of death or suicide
Mania symptoms are exhibited by the following behaviors and feelings (not all people with bipolar disorder will experience the range of symptoms listed):
• Racing speech, racing thoughts, flight of ideas
• Increased physical and mental activity and energy
• Excessive irritability, aggressive behavior
• Decreased need for sleep without experiencing fatigue
• Heightened mood, exaggerated optimism and self-confidence
• Grandiose delusions, inflated sense of self-importance
• Impulsiveness, poor judgment, distractibility
• Reckless behavior
• In the most severe cases, delusions and hallucinations
Another phase of bipolar disorder known as the “mixed” state includes symptoms from both the manic and depressive phases. During the mixed state, symptoms may include agitation, changes in appetite, psychosis, insomnia, and suicidal ideation. People can have a depressed mood while being manically activated.
Early bipolar disorder may be marked by intervals between manic and depressive episodes during which the person experiences periods of wellness, with few or no symptoms. If a person experiences four or more episodes of illness during the course of one year, they are said to have rapid cycling. In the more severe cases, a person may have difficulties with alcohol and/or substance abuse,4 and the mania or depression may be accompanied by psychosis that includes symptoms of hallucinations and delusions reflecting the mood state at that time.
There are several types of bipolar disorder; each is divided into types that reflect timing of symptomology. Bipolar I disorder is characterized by one or more manic or mixed episodes nearly every day for at least one week and one or more major depressive episodes. This is the most severe form of the disorder. Bipolar II disorder is marked by one or more depressive episodes accompanied by at least one hypomanic episode (a manic episode that is less severe than a typical manic state—these may not be severe enough to disrupt life, although they may in some people). Cyclothymic disorder is charachterized by constant mood fluctuations involving hypomanic and depressive episodes. These episodes are shorter and less severe than typical manic-depressive episodes and do not occur with the same frequency as in bipolar I and II. A final classification, known as bipolar disorder not otherwise specified (NOS) has similarities to the other classifications; however, its symptom patterns do not fit into any one of them.

CAUSATION

Bipolar disorder is a familial disease; two-thirds of people with bipolar disorder have one close relative with bipolar or depression, proving that bipolar disorder has a genetic component.5 In fact, studies investigating the genetic basis of bipolar disease indicate that multiple genes are involved in bipolar disorder.5 Studies of twins have indicated that if one twin has the mood disorder, the chances of an identical twin having it are three times higher than that of a fraternal twin; the concordance rate (the occurrence of the disorder among both twins) among identical twins is 80 percent, whereas it is only 16 percent for fraternal twins.6 Evidence of this caliber directly suggests that mood disorders, including bipolar, are partially the result of an underlying genetic susceptibility.
Uncovering the correct genetic contribution to bipolar disorder will allow for improved treatments and preventative interventions designed to target the causative factors of this illness. The cause of bipolar disorder is not only genetically linked however. The approach to this and other psychopathologic diseases is that multiple biologic and psychological factors interact to create the condition. Said otherwise, there are physical, mental, environmental, and emotional causes that when combined in certain patterns in different individuals may result in mental illnesses in susceptible people.
Unfortunately, ascribing the occurrence of bipolar disorder to genetics does not provide much information in the treatment and prevention for persons living with this disease. Whatever the exact causative factors may be, they may all interact in such a way that a person with a genetic susceptibility for bipolar disorder will manifest imperfections in the brain neurotransmitter system. Current theories hypothesize that either too high or too low of levels of neurotransmitters such as serotonin, norepinephrine, or dopamine will cause the symptoms seen in bipolar disorder, and other theories hypothesize that despite adequate levels of neurotransmitters, an imbalance exists between them, and the ratio between them is most important. Another theory suggests that differences in the sensitivity of the neurotransmitter receptors on nerve cells may lead to symptoms. All of these theories are borne out by interesting research, and chances are that each theory explains a probable role in bipolar disorder.

NUTRIENTS

One of the most popularly prescribed pharmaceuticals for the treatment of bipolar disorder is lithium. Known by many other trade names, lithium is primarily one of the basic elements and is classified in the same chemical grouping as sodium and potassium. Primarily a naturally derived substance, lithium is used to control manic episodes and is not generally sedative. The precise mechanism by which lithium works to control mania is unknown; however, it is suspected that lithium affects nerve conduction in the brain and reduces the action of the neurotransmitters norepinephrine and serotonin, thereby altering brain
chemistry. Although lithium can be considered a “natural” medicine (30 percent of all pharmaceutical drugs today are naturally derived), it is used to treat the symptoms of bipolar mania and does not necessarily contribute to resolving the cause of the symptoms. That being said, the authors acknowledge the usefulness of this medication in the treatment of bipolar disorder.
Folic Acid in Mania and Depression Folic acid, one of the B vitamins (rarely known as vitamin B-9), is intimately linked to proper brain functioning, especially in the areas of mania and depression. Several studies linking suboptimal folate levels and manic as well as depressive symptoms appear throughout the literature. A survey of 45 patients diagnosed with mania had red blood cell folate levels that were slightly less than 20 percent in comparison to those in a healthy control group.7 Serum folate in both groups were similar, however; and both groups were derived from the same socioeconomic class, demonstrating that the reduction in red cell folate in people with mania is associated with the illness and possibly related to dietary deficiency.
The roles of folic acid in psychiatric conditions have been relatively well researched, and many interesting conclusions can be drawn between this essential nutrient and bipolar disorder. A review of folic acid and its role in neu-robiology by Young and Ghadirian reveals the following information: Folic acid deficiency is quite common among people with various psychiatric disorders, absorption of folate is inhibited by anticonvulsant medications (which are employed in the standard treatment of bipolar disorder), and these patients’ psychiatric symptoms are associated with folate deficiency; several studies have displayed the effectiveness of folate in the treatment of psychiatric symptoms in folate-deficient patients; folic acid deficiency will lower brain levels of two chemicals (S-adenosylmethionine [SAMe] and 5-hydroxytryptamine [5HT]) intimately involved in proper brain function.8 S-adenosylmethionine is known to have antidepressant properties and will elevate levels of 5-hydroxy-tryptamine in the brain, leading researchers to conclude that deficiency of folate is related to decreased levels of brain 5HT. SAMe is involved in chemical reactions known as methylation, which contribute to the healthy function of membrane phospholipids, influencing nerve transmission. In addition, another study involving folate suggested that a deficient amount of this nutrient in the body might inhibit the formation of a molecule known as tetrahydrobiopterin (BH4), which is essential in the formation of 5HT and other monoamine neurotransmitters involved in bipolar and other affective disorders.9 A study investigating the therapuetic application of folic acid in patients on lithium therapy revealed that during the course of the trial, patients who were supplemented with 200 micrograms of folic acid and had the highest blood (plasma) levels of folate experienced a 40 percent reduction in affective disorders morbidity (symptoms that affected their quality of life), leading these researchers
to suggested a folic acid supplementation regimen of 300–400 micrograms daily would augment symptom control of patients on long-term lithium therapy.10 These findings demonstrate the importance of folate in psychiatric disorders. The researchers in the cited study proclaimed that at least some of the patients with bipolar and other psychiatric disorders would respond favorably to folate supplementation.
Vitamin B-12 Vitamin B-12 is another well-known nutrient that when deficient can lead to psychiatric symptoms; this has been reported in the medical literature for several decades.11 Among the symptoms caused by this vitamin deficiency are mental lassitude and depression, as well as acute psychotic episodes and mania, among others. Examples of this are highlighted in the following studies: One case of mania that was apparently due to B-12 deficiency became manifest in a patient without the telltale signs of deficiency, namely pernicious anemia.12 Supplementation with B-12 over the course of six months resolved the patient’s manic state, and continuous monthly injections of B-12 allowed the patient to maintain normal mentation. Another case report and study by Evans et al. describes the occurrence of manic psychosis that occurred in patients with no apparent he-matological manifestations of B-12 deficiency that were accompanied by changes in the patients’ electroencephalograms (EEG) along with other organic mental changes.13 The authors of this study performed a review of the literature, again citing the causal link between B-12 deficiency and brain dysfunction, leading them to suggest that the manifestation of psychiatric symptoms may occur prior to other standard manifestations (macrocytic anemia and spinal cord disease) and that all patients with neuropsychiatric diseases be screened for B-12 deficiency. Several other investigations have produced similar findings of varied manifestations of depression, mania, and other neuropsychiatric symptoms, some of which included patients with blood studies that were reflective of B-12 deficiency (macrocytic anemia) and some in which the subjects had no such mani-festations.14 All of these studies recommended nutritional status screening of psychiatric patients and blood testing in order to evaluate for B-12 deficiency upon admission to care facilities.
Selenium Minerals, in addition to vitamins, play a role in normalization of mood, including bipolar disorder. Evidence suggesting adequate intake and supply of selenium contributes to regularity in mood and exerts a positive effect on bipolar disorder (as an example of extreme mood dysregulation). A study of men utilizing the Profile of Mood States—Bipolar Form to evaluate mood in comparison to selenium levels and intake revealed that the men with initially low levels of selenium who were supplemented with a low-selenium diet scored lower on the
mood scale than those who were supplemented at a higher level; investigators hypothesized that selenium may play a role in mood regulation in the brain and that low selenium status may result in a person experiencing relatively poorer moods.15 The brain will preferentially store selenium during times of low supply, indicating an as of yet undetermined but still important role in brain function. In a review of studies involving selenium and psychological functioning, each instance revealed that low selenium intake was linked to poorer mood; se-lenium supplementation and mood is a clear example of a psychologic function modified by this trace mineral.16 In this review, the investigators revealed that although the mechanism of action of selenium on mood is not known, selenium supplementation might further activate the selenium-linked antioxidant enzyme, glutathione peroxidase.
Vanadium A trace mineral, vanadium plays numerous important roles in the body, including blood sugar regulation, proper bone growth, and as a cofactor in multiple enzymatic reactions. On the other hand, like all nutritional factors, vanadium has adverse effects when supplied or stored in excessive amounts in the human body, including kidney dysfunction, gastrointestinal upset, and central nervous system depression, to list only a few.17 Additionally, excess amounts of vanadium may contribute to bipolar disorder, as elevated blood levels have been detected in patients with mania and depression, and elevated levels have also been found in the hair of people with mania.18 Elevations in vanadium levels may cause bipolar disorder and depression by the way this trace mineral interacts with electrolyte-based nerve impulse generation systems (variations in Na-K-Mg ATPase and sodium pump activity) in the brain, which are known to be associated with bipolar disorder. Elevated blood levels of vanadium were negatively correlated with nerve cell electrolyte ratios (Na-K-Mg ATPase to Mg-ATPase) in patients with bipolar disorder, but not in healthy subjects, suggesting a relationship between vanadium and proper electrolyte-generated nerve cell transmission.19 A study of bipolar patients and their intake of vanadium revealed that both manic and depressed patients felt better with a reduced dietary intake of vanadium, further suggesting the role that vanadium may contribute to bipolar disorder.20 Although difficult to avoid, vanadium is found throughout the environment naturally and as a result of industrial processes. Decreasing vanadium levels in the diet may be difficult to achieve; however, by drinking only filtered water and avoiding excessive intake from large amounts of mineral supplements, blood levels of vanadium can be reduced by vitamin C and a compound known as EDTA (Ethylenediaminetetraacetic acid).21 Known as a chelating agent, EDTA is a complex molecule that has the ability to bind certain metals in the blood stream, assisting the body’s removal of them through the urine. Vitamin C may be helpful in the treatment of bipolar disorder through its mecha-
nism by which it reduces the ability of vanadium to alter previously described nerve cell electrolyte systems.22

BOTANICAL MEDICINES

There are several botanical (herbal) medicines that may be helpful in normalizing moods, especially during times of mania. Valerian (Valeriana officinalis) is used as a sedative-hypnotic most successfully in insomnia and for reducing anxiety-induced restlessness and sleeping disorders, often seen in individuals suffering from both mania and depression. Valerian use on a daily basis has been shown to reduce sleep latency and to improve sleep quality as reported by patients taking the herb.23 Described as having mildly sedative, anxiolytic, and antidepressant effects, the use of valerian in people with bipolar disorder may be helpful. Valerian works to relieve anxiety by the ability of its constituents (valepotriates) to prevent the breakdown of enzymes in the brain that are responsible for degrading inhibitory (GABA) neurotransmitters (allowing for greater sedation of the brain) and by another constituent known as hydroxy-pinoresinol to bind to the same brain receptors that the depressant drugs known as benzodiazapenes do.24 Although valerian is considered a mildly sedative herb, it does not appear to slow important psychomotor functions such as reaction time, alertness, and concentration; however, it may cause morning sluggishness.25 As a sedative, however, use of valerian with other “relaxing” drugs (i.e., benzodiazapenes) may cause additive effects, leading to too much sedation. This is, of course, a risk in patients with more than mild depression; patients should use caution when using this herb for bipolar disorder.
Lavender (lavendula officinalis) has mild relaxant effects and is used traditionally for restlessness, insomnia, depression, and nervousness. Lavender preparations are commonly derived from the plant oil; internal ingestion is contraindicated. However, plant oils do exert physiologic effects when inhaled, as the oil can penetrate mucous membranes lining the respiratory system. The constituents of lavender oil when inhaled lead to relaxation and decreased alertness.26 Inhalation of lavender oil scents may serve to modulate feelings of anxiety in patients with mania.
Lemon balm (Melissa officinalis) is another botanical medicine with mild calming effects and the ability to reduce alertness,27 which is useful in the treatment of nervous anxiety, as well as other nonrelated medical problems. The oils of this plant contain compounds known as terpenes, which have sedative effects are rapidly absorbed by the lungs, and can cross the blood-brain barrier, allowing them to directly affect brain function (terpenes are thought to act on some of the inhibitory neurons [GABA] in the brain, thereby eliciting their calmative effects).28 A study utilizing both valerian and lemon balm demonstrated an improvement in the amount and quality of sleep in subjects taking this herbal combination.29

CONCLUSION

Bipolar disorder, or manic depression, is a condition with many possible causes; however, little is truly known about the origins of this disease. But science is beginning to uncover the link between nutritional elements that may contribute to the symptoms of bipolar disorder. Several vitamin and mineral deficiencies (Vitamin B-12, folic acid, and selenium), as well as excessive amounts of the trace mineral vanadium, may predispose certain individuals to this condition. The importance of nutrients in proper brain function and bipolar disorder is perhaps best demonstrated in the following study: A group of DSM-IV-diagnosed bipolar disorder patients aged 19 to 46 years were given a treatment of high-dose vitamin and mineral supplements.30 After six months of this therapy, the patients experienced a decrease in symptoms by 55 percent to 66 percent and a reduction in the need for psychotropic medications by more than 50 percent; some patients were able to replace their pharmaceutical medication with the vitamin and mineral supplement, remaining well for the duration. This is an example that drives home the point that diseases are not the result of deficient pharmaceutical medications; rather they have definitive origins in nutritional deficiency. Additionally, the use of botanical medicine provides a more gentle approach to bipolar disorder and, when used properly, may serve to attenuate some of the extremes of moods with fewer side effects than those of pharmaceutical medications.
Life is full of ebb and flow, yet for patients with bipolar symptoms, the pendulum swings to the extremes and warrants concise intervention to assist them in maintaining their mental functioning between the proverbial yellow lines of the road of life. The condition we refer to as bipolar is no different then any other health concern in so much as the patient is manifesting with symptoms that need attention and a concerted effort to address the underlying cause of the problem at hand. Often patients will present with symptoms, whereas previously they were apparently symptom free. Thus the question must be asked, what was the trigger and how can it be best addressed?

NUTRIENTS

• Folate 200–300 micrograms per day
• B-12 2,000 micrograms per day
• Selenium 200 micrograms per day

BOTANICALS (FOR EPISODES OF MANIA)

• Valerian 300–400 milligrams twice per day

 • Lavender Tincture (1:5 in 50 percent alcohol) 30 drops twice per day

• Lemon Balm 80–100 milligrams twice per day


Depression

The journey of life is painted with a vast array of emotions. Good, bad, and everything in between, it is a large part of the human condition that we all feel something, at all times. However, feelings of depression should not last for more than a few days to even weeks at a time at most, throughout the course of “normal” living. Approximately 19 million American adults suffer from clinical depression in a given year; this number is equivalent to nearly 9.5 percent of the adult population.1Almost twice as many women (12 percent) as men (6.6 percent) are affected by depressive disorders each year; these numbers are equivalent to 12.4 million women and 6.4 million men in the United States.2 Depressive disorder (which includes major depressive disorder, dysthymic disorder, and bipolar disorder) accounts for three of the leading causes of disability in the United States and other developed nations (major depressive disorder ranks as number 1); many people who suffer from one mental disorder will suffer from additional disorders3; for example, many people with depression suffer from anxiety as well. The focus of this chapter is on major depressive disorder; treatment recommendations can be extended to dysthymia as well. Refer to separate chapters on bipolar and anxiety disorders for more information.
Major depressive disorder can develop at almost any age, but it occurs most commonly in a person’s mid-20s; dysthymic disorder, however, often begins in childhood, adolescence, or early adulthood.4 Depressive disorder is a mental illness that involves the mind as well as the body; it disrupts the way sufferers sleep and eat, as well as how they think of the world and themselves. It is not simply an extended “down” mood, the lack of mental or personal strength, or laziness. Untreated, people with depression can have symptoms for years on end. Defined according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV),5 depressive disorders can be defined in the following manner:
Major depression has a combination of symptoms that occur with nearly every aspect of life (work, study, sleeping, eating, enjoyment) and can occur only once or several times throughout life.
Dysthymia is a less severe form of depression that includes similar but milder symptoms that may be more chronic, preventing a person from ever feeling entirely “right.” People with dysthymia can experience major depressive episodes as well.

SYMPTOMS

The American Psychiatric Association bases its diagnosis of depression on the following criteria:
• Loss of appetite and/or weight or overeating and weight gain
• Insomnia, early morning awakening, or oversleeping
• Physical inactivity or hyperactivity
• Loss of interest or pleasure in hobbies and activities that were once enjoyed, including sex
• Decreased energy or fatigue
• Feelings of guilt, worthlessness, or helplessness
• Difficulty concentrating, remembering, or making decisions
• Thoughts of death or suicide; even attempts at suicide
The presence of five of the cited symptoms is indicative of clinical depression, whereas the presence of four indicates probable depression. Symptoms must be present for at least one month to qualify as depression. Each person is different and experiences varying grades, severity, and types of symptoms that may even change over time. Other symptoms of depression may include: feelings of hopelessness or pessimism, persistent sadness, anxiousness or emptiness, and restlessness or irritability. Persistent physical symptoms that do not respond to standard treatment, such as headaches, digestive disorders, and chronic pain may also be present in depression.

CAUSES OF DEPRESSION

Depression has several origins. Some forms run in families, hinting at an inheritable (genetic) link; other forms can occur in people with no family history of depression. Regardless of form, however, both brain structure and function changes are associated with this disease. People with low self-esteem or who are overly pessimistic or easily overwhelmed by life stressors are prone to depressive illnesses—this may represent a possible personality susceptibility to depression. However, more often than not, various factors combine to cause a major depressive episode. Serious medical illnesses (heart disease, cancer, etc.), relationship stresses, a serious loss, financial problems, and even positive life changes may
combine to cause a depressive episode. In addition, once a person has suffered from a major depressive episode, he or she may become more at risk from future episodes that may be triggered from lesser stresses. In short, combinations of psychological, environmental, and genetic factors can combine to bring about depression.

EVALUATION AND DIAGNOSIS

Determining if a person is suffering from depression involves a trained mental health professional taking a detailed history of symptom onset, duration, and severity; past or current treatments; and if they have ever occurred before. Other interview information regarding drug or alcohol use (pain, whether mental or physical, is often self-medicated), family history of depression, and suicidal thoughts should be obtained. Additionally, a mental status examination will be administered in order to determine the extent of depression from which the person may be suffering. Note: These steps and previously mentioned diagnostic criteria have been abbreviated in this text. Readers are directed to a more thorough workup of depression in the DSM-IV.

NUTRITIONAL FACTORS

Like every other mental illness, we all too often focus on the presenting symptoms of the disease. Treating symptoms in many cases can be highly beneficial for the patient. However, in order to delve deeper into medicine, we can look at body chemistry as the origin of dysfunctional neurologic function and depression; nutritional factors in depression have been researched in some detail and certain botanical medicines provide excellent treatment for depression and its origins.
Folic Acid Folic acid’s role in depression has been extensively investigated in the research. The information indicates that folate may play several roles in depression, as deficiency and low folate status have been linked in clinical studies to depression, persistent depressive symptoms, and poor antidepressant response. In a systematic review of research databases covering trials in which folate was used to augment treatment of depression, it was determined that folate has a potential role to supplement other treatments for depression; additionally it was determined that no adverse effects were encountered from the use of folate and other standard depression treatments.6 The prevalence of folate deficiency in the United States may accompany certain numbers of people with depression; this establishes folate deficiency as an associated risk. A study investigating this link determined that people who met the criteria for either lifelong major depression or dysthymia had lower folate concentrations than
healthy people without depression.7 The sample group in this study was taken from different ethnicities ranging in ages from 15 to 39. From this study, the authors suggest that folate supplementation be administered to depressed people for a year following their episode. Because of the chronic nature of depression, and the associated future susceptibility, a lifetime supplement program seems to be more advisable (not to mention the other benefits of folate on homocysteine, etc.). Clinical observations and recent advances in the understanding of folate in brain metabolism have somewhat defined the role of folate and depression; folate deficiency commonly leads to neuropsychiatric symptoms of depression.8 Additionally, low levels of folic acid have been demonstrated to result in poorer response to antidepressant medications, namely selective serotonin reuptake inhibitors.9 Establishing an even greater tie to depression, serum and red blood cell levels of folate were found to be significantly lower in patients with major depressive disorder than healthy controls, and lower serum folate concentrations were associated with a greater severity of depression.10 From just these few examples of studies tying folate to depression symptoms, it stands clear that folic acid should be one of the first supplements considered in the prevention and treatment of depression.
Pyridoxine Pyridoxine (vitamin B-6) undergoes conversion in the body to two coenzymes, pyridoxal phosphate and pyridoxamine phosphate, and is subsequently used in numerous metabolic processes. One aspect of these reactions is the synthesis of brain neurotransmitters such as GABA, serotonin (a key neurotransmitter in depression), norepinephrine, and dopamine.11 Pyridoxine is beneficial in lessening symptoms of depression in major depression as well as premenstrual syn-drome.12 The usefulness of pyridoxine in modulating central production of neurotransmitters is further evidence that deficiency, or inadequate supplies, may contribute to neurotransmitter dysregulation. High doses of pyridoxine may serve to ameliorate certain dysphoric mental states that are particularly associated with hopelessness or cynicism and to improve prognosis in this condition.13 Pyridoxine more than likely exerts its beneficial effects on the brains of people with depression via its function as a cofactor for the enzyme 5-hydroxytryptophan decarboxylase, which serves in the production of serotonin (decreased levels of serotonin are one of the main physiologic causes of depression).14 Although inadequate amounts of pyridoxine are implicated in depressive disorders, actual blood levels of this and other B vitamins associated with depression are not always found to be as low in patients exhibiting symptoms; blood vitamin levels do not reflect true brain vitamin function nor are they reflective of symptom severity in all cases.15 Pyridoxine is another important vitamin with protective effects against depression in that it assists in the production of key neurotransmitters that may be deficient in this disease.Vitamin C
Vitamin C, or ascorbic acid, is a nutrient that seems to always capture attention no matter what investigational study it undergoes. Part of the reason for this is that so many benefits are derived from vitamin C in such wide-ranging medical conditions. Although it is not new information, vitamin C does have benefits in depression and is also implicated as a precursor to the disease when deficient in the body. In a review paper studying the clinical effects of ascorbic acid deficiency in people, Hodges et al. noted that depression is one of the first symptoms of scurvy in humans who were experimentally subjected to deficient vitamin C diets.16 Indeed, scurvy is relatively rare in modern life; however, diets low in vitamin C are not, especially with processed food diets on the rise. Further studies on vitamin C and scurvy revealed an interesting link between psychiatric patients and vitamin C levels. A study of psychiatric patients (some of whom had bipolar depression) revealed that many were in a state of low vitamin C saturation, or “subacute” scurvy.17 This and another study involving a similar population of patients also demonstrated decreased vitamin C load, or borderline scurvy, without actually manifesting the symptoms of this disease.18 Patients with depression and other psychiatric diseases may be in states of sub-acute scurvy; defining the actual point of insufficiency is difficult, especially today when RDAs are designed to supply the minimal amount of nutrients to prevent disease. Receiving just enough nutrients to prevent disease does not mean that a state of optimal health is achieved. In order to prevent illness and to be in a state of optimal health, sufficient amounts of nutrients are needed, above and beyond the amounts said to prevent disease only.
Cobalamin (B-12) The role of vitamin B-12 in depression is similar to that of pyridoxine (B-6) and folate. Deficiency of B-12 may lead to symptoms of depression, among other neuropsychiatric symptoms.19 In fact, deficiency of B-12 accompanies many depressive cases in which folate is low as well; deficiencies of both vitamins are common in major depression.20 Although bodily stores of B-12 are higher (generally), a relative deficiency or inefficient utilization of this vitamin leads to a functional deficiency of folate11 (folate depends on B-12 for its own metabolism). If this were the case, a person would have an especially difficult time manufacturing the neurotransmitters that are typically in short supply in depression (serotonin) because of the effect that folate has on serotonin production. Additionally, depression is a symptom of B-12 deficiency itself and may be manifested in addition to other neurologic symptoms when B-12 is deficient.21 More specifically, B-12 is required in the synthesis of S-adenosylmethionine, which serves as a precursor to neurotransmitter production, as well as in the manufacture of proteins, DNA, and cellular phospholipids (components of cell membrane that regulate cellular metabolism).22 A study of 700 older women designed to
determine whether women with B-12 or folate deficiency were prone to depression revealed that those with a B-12 deficiency were more than two times likely to be severely depressed in comparison to nondeficient subjects.23 Supplementation of B-12 along with folate is highly important to ensure that the effects of both vitamins are rendered effective. (Folate is more dependent on B-12 than vice versa.) Folate and B-12 are also necessary for the prevention of other neuro-logic diseases such as Alzheimer’s disease and other dementias.

5-HTP

A precursor substance to the neurotransmitter serotonin is 5-Hydroxy-tryptophan (5-HTP). It is related to the amino acid L-tryptophan, which is converted in the body into 5-HTP, and it is able to cross into the brain and augment supplies of serotonin. Because of this, 5-HTP acts as an effective treatment for depression, as well as other conditions such as insomnia. Neurobiologists currently recognize insufficient activity of serotonin (including other neurotransmitters) as a key element in the pathogenesis of depression. One review article of the various precursor treatments for depression expressed that such therapies hold a therapuetic value in the treatment of depression and that more research is needed to confirm additional efficacy.24 Another review article expressed the efficacy of 5-HTP as high in treating disorders like depression, in addition to binge eating and insomnia.25 Employed as a nutritional food supplement, 5-HTP is a beneficial adjunctive treatment for patients with depression. Although the greatest task in medicine is identifying and removing the cause of disease (which in most cases of depression seems to be an inadequate activity/supply of serotonin), supplying this nutrient can act as a bridge to bolster the patient’s neuro-chemistry while other nutritional treatments can be employed that may in principle restore brain neurotransmitter dysfunction. As the patient’s symptoms decrease, tapering of supplemental 5-HTP will allow the patient to continue functioning normally, with fewer supplements.

BOTANICAL MEDICINE

Hypericum perforatum
One of the most investigated botanical medicines from a phytochemical aspect, St. John’s Wort is a viable alternative to standard pharmacotherapy for depression. A literature review of the effects of St. John’s Wort (Hypericum perfoliatum) reveals the efficacy of this herbal medicine in several biochemical pathways that play a central role in depression and its pathogenesis, including the monoamine oxidase (MAO), serotonin, gamma-amino butyric acid (GABA), and dopamine neurotransmitter systems.26 Although no single constituent of the herb has been indicated in the plant’s effectiveness in treating depressive disorders, the efficacy of St. John’s Wort is similar to that of standard pharmaceu-
tical therapeutics.27 This being said, two main constituents of Hypericum are thought to play a major role in the plant’s effect on depression. In addition to the originally identified active principle hypericin, other constituents such as hyperforin, adhyperforin, and other related compounds are thought to play an active role in the modulation of depression.28 The extracts of this plant have been intensely studied for the last decade and are now considered a viable medicine in standard antidepressant therapy. A review of the mechanism of action(s) of Hypericum’s constituents include the abilities to bind to GABA receptors, down-regulate beta-adrenergic receptors, and up-regulate serotonin 5-HT(2) receptors; these effects lead to positive changes in neurotransmitter concentrations in areas of the brain that are implicated in depression.29
Hypericum displays a currently unparalleled broad profile in its effects on neurotransmitters. Because of this, Hypericum demonstrates effectiveness in a number of pharmacology models of antidepressant efficacy.30 St. John’s Wort is tolerated well by patients and has a very low incidence of adverse affects when taken properly. Despite this benefit, several drug interactions have been uncovered with Hypericum that are clinically significant. A recent double-blind, randomized, placebo-controlled trial involving 375 patients with depression taking 300 milligrams three times a day of standardized Hypericum extract produced a significantly greater reduction in Hamilton depression scale scores and was more effective in patients with higher depression symptom scores.31 This study concluded that Hypericum extract was more effective than placebo in treating mild to moderate depression, and patients taking the extract had no more negative side effects than those people taking placebo. An effective medicine with few, if any, side effects, Hypericum can be employed as a frontline therapy in the treatment of depression. This herb represents an ideal treatment for depression, and nutritional causes are being pursued as well.

CONCLUSION

Depression is a disease that has various origins of varied nature. Treating the patient nutritionally provides a base for stabilizing brain neurotransmitter function and may lead to stabilization of symptoms when treatment is continuous. The role of vitamin factors in this disease is further backed by interesting research highlighting the various roles in which they are known to contribute. Nutritional neurotransmitter precursors such as 5-HTP provide a very specific source of fuel for the brain, supplying it with the building blocks it needs to function correctly. St. John’s Wort provides a highly effective natural medicine that can augment depression treatment, with few side effects, and can serve in place of standard pharmaceuticals that are often poorly tolerated.
Depression has been well documented throughout human history; ancient civilizations varied their perspective as to both the etiology and the treatments. Among the various treatments were bloodletting, spiritual interventions, fasting, and even transfusions with the blood of animals that were perceived as being
more potent. Indeed, the true cause of the depression needs to be addressed so that the root cause can be eliminated. A healthy mind, body, and spirit fostered via a good diet, mental hygiene, exercise, and pursuit of deepened spirituality can all help augment quality of life. It is always important to note that depression is a serious health concern and warrants close and careful management and that some patients, regardless of natural medicine interventions, may need additional assistance with pharmaceutical agents.

NUTRIENTS

• Folate 1–2 milligrams per day

• B-6 5–10 milligrams

• Vitamin C 1,000–2,000 milligrams

• B-12 500 micrograms per day

• 5-HTP 150–300 milligrams per day

BOTANICALS

Hypericum perforatum 300 milligrams three times per day (standardized to 0.3 percent hypericin or 4 percent hyperforin)

Hormonal Mental Health

This chapter, unlike the others in this book, takes a different approach in looking at optimal brain function by focusing on the body’s hormones and how they are affected by nutritional and botanical supplementation. Not an overt disease condition, hormone irregularities and their effects can highly impact one’s health and mental state of being. Hormone irregularities are common throughout the human health spectrum, and there is much we can do to assist in returning patterns toward normal and to help the body to better utilize its hormones. This approach is important, as hormones exert powerful effects throughout the body, in both sexes.
The human body synthesizes approximately 20 different hormones, all of which are normally tightly regulated by a system of glands that produce them known as the endocrine system. Often overlooked in subclinical health conditions, the glands of the endocrine system secrete hormones that influence every cell, organ, and function in our bodies. Hormones are a specific set of chemical messengers that transfer information and instructions from one group of cells in our bodies to another. In addition to their many other functions, hormones influence our moods to a greater degree than many may think. The endocrine system’s effects on the body are far reaching, and its control of body systems is comparable to that of the nervous system. Generally however, hormones operate more slowly, but have longer lasting effects in the body. Hormonal molecules are released and travel through the blood stream until they reach a specific cell that is programmed to be receptive to the hormone, allowing it to affect the cellular function. Hormones are produced in small amounts by tissues other than those of the endocrine system. The brain is one area, as well as the kidneys, liver, heart, lungs, and skin.

Hormone levels fluctuate on a variety of time schedules and are directly affected by stress, infection, and even shifts in electrolyte levels in the body. Additionally, hormones play a role in modulating our behavior, and when imbalanced, the endocrine system’s effects are felt widely throughout the body. Both men and women are deeply affected by the levels of hormones in their bodies. Humans are deeply entrained to the ebb and flow of natural cycles both inside and outside of our bodies, and we are highly sensitive to our environment despite our perceived mastery of our surroundings. Women are especially affected, experiencing a monthly hormonal cycle that governs the menses, which allows for the continuation of a new life. New insights have also brought to light the hormonal cycles of men and the possibility of a “male menopause,” known as andropause, which may affect them similarly to the way menopause affects women. Despite these findings, it is clear that women share a much greater burden from the ebb and flow of hormonal cycles and stand the greatest chances of being negatively affected by them.
Hormones play an important role in modulating our behavior, and the brain stands at the center of hormonal control, just as it does with the rest of our bodily processes. The brain controls the release of hormones through its connection with the nervous system. Located deep within the brain, an area known as the hypothalamus is able to “read” the state of affairs in the body and, in turn, is directly linked to the pituitary gland (often referred to as the “master gland”). The hypothalamus can either stimulate or suppress hormone secretions from the pituitary. The pituitary gland manufactures and secretes a set of hormones that directly control all of the other hormone glands in the body. The production and secretion of pituitary hormones can be influenced by factors such as emotions, physical states, and seasonal changes. To accomplish this, the hypothalamus relays information sensed by the brain (such as environmental temperature, light exposure patterns, and feelings) to the pituitary. One can think of the pituitary gland and hypothalamus as upper management of a corporation and the glands such as the ovaries, testes, adrenal glands, and thyroid as the employees. The pituitary and hypothalamus are continually monitoring work performance and adjusting their orders according to production. Much like master chefs, these glands “sample” the blood levels for various hormone levels and request shifts in the recipe accordingly.
The purpose of this illustration is to emphasize the importance of mental states (feelings, emotion, and external environmental clues) and the brain’s influence on hormone secretion. A healthy mental state, which can be augmented by a proper intake of nutritional supportive factors, has an effect on the rest of the body via the endocrine system. Therefore, when treating a physical problem, it is important to explore the link between brain function and hormonal influences on the body. Similarly, the reverse is true; when the body is improperly nourished, hormonal levels may become improperly regulated as the body strives to control hormonal levels as precisely as it can. When in short supply, several nutritional factors may exert an effect on hormone levels, and therefore mani-
fest physical and mental symptoms. Often times problems in the body arise from an inability to properly metabolize hormones and establish a beneficial level. Taking this a step higher, utilizing natural medicines in the form of herbs can produce excellent outcomes in the realm of hormonal balance as well.

PREMENSTRUAL SYNDROME AND PREMENSTRUAL DYSPHORIC DISORDER

Premenstrual syndrome (PMS) is perhaps the most commonly experienced symptom of hormonal irregularity. PMS is defined as a series of physical and emotional symptoms that occur in the second phase of the menstrual cycle. The most popular theory for the cause of PMS is an imbalance of hormones, namely deficiency of progesterone and excess levels of estrogen. Symptoms vary for each woman and may last typically from 4 to 10 days. The most common symptoms include acne, anger, anxiety, bloating, breast pain, uterine pain, depression, dizziness, fatigue, headaches, hostility, insomnia, irritability, mood swings, nausea, nervousness, and tension. The emotional symptoms of PMS are the most problematic and can have extensive effects on a woman’s work and social and family life. Premenstrual Dysphoric Disorder (PMDD) is not a new condition and is in fact a more severe form of PMS. The symptoms are similar; however, they markedly impair a woman’s ability to function in everyday situations at work and home and in social and relationship interactions. Research suggests that of the 80 percent of women that have PMS symptoms, 5–10 percent of them meet the diagnostic criteria for PMDD.1 PMDD is included in the Diagnostic and Statistical Manual IV (DSM-IV); whether this solidifies the condition as an “official” ailment is to be decided, but in simple terms it defines a need for better management of symptoms. Physical symptoms aside, the mental-emotional toll of PMS, if untreated, leads to significant disability on a monthly basis for millions of women. When PMS is treated in a fashion to alleviate the root cause (PMS is not an ibuprofen deficiency!), significant symptom resolution can be achieved.
Commonly occurring symptoms of premenstrual irritability, mood changes, anxiety, and appetite and sleep variation in women with PMS are experienced mostly during the premenstrual phase; however, it is thought that many other women having these symptoms may indeed suffer from mood and anxiety symptoms throughout the entire menstrual period. A study was designed in order to determine to what extent women who suffer from PMS and seek treatment for these symptoms have mood or anxiety disorders in addition to PMS. A survey of 206 women revealed that 39 percent met the criteria for mood or anxiety disorders, or both; it was determined that mood disorders were twice as common as anxiety disorders.2 The significance of these findings reveals a possible link between PMS and other mental disorders. With the majority of PMS symptoms related to hormonal dysregulation, it is possible that this may lead to increased mental dysfunction if hormonal balance becomes so skewed in a segment of the population that the women may have additional mood and anxiety disorders in

relation to PMS. Early diagnosis and treatment of mood and anxiety disorders (and with every other disease condition) provides the best chances at full recovery and lower chances of reoccurring.

NUTRIENTS IN PMS

Pyridoxine Pyridoxine (vitamin B-6) was shown to be effective in relieving depression in women taking oral birth control in a number of studies in the 1970s.3 In addition, these studies confirmed that women using birth control had an impaired B-6 status and that administration of 40 milligrams of B-6 restored normal levels and relieved clinical symptoms of oral birth control pill–induced B-6 deficiency.4 In a review of several studies that investigated the efficacy of B-6 in treating PMS and PMS-related depression, it was determined that treatment with B-6 improved both PMS symptoms and PMS-related depression.5 A separate studied examined the efficacy of B-6 in the treatment of PMS in comparison to three standard pharmaceuticals (alprazalom, fluoxetine, and propranolol).6 The following results were obtained: Fluoxetine in 10 mg doses resulted in a mean reduction of 65.4 percent in symptoms, propanolol resulted in a 58.7 percent reduction, alprazolam resulted in a 55.6 percent reduction, pyridoxine resulted in a 45.3 percent reduction, and placebo resulted in a 39.4–46.1 percent reduction. Pyridoxine was used in a dose of 300 milligrams per day; this study demonstrates the efficacy of using one individual nutrient (with virtually no side effects at this dose) when compared to pharmaceuticals with wide-ranging side effects. In this example, pyridoxine appears to be a superior choice for PMS treatment, despite its lower percentage of symptom reduction, because it provides the greatest amount of benefit, with the least amount of side effects, at a fraction of the cost.
Magnesium Magnesium, a wide-ranging mineral in the body, is another useful treatment for PMS symptoms. One of magnesium’s greatest uses is in alleviating muscle cramping and tightness, as well as generalized musculoskeletal discomfort (Epsom salt baths, highly useful for treatment of sore muscles, contain mainly magnesium salts). The use of magnesium in PMS has also been studied extensively and is found to be clinically useful for this condition for several reasons. A study examined the effects of 200 milligrams per day of magnesium for the duration of two menstrual cycles for its effects on premenstrual fluid retention.7 Each study participant kept a daily log of symptoms; no significant effect was noted during the first cycle; however, during the second cycle, a notable reduction in weight gain, swelling of extremities, breast tenderness, and abdominal bloating was noted by the participants. In addition to demonstrating the usefulness of magnesium for fluid-retention-related PMS symptoms, this study highlights a common theory
that complete tissue saturation with magnesium can take several weeks to accomplish (and thus for the patient to benefit from the effects of supplementation). It should also be noted that this study utilized a small amount of magnesium; a dose comprable to approximately 300–500 milligrams is recommended for optimal results for PMS symptoms.2 The beneficial effects of supplementation with magnesium on PMS symptoms may be due in part to magnesium’s relative deficiency in women who experience PMS. A study measuring red blood cell levels of magnesium in women who experienced PMS in comparison to those that did not revealed a decreased level of both red blood cell and white blood cell magnesium content in the group of women with PMS.8
Most importantly, magnesium has an effect on the mental symptoms that can occur with PMS. Another trial focused on magnesium’s effects on mood in PMS sufferers revealed positive results in this symptom category as well.9 A group of women affected by PMS were supplemented with 360 milligrams of magnesium three times a day, from day 15 of the cycle to the onset of menses. Utilizing the Menstrual Distress Questionnaire, researches found that treatment with this dose of magnesium resulted in lower questionnaire scores, meaning that negative symptoms associated with mood were decreased in the women taking magnesium. Because of this finding, the researchers of this study concluded that magnesium supplementation could be an effective way to treat PMS-related mood changes. In another hallmark study, magnesium was administered in order to determine its effects on nervous sensitivity, which can accompany emotional instability as part of the mood changes that a woman may experience premenstrually. This study demonstrated a decrease in feelings of nervousness in 89 percent of the study subjects, and in addition, breast tenderness and weight gain were reduced in 96 percent and 95 percent of the subjects, respectively.10
A study combining the effects of both magnesium and pyridoxine was performed in order to elucidate the synergistic effects of both nutrients on PMS-related anxiety symptoms. A significant effect using 200 milligrams per day of magnesium in combination with 50 milligrams of vitamin B-6 was observed on anxiety-related PMS symptoms of nervous tension, mood swings, irritability, and anxiety.11 This and the previously cited studies demonstrate clearly defined beneficial effects of both supplements; the aforementioned study that combined the use of magnesium and pyridoxine utilized relatively small doses of these nutrients, and further studies investigating higher doses of both nutrients may reveal even greater benefit for women with PMS-related mental symptoms. It is noteworthy that in order for magnesium to achieve proper optimal cellular effect, adequate B-6 must be present. Thus, supplementation with magnesium in some patients with a relative deficiency of B-6 will not yield adequate results unless B-6 is supplemented.
Other Nutrients Vitamin E is a fat-soluble vitamin that has demonstrated usefulness in PMS. Although not directly related to mental states, vitamin E has been shown to
significantly decrease PMS-related breast symptoms of pain and soreness (doses ranged from 150 to 600 International Units per day).12 When studied in relation to other PMS-related mental emotional symptoms, the use of 400 International Units of vitamin E per day was able to produce a 38 percent reduction in anxiety and a 27 percent reduction in depression after three months.13 In addition, the test group taking vitamin E reported an increase in energy levels, fewer simple carbohydrate (sweets) cravings, and fewer headaches.
One suspected contributor to PMS symptoms, in addition to excess estrogen, is an excess of another hormone known as prolactin. Prolactin, in a simplistic description, prepares the breast tissue to begin producing breast milk in anticipation of pregnancy. A surge in prolactin may occur in some women with PMS, which may be partially responsible for some of the breast swelling and tenderness that accompanies PMS; researchers have noted that many symptoms of PMS are similar to those caused by an injection of prolactin and theorize that some women may be excessively sensitive to prolactin. Additionally, it is known that a derivative of essential fatty acids (prostaglandin E1) can inhibit some of the effects of prolactin in the body and that an absence or deficiency of prostaglan-din E1 will allow for exaggerated prolactin effects. Because of this, several studies were performed in order to determine the effects of treating women’s PMS symptoms with gamma-linolenic acid, an essential fatty acid precursor of prostaglandin E1. In addition, evening primrose oil (also an essential fatty acid precursor of prostaglandin E1) was shown to be highly effective in treating depression and irritability, as well as breast pain and tenderness and fluid retention associated with PMS.14 A later study was able to reproduce these findings using gamma-linolenic acid in women with what was described as incapacitating PMS.15 This treatment produced a reduction in PMS-associated depression as well as other general PMS symptoms. In order to assist the conversion of essential fatty acids into prostaglandin E1, it is recommended that adequate amounts of magnesium, B-6, and zinc be included in the person’s diet, as the benefits of these nutrients on PMS symptoms may be partially derived from their effects on essential fatty acid metabolism.
Zinc levels may be associated with PMS symptoms as well. A study designed to determine whether changes in zinc and copper levels are associated with PMS symptoms revealed that zinc levels remained stable throughout the month in control subjects (women without PMS) but in the PMS patients, zinc levels were significantly lower during the luteal phase (the second half of the menstrual cycle, in which PMS symptoms occur) in comparison to the follicular phase (the first half of the menstrual cycle).16 Additionally, zinc levels were lower in PMS patients than in the control subjects during the luteal phase. Another interesting aspect of this study was the relationship between copper and zinc levels during different menstrual phases. Copper levels were found to be higher during the luteal (PMS symptoms) phase in PMS patients when compared to the control subjects; this is noteworthy because copper competes with zinc for absorption in the body and therefore the ratio of zinc to copper is a direct measurement of
zinc levels. These findings indicate that women with PMS experience a zinc deficiency during the symptomatic phase of the menstrual cycle due to the elevated levels of copper. These findings tie into the earlier section on optimal essential fatty acid metabolism, indicating further a need for micronutrients such as zinc in women with PMS. Additional studies have confirmed lower zinc-to-copper ratios in women with PMS, especially in the symptomatic phase of the menstrual cycle.17

HERBAL SUPPORT FOR HORMONAL MENTAL FUNCTION

Black Cohosh (Cimicifuga racemosa) Black cohosh is known to have mild estrogenic effects and has been shown to be beneficial in the treatment of PMS-related depression, anxiety, tension, and mood swings.18 Black cohosh is typically prescribed in a standardized form known as Remifemin; the majority of clinical studies on the effectiveness of black cohosh have used a standardized formulation that contains 1 milligram triterpene glycosides, calculated as 27-deoxyacetin. Black cohosh can alleviate hot flashes associated with the perimenopause state.19 These effects serve to help regulate hormone levels that have gone awry, leading to less mental emotional symptoms.
Chasteberry (Vitex agnus-castus) This herb has been used for menstrual irregularities (caused by hormonal dysregulation) as well as PMS and menopausal symptoms. The efficacy of this herb in these conditions may be partially explained by it ability to suppress prolactin hormone release, which may serve to normalize excessive hormonal symptoms during the luteal (symptomatic phase) of the menstrual cycle.20 Other studies have indicated that chasteberry may have both estrogenic and progesteronic activity, which when supplemented may serve to regulate hormonal levels.21
Licorice (Glycyrrhiza glabra) Licorice has a variety of uses in human health, and hormonal regulation is a primary indication for its use. In the treatment of PMS-related hormonal dysregulation, licorice has been shown to lower estrogen levels and at the same time increases levels of progesterone (PMS is thought to be caused by elevated estrogen with lower levels of progesterone).22 Licorice can elevate progesterone levels by inhibiting an enzyme that is responsible for dismantling it in the body, and at the same time licorice can increase water retention via its effects on another bodily hormone, aldosterone. Aldosterone is responsible for assisting the body in retaining salt, which in turn allows the body to store more water. Therefore, licorice should be used cautiously in PMS with water retention as a major symptom.23

All of these herbal medicines are effective at relieving PMS-related mental emotional symptoms through their effects on hormone levels that become dysregulated. Supplementation can serve to adjust these hormone levels such that patients do not as easily notice the extensive effects of hormonal imbalance.
Hormonal mental health can be achieved by using nutritional and herbal supplements that act to assist the body in regulating its hormone levels. The brief research reviewed in this chapter provides a clue to how one can control previously unregulated hormones. When in a state of disarray, hormones can begin to affect mental processes that may result in serious consequences in regard to a person’s professional and social functioning. The case of women’s monthly hormone cycles was only partially illustrated herein; with the approximate 20 different hormones in the body, there are many other conditions of hormone dysregulation that have different effects on the mental state that were not touched upon in this chapter. The previous research demonstrates the relatively simple, yet highly effective modes for which nutritional factors can be employed to alter hormonal dysfunction, leading to fewer mental symptoms.

MALE HORMONES AND BEYOND FOR BOTH SEXES

Both men and women have a composite of estrogen, progesterone, and androgens such as testosterone. Men also cycle; testosterone levels are typically highest in the morning and decrease throughout the day. More significantly, overall testosterone levels decrease beginning in the fourth decade; it is noted that low testosterone yields a male menopause and, likewise, shifts in metabolism of the testosterone lead to significant health issues such as hot flashes, decreased erections, libido, and stamina. If zinc levels are low in both men and women, testosterone metabolism does not occur properly, causing acne, mood changes, prostate changes, and, in the case of men particularly, a circumstance called gynecomastia, which is the development of enlarged breasts due to insufficient levels of testosterone that normally counters the effects of estrogen in men.
Adrenal gland function affects both male and female hormonal health. Adrenal health not only affects hormones such as cortisol and related stress response hormones (epinephrine and norepinephrine), it also buffers steroidal hormone blood levels. Indeed DHEA and other precursor hormones produced by the adrenals are essential for the entire cascade of steroidal hormone production that all start from the humble beginnings of cholesterol as the principal building block. Adrenal function can be supported nutritionally with the following nutrients.
Vitamin C The adrenal glands concentrate more vitamin C in them than any other part of the body. Because of this, large amounts of research have delved into the function of vitamin C and the adrenal glands. Vitamin C has numerous beneficial
affects in this multifaceted organ. Controlling the release of several different hormones, vitamin C serves to support the tissue of the adrenal glands by both protecting and enhancing the responsiveness of this tissue.24 This is important as a specific group of hormones, the catecholamines, are released from the adrenals to mediate the body’s stress response. As mental and physiologic stress increases, more of these hormones are released, which can assist us in dealing with our stressors. When constantly exposed to stress, as much of us are, it is important to provide the adrenal glands with the nutrients it needs to continue manufacturing these supportive hormones. Vitamin C is essential for the production of hormones in the adrenals, as well as the conversion of these precursor hormones into their active forms. A study of animals that did not have the ability to utilize vitamin C in their adrenal glands showed that they were unable to produce adequate amounts of catecholamines and soon thereafter died from inadequate adrenal function.25
Phosphatidylserine Known as a phospholipid, phosphatidylserine is manufactured in the human body in a complex series of reactions. Despite this, the body obtains most of it through the diet. This molecule has several functions, some of which include proper brain cell membrane function, cell-to-cell signaling in the nervous system, and secretory vessicle release (hormones are sent into the blood stream in “ waterproof” vesicles for transport to other parts of the body).26 Therapeutic use of phosphatidylserine increases catecholamine release in diseased animals.27 Phosphatidylserine can assist in supporting adrenal gland function by blunting the response of the gland to exercise-induced stress.28 This study demonstrated that phosphatidylserine attenuated the release of adrenocorticotropin by the brain (a hormone that stimulates the adrenal gland) and cortisol (the main “stress” hormone made by the adrenal glands).
Cordyceps Sinensis A fungus harvested in mountainous regions of China, Cordyceps is said to be an adaptogenic agent. An adaptogen is an agent that assists a person in counteracting adverse physical, chemical, or biological stressors by generating nonspecific resistance. More simplified, adaptogens bolster our body’s defenses against stress, helping us to stand up to it. Cordyceps was used to measure the physiologic stress response in animals in one study, utilizing the weight of the adrenal gland as a guage.29 It was found that the adrenal glands of the animals given the Cordyceps and exposed to stress were not as large as those that were not supplemented and exposed to stress. (The adrenal glands grow in response to stress in order to compensate for increased demand on this gland.) Cordyceps can be used to assist the body in dealing with stress, and the hormonal consequences of this, by supporting the function of the adrenal gland.

CONCLUSION

We are a composite of the total sum of our overall health quotient. Unless each segment of our body is biochemically balanced, the net result is an imbalance. Much like a bank account is managed to maintain a proper balance—debits and credits must be adjusted to achieve one’s financial goals—our health accounts must balance as well. Indeed the balance to be carried in one’s health account is not a net zero, for that would be merely survival on the brink; rather, we must each have a significant positive credit to maintain a disease-free state and to avoid the circumstances of becoming overdrawn that may lead to chronic disease or worse. There is an important differentiation to be made between biological and chronological age. Chronological age is simply how old we are relative to our date of birth. Yet, biological age is the sum of genetics, diet, and lifestyle and can differ in those of similar chronological age. Indeed, genetics may load the gun, but diet and lifestyle pull the trigger. Investing in one’s hormonal health yields big dividends and is well worth the interest.

NUTRIENTS

• Pyridoxine 50 milligrams per day, maintenance 300 milligrams per day during second half of menstrual cycle, in divided doses

• Magnesium 300–400 milligrams per day

• Vitamin E 400–800 International Units per day

• Essential Fatty Acids 2,000–3,000 milligrams per day

• Zinc 30–40 milligrams per day

• Vitamin C 1,000–2,000 milligrams per day, divided doses

• Phosphatidylserine 100 milligrams three times a day

BOTANICALS

• Black cohosh (Cimicifuga racemosa) 40–80 milligrams, standardized to 4–8 milligrams triterpene glycosides per day

• Chasteberry (Vitex agnus-castus) Crude herb: 20–240 milligrams per day up to 1,800 milligrams per day in two to three divided doses Fluid extract: 40 drops daily Tincture (1:5–1:2): 1 milliliter three times daily

• Licorice (Glycyrrhiza glabra)* Crude herb (powdered root): 2,000–4,000 milligrams per day, divided doses Tincture: 2–4 milliliters two times per day

• Cordyceps sinensis 2,000 milligrams per day *May increase blood pressure, monitoring is essential.



Insomnia

The average adult sleeps approximately 7.5 to 8 hours each night.1 Researchers are still determining the true function of sleep; however, much evidence has shown that a lack of sleep has serious consequences including medical and mental health problems, as well as memory deficits, accidents, and impaired occupation and social functioning.2 Simply put, rest is the source of “restoration” for the mind and body. Without it, the normal healing and supportive pathways of the body are not sustainable.
Although not technically a disease condition, insomnia is actually a symptom of deeper neurologic dysfunction. Insomnia can include the perception or complaint of poor quality or inadequate sleep due to difficulty in falling asleep, frequent waking during the night with difficulty falling back asleep, waking up too early in the morning, and having unrefreshing sleep. Not defined by the number of hours of sleep that one receives or how long it takes to fall asleep, insomnia can vary from person to person because sleep needs are highly individualized. The prevalence of insomnia is thought to be 32 million people, which figures to approximately 1 out of 8 people or 11.76 percent of the population having insomnia at any one time.
Insomnia is classified into three main groups:
• Transient: This is short lived, lasting from days to weeks.
• Intermittent: This entails clusters of transient insomnia that occur periodically.
• Chronic: This insomnia occurs nearly every night, lasting for a month or longer.
More specifically, insomnia is thought of as either primary, in which sleeplessness is not attributable to a medical, psychiatric, or environmental cause (a
more expanded definition can be found in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), or secondary, which is caused by a physical condition or psychological problem such as depression. Secondary insomnia is thought to be much more common than the primary form.3
The characteristics of primary insomnia are:
• A predominant complaint of difficulty initiating or maintaining sleep for a least one month
• Sleep disturbance that causes clinically significant distress or impairment in social, occupational, or other important areas of functioning
• Sleep disturbance that does not occur exclusively during the course of narcolepsy, breathing-related sleep disorder, circadian rhythm sleep disorder, or a parasomnia
• Sleep disturbance that does not occur exclusively in the course of another mental disorder (major depressive disorder, generalized anxiety disorder, a delirium)
• Sleep disturbance that is not due to direct physiological effects of a substance
A common complaint with fairly significant medical and psychologic complications, insomnia is often a symptom of an underlying medical, psychiatric, or environmental condition. More specifically, anxiety and depression are thought to be among some of the most common causes of insomnia; however, neurologic disorders like restless leg syndrome and limb movement disorder can contribute to insomnia as well. Proper management of secondary insomnia is entirely dependent on accurate diagnosis and appropriate treatment of the underlying condition whereas primary insomnia can usually be directly treated.
Insomnia tends to occur more often in those of advanced age (it is more frequent in those over 60), females, and those with a history of depression. Generally, the most common predisposing factors for primary insomnia are stress, environmental noise, changes in surrounding environment, jet lag, and medication side effects. Secondary, or chronic, insomnia is generally more complex in nature and results from underlying mental or physical disorders. These include depression (one of the most common causes of insomnia), arthritis, heart disease, asthma, hyperthyroidism, and many other diseases. Chronic insomnia can be due to behavioral factors as well, such as overuse of alcohol, caffeine, or other substances and interruptions in sleep-wake cycles from shift work or extended nighttime activities.
Behaviorally, insomnia seems to be perpetuated by the following behaviors; sometimes curtailing these activities can make a large difference.
• Drinking alcohol before bedtime
• Smoking cigarettes before bedtime
• Excessive napping in the afternoon or evening
• Irregular or continually disrupted sleep-wake schedules
• Expecting to have difficulty sleeping and worrying about it
• Ingesting excessive amounts of caffeine
Insomnia is diagnosed through a medical and sleep history intake. Usually, the patient or the patient’s bed partner completes a diary regarding the quality and quantity of sleep. In addition, specialized sleep studies may be needed to diagnose other sleep-related disorders such as sleep apnea (the cessation of breathing while sleeping) or narcolepsy (excessive daytime sleepiness, lack of REM sleep, and transient sleep like states during the daytime).
Initial treatment of insomnia involves identifying the cause, whether physical or mental. Depending on this diagnosis, additional medical intervention will be necessary to alleviate the underlying disorder. Medical problems typically cause insomnia due to physical discomfort, which may or may not be relieved, depending on the nature of the problem; surgical pain is amenable to medications that blunt the brain’s recognition of pain, whereas insomnia due to asthma may be curtailed by removing nocturnal symptoms. Although not the focus of this chapter, the resolution of insomnia by treating the underlying disorder stands to reason as the most efficacious approach. The highlights in this chapter can be utilized to resolve insomnia that originates from any number of causes, whether primary or secondary. These approaches are more favorable than the use of medication designed to bring about sleep; medications are addictive, have a rebound effect, and are typically only prescribed in small doses for short periods of time for the aforementioned reasons—they are not curative. Treating insomnia with another popular standby, alcohol, is strongly discouraged. Alcohol is commonly thought by the general public to help with sleeping. However, alcohol consumption can diminish the quality of sleep by disrupting the sequence and duration of the various sleep states, altering total sleep time and sleep latency (time to fall asleep). Consumed near bedtime, alcohol may decrease the time it takes for one to fall asleep. However, when consumed within an hour of sleep, it appears to cause disruptions in the second half of the sleep period.4 Sleep may be more fitful, charachterized by frequent awakening from dreams and difficulty falling back asleep. As one continues to rely on alcohol at bedtime, the sleep-inducing effects may decrease while sleep-disrupting effects increase.5 Seniors are more at risk from these effects, as alcohol is not metabolized as quickly in them compared to younger people, leading to higher blood/brain alcohol levels from the same amount consumed.
The effects of alcohol on sleep (wakefulness during the second half of sleep) can be induced by consuming a moderate dose of alcohol as much as six hours prior to bedtime.1 At this point, all alcohol has been eliminated from the body, which suggests a long-term change in bodily sleep regulation and mechanisms. Alcohol consumption in pregnant women has even been shown to induce sleep disruptions in the newborn baby.6 Measurements of brain activity showed that the infants of mothers who consumed at least one drink per day during the first
trimester of pregnancy had sleep disruptions and increased arousal compared to the infants of mothers that abstained from alcohol. Even more, infants exposed to alcohol in breast milk fell asleep sooner but slept less than those infants not exposed to alcohol.7 Avoidance of alcohol for insomnia is strongly recommended; it only serves to increase the problems of sleep difficulty and, over the long-term, may lead to abuse and dependency.

NUTRITIONAL CONSIDERATIONS

Vitamin B-12 Cobalamin, otherwise known as vitamin B-12, plays a role in insomnia development and control. B-12 plays a role in numerous neurologic conditions and appears throughout this book; it is not surprising that B-12 is also involved in insomnia as well. In a study to determine the effect of supplementing methyl-cobalamin (a coenzyme form of B-12) on sleep-wake rhythm disorders, researchers found a large dose of B-12, significantly improved sleep-wake cycle measures as well as clinical symptoms.8 Although noted as inconsistent, both groups (high-dose and low-dose B-12) exhibited improvement in their sleeping patterns; B-12 did provide improvements at both a high and low dosage in this particular study. An interesting extension of this study might include examining patients’ B-12 status (i.e., blood levels) and folate levels, as these two vitamins are intimately involved in metabolism.
In a more specific study, B-12 supplementation was used in two separate patients with chronic sleep-wake rhythm disorders.9 The first patient, a 15-year-old blind girl, had been entrained to a free-running sleep-wake rhythm of 25 hours. (This is a common period of time that humans, when deprived of external light cues to time, will shift their bodily rhythms toward; this creates difficulty in establishing set patterns such as falling asleep and waking.) She was supplemented with 1.5 milligrams B-12 three times a day and soon thereafter shifted to a 24-hour rhythm that was maintained as long as she continued the supplement regimen. However, at two months post-discontinuation of the B-12, her previous 25-hour pattern reemerged. Interestingly, her serum levels of the vitamin were within the normal range before and after the treatment. The second patient in this study was a 55-year-old man who experienced delayed sleep for much of his life. When supplemented with 1.5 milligrams B-12 one time per day, his sleep pattern was improved, and this effect lasted for the six months of follow-up that the patient underwent. In a combination study employing B-12 along with light therapy (exposing patients to light at preset times) and time therapy (entraining time patterns), 106 patients with various forms of insomnia that included sleep-wake rhythm disorders, delayed sleep phase syndrome, irregular sleep-wake pattern, and prolonged sleep pattern experienced improvements of 32 percent, 42 percent, 45 percent, and 67 percent, respectively.10 These subjects also experienced improvements in subjective feelings of lack of adequate
sleep, unpleasant feelings at waking, and daytime sleepiness. The use of vitamin B-12 as an adjunctive factor in treating insomnia appears to have some merit from these limited studies. Ensuring that a person has adequate B-12 in the diet and via supplementation may serve to alleviate a large portion of their insomnia, and this approach seems to have efficacy in several different forms of insomnia and sleep disorders.
Folate Folate (folic acid) is also intimately related to proper neurologic function plays several roles in the development and resolution of numerous neurologic disorders, and appears throughout this book. Its roles in amino acid metabolism, nucleic acid synthesis (DNA and RNA), and catecholamine neurotransmitters are considered essential. Among the neurologic disorders implicated in folate deficiency, insomnia is mentioned in the literature.11 The role of folate has been studied in the context of alleviating restless leg syndrome, which can be a primary cause of insomnia. Restless leg syndrome is characterized as a neurosensory disorder that begins in the evening and prevents the person from falling asleep due to the continuous need to move the legs. In a study of pregnant women with restless leg syndrome, a folate deficiency was associated with the occurrence of the syndrome, significantly delayed sleep onset, and depressed mood.12 This association was excluded from other factors such as B-12 and iron deficiency in these women, and because of these findings, investigators recommend a reevaluation of suggested folate levels during pregnancy in order to alleviate restless legs and subsequent insomnia. It is known that in psychiatric patients, symptoms are more severe and increasingly frequent in those with suboptimal folate levels in comparison to those patients with normal levels. Folate supplementation has been demonstrated to have a therapuetic effect in psychiatric symptoms, insom-nia being a prime symptom.13 Although limited in research, the application of folic acid supplementation in insomnia, especially that related to a psychiatric disorder, may serve to decrease symptoms. The interworkings of folate and the nervous system continue to be elucidated, and primary research hints at the usefulness of this supplement in conditions like insomnia.
Magnesium Magnesium is the most plentiful positively charged electrolyte in the body. It is used in over than 300 different cellular reactions required for movement of ions across cellular membranes,14 and it is a crucial part of maintaining nerve and muscle electrical potentials as well as in the transmission of nervous impulses.15 Because of its usefulness in the nervous system, the role of magnesium in insomnia has been intensely studied throughout the literature. Recognized as affecting sleep and sleep-related nueroendocrine functions as well as altering EEG (electroencephalogram) sleep patterns, magnesium was studied to determine its
usefulness in the treatment of insomnia in the elderly.16 The authors of this study noted that aging results in decreased sleep indices, namely, slow wave sleep and delta and sigma wavelength power, and that these three measures of sleep quality were improved by magnesium supplementation. Additionally, the authors suggest that magnesium, in this circumstance, may affect the glutamaterigic and GABAnergic neurotransmitter systems and that treatment with magnesium may reverse age-associated sleep changes. Magnesium deficiency and depletion is thought to disrupt normal biological rhythms, including sleep. Low magnesium correlates with both hypofunction and hyperfunction of the biologic clock; hyperfunction of the biologic clock in association with magnesium depletion is associated with nervous hypoexcitability, resulting in depression, nocturnal headaches, and excessive sleepiness, whereas hypofunction of the biologic clock associated with magnesium depletion is associated with nervous hyperexcitability, and may cause delayed sleep onset, age-related insomnia, jet lag, anxiety, and migraines.17 Researchers speculate that the role of the biologic clock and magnesium levels are linked in such a way that a balance of magnesium is necessary for the efficiency of the pineal gland and suprachiasmatic nuclei.18 Furthermore, they hypothesize that magnesium may have effects such as stimulation of inhibitory neurotransmitters such as GABA and taurine and may antagonize “neuro-active” gases such as carbon monoxide and nitric oxide. Magnesium plays an intricate role in the regulation of the biologic clock; much more research into this area is needed to further elucidate its role. Regardless, current research demonstrates a causative effect of low magnesium status and insomnia.
Tryptophan, 5-HTP, Melatonin, and Serotonin Tryptophan is an essential amino acid not produced in the human body and is therefore required in the diet. A precursor of the neurotransmitter serotonin, tryptophan has a sedative effect.19 A highly useful dietary supplement, tryptophan was stigmatized in 1989 when one particular manufacturer’s batch of tryptophan was associated with a disabling and fatal condition known as eosinophilia-myalgia syndrome (EMS). Despite the evidence that this outbreak of EMS was largely thought to be a result of contamination in the manufacturing process,20 the FDA removed over-the-counter tryptophan supplements from the market in 1990. Tryptophan is available by prescription, however, from a compounding pharmacy.
Tryptophan is useful in the treatment of insomnia, as well as seasonal affective disorder, a condition charachterized by seasonally related insomnia and either oversleeping or insomnia.21 The most frequently used dose of tryptophan is 1 gram, and this has been shown to increase subjective feelings of sleepiness and decreased waking time.22 Tryptophan is thought to induce sleep through its ability to increase serotonin levels in the brain (tryptophan is a precursor molecule to serotonin). Serotonin plays numerous roles in the brain, primarily modulation of the circadian rhythm and sleep and wake cycles. Depending on location
in the brain, serotonin and serotonergic effects include sleep, wakefulness, and behavioral states.
5-hydroxytryptophan (5-HTP) is an intermediary precursor to serotonin and is derived from tryptophan. Available as a supplement, 5-HTP crosses the blood-brain barrier and thereby increases serotonin synthesis. One study demonstrated this effect when a dose of 100 milligrams was shown to increase slow-wave sleep.23 5-HTP enters the brain easily and effectively augments serotonin levels; this has been shown to be of clinical benefit in insomnia as well as conditions such as depression, fibromyalgia, and binge eating.24 Because of these effects, 5-HTP may be an effective agent for reducing insomnia symptoms resulting from serotonin dysfunction.
Melatonin is a hormone that is produced from serotonin. Melatonin seems to affect the neurotransmitter GABA by assisting its binding to its receptors and by decreasing neurotransmissions by directly affecting neurons in the brain.25 Primarily, melatonin appears to regulate the circadian rhythm and sleep patterns, as well as endocrine secretions. Melatonin levels are influenced by day and night cycles; light will inhibit melatonin production and darkness will stimulate its secretion.26 This may partially explain increased somnolence in wintertime, especially in northern climates. Production of melatonin decreases in the elderly, and serum levels are decreased in people with insomnia and depressed moods.27
Low-dose supplementation of melatonin, enough to achieve normal nighttime levels (in those with low melatonin levels), will promote sleep onset and maintenance without altering neurologic sleep indices (sleep architecture).28 Additionally, melatonin can advance or delay circadian rhythms (when given in the evening or in the morning, respectively). Melatonin has been shown to benefit insomnia as a result of numerous factors and conditions. For instance, melatonin supplementation is effective for relieving insomnia that results from jet lag,29 in the elderly,30 in children with mental retardation,31 and in those with Asperger’s syndrome,32 as well as in children with chronic sleep-onset insomnia.33 Melatonin has been shown in the research to be beneficial in insomnia from a variety of additional causes; these are only a few of the most recalcitrant causes of insomnia in which melatonin has been shown to be of benefit.

BOTANICAL MEDICINES

Passiflora incarnata (Passionflower)
Passionflower contains several active constituents, including the flavonoid compounds and harman alkaloids.34 Passionflower acts as a sedative and hypnotic and anxiolytic agent and also has antispasmodic and pain relieving effects.35 Some research shows that a constituent of passionflower, apigenin, is capable of binding to benzodiazapenes receptors in the brain, thereby acting as an anxiolytic.36 Other research points to the ability of passionflower to reduce restlessness and aggressiveness while raising the pain threshold.37 Passionflower
extracts are widely used as a sedative agent in complementary sleep-aid products. Several pharmacologic investigations have demonstrated the sedative effects of passionflower as well as an anxiolytic effect, underlying its role as an important agent in restlessness, irritability, and insomnia as a result of anxiety.38
Valeriana Officinalis Valerian root is commonly used for sleeping disorders due to its known sedative-hypnotic and anxiolytic effects.39 The active constituents of valerian include the valepotriates, volatile oils, and monoterpene and sesquiterpene constituents.40 Despite the identification of several possibly active constituents in valerian, the effectiveness of the herb is probably more accurately attributable to more that one compound (as is the case for most herbal medicines). Valerian is effective when used to alleviate insomnia by reducing sleep onset time and by improving reported sleep quality.41 In addition, valerian is effective at improving sleep quality in people undergoing withdrawal from benzodiazapenes (for treatment of insomnia).42 Valerian is most effective for insomnia when taken over a period of several days to weeks rather than a one-time-only dose; however, this approach can be effective at increasing sleep as well.43 The effectiveness of valerian in treating insomnia is more than likely attributable to both its anxiolytic effects (thereby reducing anxiety) and its sedative-hypnotic effects on the brain.
Matricaria recutita (Chamomile)
Known as a mildly sedative herb, chamomile is useful in inducing sleep in a gentle manner, with no morning side effects. Categorized as a sedative in the medical literature,44 chamomile is beneficial for reducing nervous activity in the evenings, allowing a person to fall asleep with greater ease. Chamomile’s effects appear to be carried out on the central nervous system and may reduce aggressive behavior, thereby curtailing anxious energy.45 The sedative activity of chamomile has been proven in a number of studies, making chamomile a good choice for those suffering from insomnia that delays sleep onset.46
Combination Homeopathics There are a few combination homeopathic medicines that can be used for the treatment of insomnia. Containing homeopathic doses of passionflower, oats (a mildly calming herb), chamomile, and homeopathic salts, these combinations are found to be useful by some people. In the treatment of insomnia, using homeopathic medicines provides a nontoxic form of treatment with no side effects. These medicines are effective in roughly 33 percent of the people who use them and are very inexpensive.

SLEEP HYGEINE

The importance of sleep hygiene, or maintaining a healthy sleeping environment, can be vital to correcting patterns of insomnia. Many people, when going about their routines of going to bed, follow certain patterns each night. The development of a healthy pattern is essential in allowing the body and mind to adjust to a different physiologic phase. Just as an athlete goes about a ritual of warming up, stretching, and mental preparation before an event, a person should have similar processes in preparation for sleep. As part of this process, one should:
• Avoid television just before or in bed (especially the nightly news, which always contains stories of mayhem)
• Avoid eating late at night
• Organize the day ahead on paper, and preview the next day, so that you can rest knowing you are prepared
• Keep a clean, soothing bedroom. Work clutter and other unnecessary items only keep your mind running when it should be winding down

CONCLUSION

Insomnia is both a symptom and a condition. Depending on the nature of its origins, insomnia can be treated as a symptom of another disease process or as a primary symptom. Ideally, treatment of insomnia will involve addressing the initial cause (of which a majority of insomnia is attributable) before direct modulation of sleep patterns is carried out. Conversely, assisting the person in overcoming insomnia and obtaining sleep is highly important in the treatment of almost every disease processes. Utilizing natural therapies rather than standard pharmaceutical medications (which are costly and can be addictive) to treat insomnia can be achieved with a variety of nutritional and herbal applications.

NUTRIENTS

• B-12 500 micrograms daily

• Folate 400–800 micrograms daily

• Magnesium 300–400 milligrams, ½ hour before bed

• 5-HTP 150–200 milligrams in the evening

• Tryptophan 1–3 grams in the evening; start with the lowest dose and work up to 3 grams, if necessary

• Melatonin 0.3–5 milligrams in the evening; start with the lowest dose and work upward

BOTANICALS

• Passionflower Crude herb: 0.25–2 grams, three times daily; or one cup of tea three times daily, with the last dose half an hour before bedtime Liquid extract (1:1 extract): 0.5 to 1.0 milliliter three times daily Tincture: 0.5–2 milliliters three times daily

• Valerian 400–900 milligrams valerian extract up to two hours before bedtime

• Chamomile Crude herb: 0.25–2 grams, three times daily; or one cup of tea three times daily, with the last dose half an hour before bedtime Tincture: 2 milliliters half an hour before bedtime



Mental Fatigue

Mental fatigue is a condition that virtually everyone has experienced at some time in his or her life. For many others, however, peak performance in life is attenuated by constant mental fatigue resulting from several factors. Among the obvious are overwork, and “burning the candle at both ends,” a scenario that many of us in the modern working world experience. For many, life is a series of fast-paced events and situations that demand absolute attention; personal, family, and work priorities all demand 100 percent of our focused energy. For the majority of Americans, mental fatigue is a fact of life. Our dependence on mental labor today has strong effects on the neuroendocrine and immune systems; it is no wonder people are in the midst of psychological and emotional dysfunctions that result in depression, anxiety, and fatigue.
Mental fatigue affects people in different ways for differing periods of time. Primarily the result of brain overactivity, mental fatigue is really an exhaustion of the neurologic system, which is very similar to exhaustion of the physical body from physical labor. Mental fatigue is caused by continuous mental effort and attention on a particular task or related tasks or from high levels of stress or emotional states. Really, any excessive mental process can result in this disorder. The most common manifestation of mental fatigue occurs near the end of the working day (which can extend late into the evening). Fatigue appears as duties seem more complicated and impedes thought processes, making concentration low and raising the occurrence of mistakes.
Mental fatigue at first seems easily taken care of by just resting or switching one’s concentration. Unfortunately, the events that lead one to become mentally fatigued are usually lifestyle based (job and home life) and are not easily left alone for any extended period of time. The brain, being the incredible creation that it is, is highly able to respond to slight changes in the way we take
care (or for that matter, do not take care) of ourselves. Supporting this organ nutritionally will provide the nutrients that contribute to mental energy processes and will also replace those nutrients that are consumed in the process of mental activity.
The definition of mental fatigue is the subjective feeling of fatigue, combined with negative effects on performance due to time spent on cognitively demanding tasks.1 Additionally, these feelings of fatigue and performance changes can occur independently from influences such as the time of day, learning capabilities, or physical effort. (This may explain why those with mental fatigue can feel exhausted even after a solid night of sleep; the process is chronic and not easily ameliorated.) Researchers in this area note that among the most important changes in performance in mental fatigue is a deterioration of the organization of behavior; behavior appears to lose cohesion when people become mentally fatigued.2 The following characteristics are noted as defining factors of mental fatigue:
• Subjective feeling of fatigue
• Negative change in performance due to time spent in cognitively demanding tasks
• Independence from time of day, learning, or investment of physical effort
Neurologic processes that are thought to be affected by mental fatigue include3:
• Inhibition of interfering stimuli
• Inhibition of prepotent responses (irrelevant information that “pops” into one’s mind)
• Working memory processes that enable retrieval of information
• Working memory processes concerning preparation of responses

DIET AND FATIGUE

Mental energy, based on similar physiologic mechanisms as is physical energy (muscular), would seem to be responsive to similar nutritional guidelines that are followed for physical fatigue. Therefore, similar dietary recommendations for peak physical energy also should be adhered to in persons with mental fatigue. True, neurochemistry is starkly different from muscular and metabolic physiology, but both systems derive energy from the same general sources: carbohydrates, proteins, fats, and the vitamins and minerals they contain. One of the fist places a person with mental fatigue should look (other than the overindulgence in activities that led to the fatigue) is at their nutritional status (i.e., dietary intake). The topic of mental fatigue is one that demands an evaluation of overall macronutrient intake and its effect on this condition. Not defined as a standard
disease, mental fatigue is definitely a symptom of overwork and undernutrition and may someday be considered an associated risk factor for true mental disease.
Regaled in the media as of late as a highly undesirable food component, carbohydrates are necessary for human (and for that matter, animal) metabolism. Overindulgence in simple carbohydrates and resultant insulin resistance is without a doubt one of the main reasons for much of the diabetes, obesity, hypertension, and cardiovascular disease seen in modernized countries today.4 However, carbohydrates are a primary and necessary fuel source that must be consumed for proper energy metabolism. An interesting study compared the effects of various macronutrient balanced lunchtime meals on perceived fatigue in people consuming them.5 Specifically, healthy subjects consumed lunchtime meals (after fasting overnight and then consuming a normal breakfast) consisting of either a high-carbohydrate, low-protein meal, a similar meal containing equal amounts of both carbohydrates and protein, or a high-protein, low-carbohydrate meal, or they continued to fast. All meals consisted of the same amount of calories and had equal fat contents. The only meal to cause a significant, immediate increase in fatigue was the high-carbohydrate lunch; this was not attributed to reactive hypoglycemia as patient blood glucose levels remained elevated. Investigators were able to partially explain the postcarbohydrate fatigue as being relative to elevations in plasma tryptophan levels; however, the fatigue ceased even though tryptophan levels remained high within the time frame of the study.
In another related study, subjects consumed breakfast meals consisting of low-fat, high-carbohydrate content; medium-fat, medium-carbohydrate content; and high-fat, low-carbohydrate content, or they had no meal.6 These people were then tested on a number of tasks designed to measure cognitive performance and mood following the breakfast meal. Although no differences in cognition were noted, significant changes in mood were noted, specifically demonstrating that macronutrient content of foods can affect mood states following consumption. The significance of these findings is that food intake can alter mood, and there is no doubt that mood state can affect one’s performance at work and in other areas of life.
Providing a low-glycemic diet may be helpful in offsetting any food-induced cognitive deficits following the food intake. Foods high in sugars such as simple carbohydrates (cakes, cookies, soda, etc.) create the well-known phenomenon of reactive hypoglycemia in which, following consumption of such foods and the resultant insulin response, blood sugars are left lower than their previous levels.7 This is undoubtedly detrimental to mental function, as glucose is the brain’s main fuel supply; many people are familiar with the late-afternoon hypoglycemic “crash” in which they become hungry and irritable and have decreased performance.
An interesting study investigated the cognitive effects of different macronutrients (fat, protein, and carbohydrates).8 In this study, fat ingestion lead to the best postprandial (after eating) cognitive performance, whereas carbohydrates
and protein consumption resulted in lower overall cognitive performance. However, different cognitive functions were affected by each macronutrient; carbohydrate ingestion caused better short-term memory and task accuracy, whereas protein ingestion led to better attention and task efficiency. Such findings support the idea that both stable and best cognitive performance is related to balanced glucose metabolism and metabolic states.
Another analysis of breakfast meals was performed and highlighted in a review article that compared the findings of three separate studies investigating the importance of adequate blood glucose in improving memory function in people who ate breakfast.9 The findings from this review revealed that eating breakfast influenced cognition through several mechanisms, one of which was increased blood glucose. Eating breakfast (and maintaining adequate blood glucose levels) resulted in improved memory function, whereas fasting was found to adversely affect recall; this performance decline was reversible by consuming a glucose-rich food. Luckily, failure to eat breakfast did not affect performance on intelligence tests.
There is much research regarding the role of folate in mental health; the role that folate plays in the synthesis of neurotransmitters can be applied to its use in mental fatigue as well. Neurotransmitters are essentially the language of the brain, and theoretically, very little neurologic work could happen in their absence. Previous chapters have highlighted the role of folate in brain metabolism and their improvement when deficiencies are corrected. The role of folates in neurotransmitter synthesis and function, as well as their role in neuronal structure, stresses the importance of this vitamin and its forms in proper neurologic function and that deficits are associated with mental health problems. Among the other functions of folate, it contributes to the formation of glutamate, and excitatory neurotransmitter, just to name a few.10

BOTANICAL MEDICINES

There are several herbs with so-called nootropic effects, meaning they have an affinity for improving brain function. Although the role of proper nutrition in mental health and prevention of mental fatigue cannot be disputed, the addition of botanical medicines that further assist the brain on a metabolically enhanced level are important to consider. The botanical medicines mentioned herein do not act as stimulants; several stimulants (caffeine, ephedra) have been intensely studied and show a definite increase in cognitive function. However, the metabolic premise of these and other neurologic stimulants can be likened to robbing Peter to pay Paul. Rather, stimulants only increase energy at the expense of the brain’s nutrient supply; pushing on the accelerator makes the car go faster, but it also uses the fuel more rapidly and accelerates wear and tear on the vehicle. Botanical medicines that are used to avert mental fatigue do so primarily by supporting cognitive function through their effects on neurologic metabolism.
 Rhodiola rosea
A native plant to the Arctic regions of Siberia, Scandinavia, Lapland, and Alaska, Rhodiola has a long history of medicinal use dating back to the first century A.D.11 This herb has been used to increase energy and stamina as well as mental capacity; it is classified as an adaptogen, or substance that assists the body in resisting physical, chemical, and environmental stressors. Recent research has investigated the efficacy of this plant as applied to modern-day life stresses with interesting results. One study investigated the antifatigue effects of Rhodiola on mental work capacity in a situation of background fatigue and stress (military cadets).12 The study results demonstrated a significant antifatigue effect in the cadets taking the herb, and this effect was statistically significant in comparison to the placebo group. Another study more applicable to mental fatigue investigated the effect of a standardized extract of Rhodiola on fatigue during night shifts among healthy young physicians.13 Mental performance in this study was measured using tests designed to monitor mental fatigue involving perceptive and cognitive cerebral functions such as associative thinking, short-term memory, calculation, concentration ability, and audiovisual perception. Results demonstrated statistically significant improvements in mental performance as measured using the mentioned objective points; no side effects were reported in subjects using the herb.
Studies such as these demonstrate the fascinating effects of this plant on stress-related mental function; this is applicable, of course, to many people’s everyday lives that are full of stressful events, with little reprise. Another study used Rhodiola in students during an acute stressful period of test taking that occurred over a period of several weeks.14 Rhodiola was used to attenuate the effects of stress as measured by mental fatigue, neuromotor tests, and physical fitness, before and after supplementation, over a 20-day period. Self-assessment of general well-being improved following the study period, and significant improvements were noted in the areas of physical fitness, mental fatigue, and neuromotor test categories as well. Rhodiola is an interesting adaptogenic botanical medicine with definite uses in those that suffer from mental fatigue. A large amount of research was performed on this herb in the late 1960s and 1970s, primarily in Russia, with interesting results in fitness and mental work performance. Researchers are again investigating the promising effects of this herb; it has properties that make it an ideal supportive aid for mental fatigue.
Ginseng Ginseng is derived from three main varieties of this herb (Panax, Siberian, American). Another traditionally used botanical with thousands of years of use, the ginsengs are also considered adaptogenic botanicals. The term “adaptogen” covers a huge area of physiologic responses and is elicited differently with individual herb species. Past research on ginseng reveals physiologic effects that may
benefit cognitive performance and mood; animal studies indicate modulation of stress, fatigue, and learning capacities, and single doses administered in human subjects have been shown to improve memory.15 Components of ginseng, known as ginsenosides (which are derived from all three species of ginseng), have numerous pharmacologic actions on the brain and nervous system (in addition to other areas of the body). A study using a ginseng component was shown to enhance the growth of neurons and protect them from damage induced by a commonly used experimental neurotoxin (MPTP).16 Results from this study suggest that the neuroprotective and neurotrophic (nerve-growing) effects of ginseng may account for the enhancement of cognitive function that is experienced in people using ginseng as a supportive agent. Another effect of ginseng that may contribute to the herb’s benefit on brain function is the ability of one ginsenoside to facilitate the release of a neurotransmitter (acetylcholine) from an area of the brain known as the hippocampus.17 Researchers noted that this increased release of acetylcholine might be associated with the ability of ginseng to prevent memory loss by modulating the metabolism of this neurotransmitter.
Ginkgo biloba
Ginkgo biloba is best known for its preventive effects on the brain in various forms of dementia (please see the chapter on Alzheimer’s disease for more information). Not surprising, this herb also has neurologic benefits prior to the onset of age-related decline; it is a challenge to recall that many herbs, containing several active constituents, have various effects on same-organ systems, as well as other bodily systems. Ginkgo is beneficial in conditions of mental fatigue perhaps in part due to its ability to increase blood flow and oxygenation to the brain, among other functions. Its combination with ginseng demonstrates additional neurologic benefit that has been highlighted in several studies.
Ginkgo extract, in addition to being effective in preventing Alzheimer’s disease, vascular dementia, and age-related cognitive decline, also has potent antioxidant activity and directly affects the cholinergic neurotransmitter system; recent research demonstrates that ginkgo acts as a nootropic agent that works to improve brain function. A randomized, double-blind, placebo-controlled study utilizing ginkgo extract for 30 days demonstrated significant improvements in working memory, rapidity of information processing, and mental processing.18 These results are suggestive of the ability of ginkgo extract to improve brain functions that are associated with both mental fatigue and measurements of intelligence.
Research involving combinations of both ginkgo and ginseng have provided fascinating results regarding mental performance. Although not surprising, combinations of these two powerful brain-specific botanical medicines provide further benefits for combating the fatigue of mental exertion. Utilizing a combination of the two herbs, one study attempted to define calculation skill improvements following serial doses of the two herbs.19 Study subjects experienced significant
and sustained increased ability to calculate (Serial Sevens) following dosing of the herb combination at one, two, four, five, and six hours following administration. Another study revealed that after receiving a combination of the two herbs, those receiving the active compound experienced a dose-dependent improvement in performance in the “quality of memory” test factor in cognitive performance.20 This effect was specifically more prominent at longer term memory function. These results are quite profound in that a near-immediate effect on specific brain functions were realized following administration, and it lasted for some time thereafter. Keeping in mind that the effects measured in these particular studies represent only a miniscule fraction of cognitive function, it is exciting to see such outcomes; extrapolation of these results in relation to mental fatigue seems quite promising as this study demonstrates the utility of these herbs as an immediate remedy. Ginkgo and ginseng are both safe botanical medicines with very specific effects on cognitive function. These effects can be interpreted as improvements in cognitive function that makes them superior choices in combating mental fatigue. These herbs seem to have several effects on the brain. Whether increasing cognitive function in the healthy or ameliorating the effects of dementia, they present an as of yet unparalleled nutritional treatment that is not matched by any other compound.

OTHER CONSIDERATIONS

In addition to avoiding low blood sugar symptoms by consuming regular, balanced meals, certain nutrients may help to assist the body in maintaining its blood sugar. Chromium is an essential trace element that the body uses to utilize blood glucose. Part of a complex of molecules known as glucose tolerance factor, chromium is thought to be the active part of the complex. Chromium is thought to enhance the activity of insulin, a bodily hormone that is responsible for transporting glucose into the cells. Chromium increases the number of insulin receptors, or doorways through which insulin and glucose enter cells, as well as receptor affinity to glucose.21 Without chromium, insulin does not bind as well to cells, and the number of insulin receptors decrease. Chromium also serves to assist with the metabolism of glucose itself, as well as its transformation into fatty acids and cholesterol.22 What all of this means is that taken supplementally, chromium helps the body utilize foods (primarily carbohydrates) more efficiently, thereby preventing hypoglycemia (decreased blood sugar) that contributes to decreased mental focus and attention.

CONCLUSION

Mental fatigue is primarily the result of overburdening the central nervous system. However, with modern life and its constant demands, people require additional support of their cognitive functions in order to cope with daily stressors and to avert future mental dysfunction. Appropriate support of the brain
begins with an adequate nutritional plan; research demonstrates the importance of balanced, regular meals as a first step in achieving this goal. As always, healthy nutrition should be reinforced with a multivitamin and mineral supplement, as a supportive element. In addition to nutrition, the botanical medicines Rhodiola rosea, Ginkgo biloba, and ginseng species provide adaptogenic as well as specific neurologic function support for combating mental fatigue. The person suffering from fatigue can effectively employ combinations of these botanical medicines as a preventive strategy against mental fatigue and decline.
The key to helping treat mental fatigue is to eliminate deficit spending. Or put another way, if a car burns a higher rate of gasoline than is put in the tank, it will run on vapors until it ultimately runs out of fuel. The human body is very comparable. Indeed, proper fueling of the body is critical, yet, even with a full tank of fuel, a body that has become deconditioned from overuse, excess stress, insufficient rest, or underlying other health issues will increase the likelihood of potential catastrophic failure of the neurological functioning resulting in diminished mental alertness and foundational energy. On the positive note, the body is remarkably recuperative, and with the slightest inclination, significant strides can be made to regain lost ground. The take-home message is not one of just fueling the body properly; it also imparts that, when endeavoring to build up the body’s reserves, overt losses of current gains must be curtailed. Providing the body with some down time and avoiding continuous mental stimulation that leads to the mental fatigue in the first place will allow the brain to recuperate and recover from fatigue.

NUTRIENTS

• Macronutrients Ensure adequate consumption of carbohydrates, proteins, and fats in a ratio of 40:30:30 three times daily

• Folate 1,000 micrograms per day

• Chromium 200 micrograms per day

BOTANICALS

Rhodiola rosea 50 milligrams, twice daily

Ginkgo biloba 60–120 milligrams, twice daily

• Ginseng 0.25–0.5 grams twice daily


Parkinson’s Disease

Parkinson’s disease (PD) is a disorder that progressively affects the brain; it is characterized by a decreased ability to elicit spontaneous movements, difficulty walking, postural instability, and rigidity and tremor. PD is caused by a degeneration of a particular group of nerve cells in a part of the brain known as the substantia nigra. Degeneration of these nerve cells causes a scarcity of dopamine, a vital neurotransmitter. The shortage of dopamine is what leads to the characteristic impairments of movement in PD.
Men and women are both affected by PD, with slightly higher occurrences in men. The frequency of the disease is higher in people over the age of 60, and although not a new disease (Parkinson’s symptoms are mentioned in ancient medical texts), there has recently been an astounding increase of younger people diagnosed with this disease. In the United States, it is estimated that approximately 500,000 people have Parkinson’s, with 50,000 new cases diagnosed per year.1 Both the prevalence and incidence of PD is expected to increase as the general population ages. The average age of onset is 60, with peak incidence in the late 70s and early 80s age group. Parkinson’s is found throughout the world, and disease rates differ from country to country.
The cause of Parkinson’s disease is not definitively known, although several promising theories exist. Parkinson’s has been shown to be an inherited disease based on twin and family studies, and some environmental factors may contribute as well. PD has been reported in people that at one time took an illegal street drug that was contaminated with a substance known as MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). In addition, there is strong evidence that an alteration of a gene on chromosome 4 may lead to PD as well. The most accepted theory suggests that some people probably have an inherited susceptibility to the disease that is affected by certain environmental factors.
Symptoms of PD most often begin with a tremor of a person’s limb while at rest, which often starts on one side of the body, usually a hand. As the disease progresses, it becomes more difficult for the person to move (akinesia); the limbs move rigidly, the gait is described as “shuffling,” and posture becomes more stooped. The ability to create facial expressions is limited, and people with PD may experience depression, personality changes, dementia, sleep difficulty, and speech impairments. The disease is progressive and typically continues to worsen over time.
PD is diagnosed based on patient symptoms. There is no specific laboratory test that can diagnose it; a neurologist will typically evaluate the patient and their symptoms and make a diagnosis based on the findings. Sometimes, a specific type of brain scan may help doctors identify PD; other times, a patient with suspected PD will be given anti-Parkinson’s drugs to determine if they benefit from them. Absolute diagnosis of Parkinson’s is achieved by identification of microscopic Lewy bodies, which are found in the cells of the brain. A hallmark of PD, Lewy bodies have been found in a large number of people that were never diagnosed with the disease. Because of this, some researchers feel that if everyone lived long enough, most people would develop the disease.
Standard treatment of PD involves the use of drugs that are converted into dopamine in the brain, which allows for replacement of the lost dopamine that is normally synthesized within the brain. This drug, known as levodopa, does not prevent progressive changes of PD and causes side effects because it is converted into dopamine before it reaches the brain. Levodopa can be taken with another medication (carbidopa, or Sinemet) that will prevent its conversion to dopamine prior to reaching the brain; this serves to “conserve” the levodopa so its full potential is used in the brain.

NUTRITIONAL FACTORS

Parkinson’s disease is essentially a neurodegenerative disease. When viewed in this sense, the importance of nutrition is highlighted, as the brain requires a large amount of energy to maintain not only its function, but its structural integrity as well. Because of the increased appearance of PD at older ages, it makes sense that nutritional support plays a role in the prevention of this disease, as chronic insufficient nutrition may lead to the appearance of several disease states, especially those of degenerative nature. The role of nutrition in PD appears throughout the literature; the following is a brief overview of some of the most salient information.
Vitamin C In one study investigating the role of oxidation and antioxidant levels in the brains of patients with PD, ascorbic acid was found to be deficient.2 And in another trial investigating the use of vitamin C in the treatment of Parkinson’s
disease symptoms, supplementation was found to cause modest improvements in the functional performance of people with PD.3 In a trial using both alphatocopherol (a form of vitamin E) and ascorbic acid, both vitamins were given to people with early forms of PD.4 The purpose of this study was to determine the preventative effects of high-dose antioxidants on the progression of PD. Compared to other patients (study subjects were limited to those patients taking anticholinergic medications only, as a marker for Parkinson’s disease that had not advanced to a stage requiring dopamine agonists), those receiving the mixed antioxidant therapy of alpha tocopherol and vitamin C did not require levodopa treatment for two and a half years after those who received no antioxidant therapy did. This study suggests that antioxidant therapy in the form of vitamin C and alpha tocopherol may slow the progress of PD. And in an older study utilizing vitamin C for the treatment of levodopa side effects, 4 grams per day of the vitamin were able to reduce nausea and other levodopa side effects in a patient with PD.5
Vitamin E This vitamin may serve as a potential preventive therapeutic as well in the development of PD. A survey conducted in the late 1980s concerning the dietary habits of Parkinson’s patients before the age of 40 revealed that increased intakes of foods high in vitamin E were associated with lower incidence of PD.3 Because of the widespread evidence that oxidative stress in the substantia nigra plays a role in the pathogenesis of PD, the role of vitamin E in preventing this type of damage was investigated.6 Researchers propose that chronic high-dose vitamin E may serve as beneficial therapy in the prevention and treatment of PD (through protection of the substantia nigra cells from oxidative damage).
B Vitamins B vitamins are particularly important in PD, specifically folate and B-12 in their role in the synthesis of neurotransmitters. Additionally, there is evidence that a standard medication for PD, levodopa, may contribute to deficiency of folic acid and B-12 therefore perpetuating the disease cycle.7 Niacin may become deficient in patients who are treated with levodopa and other PD medications (benserazide and carbidopa, decarboxylase inhibitors).8 Supplementing niacin concomitantly with standard PD treatment may serve to prevent deficiency and may actually assist in maintaining elevated brain levels of levodopa, thereby increasing therapeutic value of the drug by elevating levels of dopamine in the brain.9 Vitamin B-6 may become deficient when patients are treated with a combination of levodopa and carbidopa, and treatment with vitamin B-6 was shown to be beneficial in some patients in two older studies.10 B-6, in addition to thiamine (B-1), was shown to provide symptomatic relief of PD when it was injected intraspinally in one case study.3 Although this is not a standard mode of
supplementation, it demonstrates the efficacy of vitamins as medicine and their effectiveness when used to treat symptoms of this disease. It is also important to point out that B-6, when administered with levodopa, enhances the metabolism of this drug, hastening its conversion to dopamine outside of the brain, which leads to decreased drug efficacy. This does not occur, however, when a person is taking levodopa with carbidopa.

ANTIOXIDANTS

The role of oxidative processes continues to dominate some of the causative research in PD. Increasing evidence implicates the oxidative process and inflammation in impairment of mitochondrial function (the mitochondria is considered the “powerhouse” of the cell).11 Studies reviewing the benefits of nutritional antioxidants have demonstrated a neuroprotective effect from vitamin E and polyphenols (phytochemicals derived from green tea and other plants), which may serve to protect against neurodegenerative diseases such as Parkinson’s.12
Glutathione is a small protein composed of three amino acids: cysteine, glutamic acid, and glycine. Synthesized in the liver and found throughout the body, glutathione is a potent antioxidant.13 It is involved in DNA synthesis and repair, protein synthesis, amino acid transport, immune system function, and prevention of oxidative cellular damage.14 Glutathione is thought to play a major role in protecting cells from oxidative damage and is known to become more depleted in the substantia nigra as PD progresses.15 Because of the degree of glutathione depletion in the substantia nigra is so evident as disease progresses, researchers advocate the supplementation with glutathione be a high therapuetic priority for PD patients.16 The use of glutathione as an adjunctive treatment for PD was shown to provide much benefit when administered intravenously as well.17 As a supplement that is normally synthesized within the cells of the body, replacing it in people with PD may serve to slow the progression of this disease; it is not known exactly what leads to the deficiency of this protein in the cells of people with PD, but replacement may be provide benefit in these patients.
Coenzyme Q10 Coenzyme Q10 (CoQ-10) is a compound found within every cell of the body; it is found in the greatest concentrations in the most metabolically active organs. An essential cofactor of the electron transport chain as well as an important antioxidant, nearly 30 percent of the body’s CoQ-10 is found in the nucleus, and nearly 50 percent is found within the mitochondria. CoQ-10 is soluble in fat and acts as an antioxidant and membrane stabilizer in the cells, and perhaps the most important function of CoQ-10 is its role in the generation of adenosine triphosphate (ATP) in oxidative respiration.18 CoQ-10 is a vital part of cellular energy production and because of this it has several therapuetic uses.

Regarding its role in PD, research has found that CoQ-10 may play an important part in disease modification. Some of the main features of PD are associated with CoQ-10 deficiency, and a study that supplemented subjects with 360 milligrams of CoQ-10 for four weeks found that it was able to provide significant mild symptom improvement of PD symptoms including visual function, which itself is a PD symptom.19 In a multicenter trial investigating the use of CoQ-10 and its effect on slowing the progression of PD, CoQ-10 was supplied in doses of 300, 600, or 1,200 milligrams per day in 80 subjects with early PD who were not undergoing any other treatment.20 The study subjects were followed for a period of 16 months and were evaluated using the Unified Parkinson Disease Rating Scale (UPDRS) at follow-up visits occurring at the first-, fourth-, eighth-, twelfth-, and sixteenth-month visits. Researchers concluded that based on their findings, CoQ-10 was safe and well tolerated by the patients at all doses, and less development of disability was noted in the CoQ-10 supplemented group than the placebo group; the most benefit occurred in the 1,200 milligram per day dose group. From these studies, the effectiveness of CoQ-10 in treating the symptoms and in slowing progressive deterioration in PD is quite apparent.

PROTEIN

The evidence surrounding specific dietary changes in PD is compelling, focusing on macronutrients such as protein. An effect that is associated with patients taking levodopa for symptom management, a high-protein diet is known to interfere with the availability of levodopa in the brain and can lead to recurrent loss of symptom control, known as the “off-on” phoenmenon.21 Subsequent studies were performed to determine the effects of low- versus high-protein intakes in PD patients. A low intake of 0.5 grams protein per kilogram per day appeared to improve symptom control during the course of the day in comparison to a high-protein diet of 10 grams per kilogram body weight per day, which actually increased the symptom periodicity.22 Another study that evenly divided low-protein (0.8 g/kg) intake throughout the day revealed that the amount and distribution of dietary protein could affect response to levodopa treatment; it is thought that levodopa is affected by protein not by absorption but through a variation in plasma amino acids.23
Other interesting studies of dietary protein and PD include one in which a low-protein diet of 50 gram per day for men and 40 grams per day for women was compared to a high-protein diet of 80 grams per day for men and 70 grams per day for women.24 The patients on the low-protein diet experienced greater performance, decreased tremor, and better hand agility and movement capabilities in comparison to the high-protein group. Researchers in this study suggest that protein may affect levodopa efficacy in the brain, rather than in the blood stream. The results of these studies suggest an important role for the modification of diet, especially in regard to protein intake. By simply altering protein levels, patients may experience fewer symptoms that may even allow them to use less of their medications at times.
Amino Acids in Parkinson’s Disease
Amino acids are the individual building blocks of proteins. Proteins are widely used throughout the body; to say they are essential to proper function is an understatement, as proteins (and their constituent amino acids) are used in nearly every metabolic reaction in the body and are incorporated into nearly every structure from bone to cellular membranes. More specifically, neurotransmitters are composed of the very amino acids that may be prohibited from absorption by the pharmaceutical drug levodopa.
L-tyrosine L-tyrosine is a precursor of dopamine and may be insufficiently utilized in PD patients due to altered biopterin levels (biopterin serves as a cofactor in tyrosine hydroxylase) in their blood.25 Tyrosine was compared to levodopa for its effects on symptom management in a group of PD patients.26 During the course of treatment (for three years), patients taking L-tyrosine experienced better clinical results with fewer side effects than those patients taking levodopa or other dopamine agonist drugs.
D-phenylalanine A single study of this amino acid revealed that use of the D form (amino acids appear in two main forms known as L and D, which refers to their structural arrangement) improved symptoms of rigidity, speech, walking, and depression, but did not relieve tremor symptoms.27 However, some evidence suggests that amino acids such as phenylalanine may aggravate the “on-off” effect in patients taking levodopa.
L-tryptophan L-tryptophan is useful in PD for two reasons. First, it is found in lower levels in PD patients who are treated with levodopa (L-tryptophan and levodopa compete with each other for absorption);28 second, it is useful in the treatment of PD-associated depression.29 In one study, the use of L-tryptophan in PD patients improved factors such as mood and motivational drive in comparison to a placebo, and it improved functional ability more so than when compared to levodopa.30
All three of these amino acids may be prevented from being completely absorbed by levodopa, leading to insufficient supply in the body. From the cited studies, it appears to be important that these amino acids are supplied to the PD patient due their positive effects on symptoms and mood.

OTHER FACTORS: GINKGO AND MAGNESIUM

In addition to the earlier suggestions, the addition of other substances such as magnesium and ginkgo may possibly serve to further enhance the bioavailablity and absorption in the brain when using these addiotnal substances. Both ginkgo and magnesium are known to dilate blood vessels in the body, under different mechanisms. Ginkgo works specifically on the vasculature of the brain to dilate the vessels and is well documented in the literature to provide increased blood flow to the brain, increasing oxygenation.31 Additionally, when combined with phosphatidylcholine, a phospholipid molecule, ginkgo is more readily absorbed into the tissues. This allows even greater efficacy for this herb to work on the brain. Magnesium works as a smooth muscle relaxant (calcium channel blocker) and can dilate blood vessels because of this. Some evidence exists that magnesium dilates blood vessels in the central nervous system (CNS) to reduce ischemia.32 Because of the actions of ginkgo and magnesium, we theorize that by increasing oxygenation and blood flow to the brain, this organ will be better conditioned to avoid continued degenerative changes. Blood flow to areas of injury is vital, as evidenced by an uncontrolled diabetic, who may begin to lose toes due to insufficient vascular nutrition when blood flow is compromised. Therefore, people with PD may benefit from ginkgo and magnesium as added cerebral blood flow enhancing agents.

CONCLUSION

Parkinson’s disease is a terribly debilitating illness with no real standard treatment other than symptom management. Characterized by degeneration of specialized dopamine-producing neurons in the substantia nigra, there are many theorized causes of this destruction. Foremost among them is an acceleration of or a susceptibility to oxidative damage in this area; supplementation with common vitamins supports the production of neurotransmitters and acts as antioxidants. Providing the PD patient with extra antioxidants, regardless of form, can serve to benefit them in hopes of delaying or preventing the cumulative neuro-degenerative damage from oxidative stress. Nutritional supplements that are normally produced in the body can provide additional support for symptoms of PD and act as buffers against disease progression. Regulation of dietary protein is a relatively simple step to be taken that can attenuate the symptoms of PD, especially in those being treated with levodopa. Finally, a few key amino acids, when provided in supplemental form, can help to offset symptoms that may be induced by standard pharmaceutical treatment of PD.
PD, as a condition, reflects the vulnerability of the central nervous system, which is often compared to a mainframe computer that is amazingly able to juggle countless functions and tasks with ease. Indeed, just as the rest of our bodies are not impervious to assaults from the environment, our brains likewise can become susceptible. Addressing the issue of susceptibility at the earliest sign of symptoms
or potential symptoms is essential. The adage “an ounce of prevention is worth a pound of cure” is important. Likewise, it is important to realize that the best offense is a good defense and that upon fueling the body optimally, one is most able to succeed in the ultimate of target goals: maintaining function and alleviating symptoms within the confines of current knowledge. Indeed, the incorporation of natural medicine interventions are a must when it comes to this health issue.

NUTRIENTS

• Vitamin C 1,000–2,000 milligrams per day

• Vitamin E 400–800 International Units per day

• B vitamins A B-complex vitamin should be taken to avoid pharmaceutical-induced deficiency of B-12, folate, and B-6

• Glutathione 250 milligrams per day

• Coenzyme Q10 1,200 milligrams daily in 4 divided doses

• L-tyrosine* 1,500 milligrams per day, divided doses

• D-phenylalanine* 500 milligrams per day

• L-tryptophan* 500 milligrams per day or 50 milligrams 5-HTP 2 times per day

• Dietary Protein Limit to 0.5–1.0 grams per kilogram body weight if taking levodopa

• Magnesium 300–400 milligrams per day, divided doses

*All amino acids should be taken 30 minutes away from protein meals. Consult your doctor prior to taking these amino acids.

BOTANICALS

Ginkgo biloba 120–240 milligrams per day, divided doses

Schizophrenia

A chronic, severe, and disabling disease of the brain, schizophrenia is marked by symptoms such as hearing internal voices and believing that others may be reading their minds, controlling their thoughts, or plotting against them. Terrifying to the person experiencing them, these symptoms often cause people with schizophrenia to be fearful and withdrawn, and their speech and behavior often appear disorganized and incomprehensible. Often, the first signs of schizophrenia appear as troubling changes in behavior, and coping with these changes is incredibly difficult for people who know the patient. The change in behavior, when people cannot tell the difference between reality and illusion, is known as psychosis, or a psychotic episode. In order for a person to have a diagnosis of schizophrenia, the person must experience two or more of the following symptoms for at least one month’s duration:
• Delusions: These are bizarre, false beliefs that may include paranoid thoughts (someone is “out to get them”) or grandiose thoughts (believing they are a president, etc.).
• Hallucinations: These are unreal perceptions of the environment, which may affect auditory (hearing voices), visual (seeing faces or lights), olfactory (smelling), and tactile (touch, as if something is crawling on or touching them) senses.
• Disorganized thinking/speech: Abnormal thoughts are usually measured by disorganized speech, which can be disjointed, or very little speech.
• Negative symptoms: The other symptoms note the presence of abnormal behavior, whereas negative symptoms include flat affect (no emotion or expression, low energy), social withdrawal, and even poor hygiene and grooming
• Catatonia: This is characterized by “waxy flexibility.” People may become fixed in a certain position for extended periods of time, and if moved by another person, they will continue to stay fixed in that position.
A display of any of these systems indicates an active phase of schizophrenia; however, schizophrenics oftentimes will have milder symptoms both before and after the active phase. There are three basic types of schizophrenia, including
1. Disorganized schizophrenia, which is marked by lack of emotion and disorganized speech.
2. Catatonic schizophrenia, which is marked by waxy flexibility and rigid posture, but sometimes excessive movement.
3. Paranoid schizophrenia, which is marked by strong delusions or hallucinations.
Some people may only have one psychotic episode, whereas others may have many of them throughout their lives and may be able to function relatively well in between episodes. A person with more chronic schizophrenia may never fully recover from episodes and requires continuous treatment to control symptoms. Most people with schizophrenia will have symptoms throughout their lives; only one in five people with schizophrenia will recover completely. (It is notable that many statistics shared regarding recovery from any given health condition is based on conventional treatments only and does not reflect the appropriate addition of natural medicine supportive therapies targeted at supporting healthy function.) A complete diagnostic evaluation is available in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV).
Schizophrenia is one of the most common mental illnesses; one estimate figures that about 1 of every 100 people is affected by schizophrenia, which equates to 1 percent of the population.1 It is estimated that over 2 million Americans suffer from this illness in a given year. Found throughout the world, schizophrenia affects men and women equally. Schizophrenia seems to appear earlier in men than women (men usually develop signs in their early 20s whereas women develop signs in their late 20s to early 30s). It is estimated that the cost of schizophrenia to society approaches $32.5 billion dollars per year in the United States alone.1

CAUSES OF SCHIZOPHRENIA

There are several contributing factors to schizophrenia, ranging from brain anatomy to genetics to nutrition.
 Anatomy
Recent research has placed an emphasis on brain structures as part of the puzzle in finding the cause of this disease. The brains of schizophrenics commonly have larger lateral ventricles (part of series of spaces within the brain that contain cerebrospinal fluid). The exact significance of this is not fully understood at this time, but provides an interesting link between brain structure and proper function. Additionally, other brain structures have been noted to be of abnormal size as well. A reduced size of the hippocampus, increased size of the basal ganglia, and abnormalities in the shape of the prefrontal cortex have been somewhat consistently noted in people with schizophrenia (however, these changes have been seen in people without schizophrenia as well).
Genetics Schizophrenia is known to be more common in families who have one or more members with the disease, indicating a genetic component to the passing of this disease from one generation to another. Utilizing studies of twins, researchers have shown that the tendency for both identical twins to develop schizophrenia is around 30 percent to 50 percent, and the tendency for fraternal twins (they share only one half the same genes as the other twin, whereas identical twins have the exact same genetic makeup) is approximately 15 percent. This is the same percentage for nontwins as well.
Environment Other factors that may contribute to the development of schizophrenia include family stress, poor social skills and interactions, infections at an early age, or mental emotional trauma early in life.
Neurotransmitters One popular theory of schizophrenia focuses on the possibility that an over-active dopamine neurotransmitter system may be part of the cause. Strong evidence in the literature supports this theory; yet at the same time, there is other evidence that does not provide strong support for this theory and serves to refute it.
There are many factors that contribute to the development of this disease. Intensely studied, science continues to uncover interesting factors that relate to the causes of this disease, many of which focus on the role of nutrition as a causative and curative factor for schizophrenia. Schizophrenia causes a high degree of disability in those affected by it, and current medications are not greatly effective at controlling its symptoms and do not endorse a curative effect by treating the underlying cause. When used continuously, patients are often troubled
by the side effects of the medication and symptoms that are refractory to treatment by medication.

NUTRITION

Folic Acid Several nutrients have been studied in relation to their effects in schizophrenia. Folic acid continues to be implicated in many of the diseases covered in this book, and schizophrenia is not an exception. Specifically, folate deficiency has been attributed to symptoms of several neuropsychiatric diseases, including schizophrenia symptoms. For example, folic acid deficiency has been shown to be high in patients with schizophrenia, and psychiatric symptoms are known to occur with greater frequency and severity in those patients with a deficiency of this vitamin.2 Additionally, other researchers have indicated that schizophrenic-like symptoms are a secondary effect of folate deficiency.3 Deficiency of folate is known to exacerbate symptoms associated with declining cognitive function as well, demonstrating the integral role of this vitamin in maintaining healthy neurologic status.4 In a study of 123 patients with psychiatric disorders, including schizophrenia, it was found that 33 percent of these patients were either borderline or clearly deficient in red blood cell levels of folate.5 These patients were supplemented with 15 milligrams of methylfolate per day for six months in addition to their normally prescribed medications. At the end of the trial, the patients receiving the methylfolate treatment experienced a significant improvement in clinical and social outcomes, and these improved over time. In one particular case of folate-responsive schizophrenic-like symptoms, a mildly retarded adolescent girl was, after considerable testing of blood amino acids and their enzymes (defect in N5-10-methylenetetrahydrofolate reductase, also known as methylene reductase), determined to have an inability to properly metabo-lize folic acid. This was speculated to be the cause of the schizophrenic symptoms, which was treated by dosing the patient with folate.6 Following up on this study, another group of investigators examined whether abnormally low levels of the aforementioned enzyme might contribute to schizophrenia pathology.7 They did not find a statisically significant difference in the activity of the enzyme between healthy, nonschizophrenics and schizophrenic patients. The investigators did, however, proclaim that their findings did not rule out that abnormal methylene reducatase activity might be present in an as yet undiscovered subgroup of schizophrenic patients. All of these studies point to the importance of folate in schizophrenia and symptom control. The importance of methylation reactions and folate, which serves as a cofactor in these reactions, is highlighted in these studies. A low-cost and low-risk therapy, supplementation of schizophrenic patients with folate may assist in providing a therapeutic Pyridoxine
Pyridoxine, or vitamin B-6, plays an important role in the synthesis of neurotransmitters that are involved in the development of psychotic states. There are many reports of supplemental B-6 alleviating psychotic symptoms in schizophrenia and other mental disorders.8 A study that utilized supplemental B-6 in the treatment of schizophrenic patients with comorbid minor depression produced positive results.9 Patients were supplemented with 150 milligrams per day, in addition to their standard medications, for four weeks. A small percentage (22 percent) of the patients experienced significant improvement in depressive symptoms as well as schizophrenic symptom scores, indicating that a portion of schizophrenics with depression may benefit from supplemental pyridoxine.
Vitamin B-6 was used to ameliorate symptoms in a schizophrenic patient with drug-induced Parkinsonism (this occurs as a side effect of some schizophrenic medications) using 100 milligrams per day. This treatment resulted in a dramatic and persistent decrease in the Parkinson’s-like symptoms as well as a reduction in psychotic behavior.10 The investigators in the trial attribute the effectiveness of B-6 in this case to several reasons. Pyridoxine deficiency is associated with decreased brain serotonin concentrations as well as melatonin production in animal studies, suggesting that the movement disorders and psychosis symptoms may have been ameliorated simply by enhancing the functions of those two neurotransmitters; an effect of pyridoxine on GABA and dopamine activities was suggested as well. Deficiency of pyridoxine in schizophrenic patients may contribute to additionally psychotic behavior and seems to increase the risk of drug-induced movement disorders in some schizophrenics. Another inexpensive and simple treatment, B-6 supplementation should not be overlooked in the treatment of schizophrenics.
Vitamin C Low levels of vitamin C, or ascorbic acid, has been implicate in schizophrenia. This common vitamin has multiple indications for health and is probably the most researched vitamin throughout the literature. Interestingly, it may play a role in schizophrenia as well. In a study designed to determine the utilization of vitamin C in hospitalized schizophrenics, it was revealed that schizophrenic patients might require higher levels of vitamin C than the suggested optimal intake required for healthy people in comparison to other patients; this was determined after analyzing intake, plasma, and urinary excretion levels of both schizophrenic and nonschizophrenic patients.11 Another study investigating similar vitamin C parameters in a different group of schizophrenics revealed similar results, suggesting impairment in the metabolism of vitamin C in people with schizophrenia.12 These studies, performed on different groups of patients with schizophrenia, provide interesting insight into the role of vitamin C in this disease; if these patients do not metabolize vitamin C as well as nonschizophrenics,
this must be taken into account when considering nutritional treatments and supplementation therapies. Applying this to patients, one case study involved a 37-year-old schizophrenic who benefited substantially from the addition of supplemental vitamin C to his standard medical treatment, demonstrating the possible usefulness of this vitamin when applied to schizoprhenia.13
Niacin Niacin, and its other form, niacinamide (Both are forms of vitamin B-3) is one of the longest-used vitamins in the treatment of schizophrenia, having been employed since the 1940s to treat psychiatric conditions. In a large clinical trial, over 1,000 schizophrenics were treated with either niacin or niacinamide at doses of 1.5 to 6 grams per day for a duration of three months to five years.14 The treating physician in these cases proclaimed that this treatment was most effective in patients with early and acute schizophrenia and not effective in those with a chronic condition.
In another study, niacinamide was found to produce antianxiety effects equivalent to benzodiazepine medications; niacin is thought to stimulate, without binding to, the same neurotransmitter receptor sites (GABA) as benzodiazapenes.15 Other research regarding treatment with niacin and niacinamide is both positive and negative; more investigations into its use are needed to fully elucidate its utility in schizophrenia.
Fatty Acids Fatty acids, which occupy many central physiologic functions throughout the body, play several important roles, especially in the area of cellular membrane function. A highly interactive portion of the cell, the cellular membrane is the final factor that determines what enters and leaves the cell, and newer research is uncovering the role of the cellular membrane in regulation of other bodily functions (i.e., cellular signaling). Much evidence is indicative of the role of disordered membrane phospholipid metabolism in schizophrenia. A new theory of schizophrenia is that it is a disorder of membrane phospholipid metabolism that is associated with an increased loss of polyunsaturated fatty acids from the cellular membrane, through enhanced activity of phospholipase A2.16 Membrane changes that result from this process occur throughout the body, leading to physical abnormalities; these membrane abnormalities may stand to have highly adverse effects on the brain, where sequential coordination of millions of neurons are dependent on cohesive functioning on the cellular membrane.
Additional evidence of the fatty acid link to schizophrenia includes the theory of abnormal brain turnover of phospholipids detected by magnetic resonance imaging and reduced cellular membrane levels of omega 3 and 6 polyunsaturated fatty acids. Additionally, four out of five trials using eicosapentaenoic acid (EPA) in the treatment of schizophrenia provided positive results.17 Increased phospholipid breakdown and decreased levels of polyunsaturated fatty acids (PUFAs), especially arachidonic acid (AA), have been demonstrated throughout the literature in other studies.18 Research is currently delving into the various physio-logic functions of membrane phospholipids and PUFAs and their role in schizophrenia. Most of this research hints at altered cellular signaling and how it relates to neurobiological manifestations of schizophrenia and therapeutics. Supplementation of schizophrenic patients with a mixture of PUFAs (EPA/DHA at 180:120 milligrams) and antioxidant vitamins (vitamin E/C, 400 IU: 500 milligrams) twice daily for four months produced significant reductions in psychopathology based on the outcome scores of several psychiatric rating scales.19 Interestingly, PUFA levels returned to pretreatment levels four months after the conclusion of the study, yet the previously experienced clinical improvements remained in effect for the study subjects. In a comprehensive review of the scientific databases containing descriptions of clinical trials utilizing PUFAs to treat symptoms of schizophrenia, it was determined that the use of PUFAs produced favorable results in the subjects, with little or no side effects.20 Many studies performed using this treatment were carried out for relatively short periods of time in which to expect physiologic changes to occur. It is estimated that every cell in the human body is replaced within 120 days; if there is merit to this theory, it makes sense to determine the results of fatty acid supplementation and its effects on membrane phospholipid content after enough of a time period to allow for complete replacement with these fatty acids. Given the already positive results of these studies, it stands to reason that a longer study period may affect better outcomes using PUFAs for symptom management.

CONCLUSION

Schizophrenia, like other disease involving the brain, has numerous contributing factors, none of which has been shown to be 100 percent causative. In all reality, this will continue be the case, but examining potential therapies provides medicine with additional therapies that work to avert symptoms, without further contributing to side effects. From the brief studies included in this chapter, it has been shown that supplementation with even solitary vitamins can attenuate symptoms, and, in some cases, can quite drastically avert them. The role of fatty acids in schizophrenia adds more fuel to the importance of a proper diet containing these essential fats. PUFAs continue to appear throughout the literature as an important preventive therapeutic for a number of diseases; schizophrenia is yet another. The importance of proper cell membrane function continues to appear in the research as a prevention for many of these diseases, and alteration of the cell membrane fatty acid content is relatively easily achieved utilizing dietary modifications and supplementation.
Clinically notable benefits have been seen among individuals suffering from schizophrenia when adjunctive natural medicines therapies have been used. The mentioned nutrient-based interventions are by no means the only therapies
that assist a patient to reestablish improved quality of cognitive processes. Indeed, the support of proper biochemical pathways regardless of the ultimate diagnosed condition, whether it is psychological or physical, creates a foundation for improved health outcomes. Added benefits include support of neurological and overall body tissues that endure significant stress from schizophrenia.

NUTRIENTS

• Folic Acid* 10–15 milligrams per day

• Pyridoxine 100–150 milligrams per day

• Vitamin C 1,000–2,000 milligrams per day, divided doses

• Niacin** 3–5 grams per day, divided doses

• Essential Fatty Acids Eicosapentaenoic Acid/Docosahexaenoic Acid (EPA/DHA) at 150 milligrams, two to three times daily *Folic acid should not be supplemented without concurrent B-12 to prevent masking adverse neurological pathology.
**Under close medical supervision due to niacin flushing and potential liver toxicity.